Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),0.7573917802584157,2.106790274685912,0.0,0.007712215437494793,0.007,12/30,6.20%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,ligand-gated channel activity (GO:0022834),0.7603424072845001,2.0980957400411837,0.0,0.005784161578121094,0.011,12/29,6.20%,GRIA3;CHRNB4;GRID2;GRIN2B;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,retinoid binding (GO:0005501),-0.6622659134800185,-1.9504942354484613,0.0,0.1032712758421076,0.09,7/22,6.77%,PTGDS;ALDH1A2;CYP26B1;RBP1;RBP4;RXRA;CRABP2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.7835947833507252,1.9059319445094114,0.0016474464579901153,0.15520833567958267,0.337,9/17,6.20%,GRIA3;GRIN2B;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6545336968902462,-1.8517521591670936,0.007177033492822967,0.20547789935594607,0.281,7/17,8.53%,PITPNC1;ATP10A;PITPNM2;PLTP;PITPNA;ABCA3;ATP8B1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6666315303095898,1.8292136302009865,0.00778816199376947,0.3055965367107311,0.649,10/28,10.51%,CHRNB4;GRID2;GRID1;GABRA1;GRIK5;GRIK2;GRIK4;GRIK1;GABRG3;GABRG2
prerank,cGMP binding (GO:0030553),-0.7352266222115527,-1.8224874437672174,0.002257336343115124,0.19838021716748505,0.385,3/11,8.57%,PDE5A;RAPGEF2;PDE11A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.7345112125965529,1.803806259730875,0.011986301369863013,0.3258411022341549,0.742,2/15,0.34%,SLC1A3;SLC1A5
prerank,amino acid:sodium symporter activity (GO:0005283),0.8060641740632265,1.7793444108541847,0.012152777777777778,0.34817439277190027,0.817,2/11,1.38%,SLC1A3;SLC6A13
prerank,transmitter-gated ion channel activity (GO:0022824),0.6478693974750706,1.7790166057786545,0.007874015748031496,0.29995009326542243,0.817,13/29,13.82%,GRID2;GRID1;GABRA1;GRIK5;GRIK2;GRIA4;GRIK4;GRIK1;GABRG3;GLRA3;GABRG2;GLRA2;GABRB1
prerank,ligand-gated calcium channel activity (GO:0099604),0.6973366165883537,1.7689622443721273,0.009868421052631578,0.29125663613163927,0.85,10/19,18.00%,TRPA1;ITPR1;GRIN2B;RYR2;GRIN2A;P2RX4;TRPM2;RYR3;MCOLN1;RASA3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5968225661476885,-1.7683582602941204,0.0055248618784530384,0.2847944978119978,0.621,7/23,15.34%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,signal sequence binding (GO:0005048),0.608138328406989,1.751931045658339,0.004672897196261682,0.3034542546447604,0.885,6/35,5.92%,CEMIP;KDELR3;KDELR2;NUP214;KCNIP2;POM121
prerank,LRR domain binding (GO:0030275),-0.6605691557704699,-1.745136282836236,0.012468827930174564,0.28958543328920894,0.705,3/14,1.33%,PAWR;ERC1;ROBO1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6961317050828592,1.738529528411246,0.008361204013377926,0.3115735036747896,0.914,9/19,10.51%,GRID2;GRID1;GABRA1;GRIK5;GRIK2;GRIK4;GRIK1;GABRG3;GABRG2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.6815749757964394,1.7359105077280061,0.008210180623973728,0.2911361327654284,0.92,13/21,14.01%,POLG;POLK;POLQ;POLA1;POLL;POLE4;REV3L;POLH;POLN;POLB;POLE3;REV1;POLI
prerank,insulin-like growth factor I binding (GO:0031994),-0.67693881497723,-1.724019606559385,0.010075566750629723,0.2950861369852662,0.761,9/13,11.86%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3
prerank,glutamate receptor activity (GO:0008066),0.6972118465049021,1.7035935775166369,0.012987012987012988,0.35805566880119044,0.97,12/19,18.14%,GRID2;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIK1;GRM5;GRM7;GRM1;GRIA2
prerank,CXCR chemokine receptor binding (GO:0045236),0.7516382728889845,1.7000192575766604,0.013592233009708738,0.34074644168546697,0.973,2/11,1.71%,CXCL10;CXCL1
prerank,glycine binding (GO:0016594),0.7472728797610578,1.6995189100897083,0.01651376146788991,0.31723371893337954,0.973,7/11,17.61%,GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRIN3A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6819178326706177,-1.693459488633459,0.0024691358024691358,0.33947199952810636,0.85,8/12,25.64%,KDM4A;KDM4C;PHF8;HR;KDM4B;KDM3B;PHF2;KDM1A
prerank,phospholipid transfer activity (GO:0120014),-0.5803635523344999,-1.6870934202217196,0.010443864229765013,0.3150040076266349,0.868,9/21,15.24%,PITPNC1;PITPNM2;CERT1;PLTP;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1
prerank,tropomyosin binding (GO:0005523),-0.6192594866572829,-1.6814653708343452,0.009779951100244499,0.29538187374311875,0.879,3/16,1.10%,NEBL;TMOD3;CALD1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7116962616262269,1.6792950778293763,0.023769100169779286,0.3528338562653867,0.989,3/14,2.38%,ADH1A;RDH10;RDH11
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.75051494462159,1.6744358613796566,0.019891500904159132,0.34536264756031365,0.99,7/11,18.00%,TRPA1;ITPR1;RYR2;TRPM2;RYR3;MCOLN1;RASA3
prerank,cadherin binding (GO:0045296),-0.3541006668472483,-1.6733565921898428,0.0,0.28809492002963216,0.896,107/315,18.20%,PHLDB2;PKP4;PTPRB;TJP1;TMOD3;PICALM;BAIAP2L1;ERC1;CALD1;PDLIM5;VCL;PTPRJ;FNBP1L;BSG;EGFR;AFDN;WASF2;ITGB1;NOTCH3;EZR;CDH1;PACSIN2;AHNAK;F11R;PROM1;ITGA6;BMPR2;CSNK1D;RDX;IQGAP1;FXYD5;KDR;EIF5;COBLL1;PLEC;NDRG1;ANLN;CDH8;HSPA8;MRTFB;S100A11;RPS2;ANXA1;APC;CTNND1;CHMP2B;GIPC1;TRIM25;CAPZB;YWHAB;NCK1;TJP2;EPN2;VAPA;LDHA;SLC3A2;CLINT1;ACVR1;RANGAP1;ZC3HAV1;EEF1G;EHD4;EPS8L2;CLIC1;PPFIBP1;VAPB;ARHGAP18;IST1;NIBAN2;TAGLN2;PTPN1;UBFD1;RPL34;PPL;GAPVD1;UBAP2;CD2AP;USO1;BAG3;PRDX1;PKM;RPL29;LIMA1;ENO1;FLNA;RAN;MACF1;PLIN3;EEF1D;BAIAP2;TES;CDH5;PSMB6;CTNNA1;RAB1A;PAK2;PKN2;EIF3E;RPL23A;EIF4H;EPHA2;CHMP4B;HNRNPK;ALDOA;DLG1;CDH4;SERBP1
prerank,chemokine activity (GO:0008009),0.5839288919224805,1.6712471443694619,0.006535947712418301,0.33491429686650176,0.992,5/31,10.56%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.6366745616612931,1.669064841257659,0.012944983818770227,0.321877880412109,0.992,4/21,2.74%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,DNA polymerase activity (GO:0034061),0.6498307405807668,1.664292635376005,0.013071895424836602,0.3181288867966602,0.993,13/22,14.01%,POLG;POLK;POLQ;POLA1;POLL;POLE4;REV3L;POLH;POLN;POLB;POLE3;REV1;POLI
prerank,protein phosphatase 1 binding (GO:0008157),-0.5623778494615665,-1.6630731224750859,0.01990049751243781,0.28542361055142956,0.92,10/21,17.80%,SHOC2;PPP1R16A;AKAP11;PPP1R3B;SH3RF2;PPP1R16B;PHACTR4;KCNQ1;PPP1R3C;PPP1R11
prerank,anion transmembrane transporter activity (GO:0008509),-0.6433749622218512,-1.6617200574382238,0.029082774049217,0.2643886615201724,0.924,4/12,5.79%,ABCG2;SLC22A6;SLC26A11;SLC39A8
prerank,hyaluronic acid binding (GO:0005540),0.7656878496388323,1.6464242050254283,0.01607142857142857,0.35133961452437207,0.996,1/10,0.02%,CEMIP
prerank,sodium channel activity (GO:0005272),0.5610320805310083,1.637388929292803,0.015015015015015015,0.35926070246329905,0.996,13/37,13.61%,ASIC2;GRIK5;GRIK2;GRIK4;CACNA1G;GRIK1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,calcium-release channel activity (GO:0015278),0.6610300549095964,1.6334335292471862,0.023064250411861616,0.353666424977389,0.996,9/17,18.00%,TRPA1;MCOLN2;ITPR1;TPCN1;RYR2;TRPM2;RYR3;MCOLN1;RASA3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6118654134199782,1.6307411549150281,0.02388535031847134,0.3461694961862472,0.997,4/23,2.74%,PDE1C;PDE9A;PDE7B;PDE4B
prerank,exonuclease activity (GO:0004527),0.5457580603525908,1.616542968702324,0.01544943820224719,0.3733997640987062,0.997,18/46,19.04%,ENPP1;POLG;FAN1;FEN1;PDE12;ENPP3;REV3L;EXOSC9;ISG20L2;EXOSC10;CNOT7;EXOSC8;EXOSC5;APEX2;DXO;WRN;REXO4;TRIR
prerank,platelet-derived growth factor binding (GO:0048407),0.7183080340216235,1.6111098441121177,0.03225806451612903,0.37350259363787275,0.997,3/11,6.76%,PDGFRA;COL4A1;COL1A2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6749668901952599,1.6094001962257045,0.03754266211604096,0.3635864643272785,0.997,3/14,8.61%,SLC1A3;SLC7A11;SLC25A22
prerank,phosphatidylinositol binding (GO:0035091),-0.39053834171213847,-1.6047269100008772,0.0,0.38843430715235244,0.982,35/91,23.50%,PITPNC1;PICALM;SNX24;PITPNM2;EEA1;MTM1;MCF2L;HIP1R;PARD3;ITPR2;MITD1;WDFY3;SCARB1;PITPNA;MAPT;TNFAIP8L3;PIGU;MYO1E;CCDC88A;GPAA1;SNX17;ESYT3;HIP1;DENND1A;PLEKHF2;BCAS3;DENND1B;NUMA1;EXOC8;FES;WDR45;PIGK;PASK;PITPNM1;EPB41
prerank,sterol binding (GO:0032934),0.5182660018801633,1.6034844372760877,0.0196078431372549,0.36697291790079384,0.998,6/56,3.45%,APOD;RORA;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,potassium channel activity (GO:0005267),0.4773694762194829,1.5950458382977013,0.010217113665389528,0.3764525160427145,0.999,21/89,12.40%,KCNK2;KCNS2;KCNT2;GRIK5;GRIK2;KCNQ3;KCNMA1;GRIK4;GRIK1;KCNG1;KCNH4;TMEM38B;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNK1;KCNN2;KCNH7
prerank,sialyltransferase activity (GO:0008373),-0.5592961656903052,-1.594938908185953,0.009876543209876543,0.3886741464131163,0.985,11/20,15.78%,ST3GAL6;ST6GAL1;ST8SIA4;ST3GAL4;ST3GAL1;ST6GALNAC2;ST6GALNAC3;ST3GAL3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4998667472731798,1.5943400356054556,0.015558698727015558,0.36513351019587414,0.999,11/60,4.82%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;EPHA6
prerank,PDZ domain binding (GO:0030165),-0.41434575047106065,-1.5929661479881527,0.007246376811594203,0.36829872875924147,0.987,24/61,19.15%,CRIM1;RAPGEF2;ERC1;DOCK4;CXADR;F11R;SLC22A4;USHBP1;ATP2B1;FZD4;FZD7;ATP2B2;SNTG2;CXXC4;CRIPT;MAP2K2;PLEKHA2;FZD3;CCDC88C;KIDINS220;LLGL2;FZD8;SLC26A6;TGFBR3
prerank,ligand-gated cation channel activity (GO:0099094),0.48900463089875557,1.5919157099342252,0.00945945945945946,0.35935710515626773,0.999,22/75,18.56%,GRIA3;CHRNB4;GRIN2B;ASIC2;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;GRIK1;ASIC1;P2RX4;TRPM2;KCNK1;KCNN2;KCNJ8;KCNJ10;MCOLN1;GRIN3A;GRIA2;KCNJ3
prerank,outward rectifier potassium channel activity (GO:0015271),0.7106451310698555,1.5861593724691727,0.0423728813559322,0.36275400434829336,0.999,4/11,10.52%,KCNK2;KCNT2;KCNIP2;KCND2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.5952804040374347,-1.580996218966467,0.025,0.38028050350363723,0.991,4/15,6.66%,PICALM;EEA1;WDFY3;SCARB1
prerank,transcription coactivator binding (GO:0001223),0.6173544117052584,1.5778872343937234,0.03099510603588907,0.3726867858486253,1.0,4/20,4.13%,RORA;PGR;PPARD;TEAD2
prerank,hexosaminidase activity (GO:0015929),0.6862895692613653,1.5663483544443917,0.04044117647058824,0.3916870628254931,1.0,2/12,5.09%,CEMIP;CEMIP2
prerank,chemokine receptor binding (GO:0042379),0.5410456772367501,1.5660244762992346,0.025806451612903226,0.38087569842598357,1.0,5/35,10.56%,XCL1;CXCL10;CXCL1;CCL15;CCL25
prerank,Wnt-activated receptor activity (GO:0042813),0.6390872494877862,1.5567450760443475,0.06108202443280977,0.39428701424192125,1.0,1/15,0.05%,ROR1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4986756589792026,-1.5406616790933583,0.022408963585434174,0.4894895645736283,0.999,8/27,7.96%,XPR1;SLC26A7;SLC26A2;ANO1;SLC22A6;SLC26A11;SLC39A8;SLC22A8
prerank,actinin binding (GO:0042805),-0.5169065919140176,-1.5302424415865006,0.04314720812182741,0.5023384568883276,0.999,6/21,12.19%,CACNA1C;PDLIM5;NFKB1;PROM1;DAG1;CSRP2
prerank,leucine zipper domain binding (GO:0043522),-0.6397004736464117,-1.5272006641321576,0.04805491990846682,0.4858176676891335,0.999,2/10,0.80%,PAWR;ERC1
prerank,phosphatidic acid binding (GO:0070300),-0.5173374731421799,-1.5088118053134738,0.035897435897435895,0.523808945508422,1.0,7/19,5.29%,PITPNC1;RAPGEF2;MARK1;RAPGEF6;PACSIN2;SMPD3;PLTP
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.47228528813630277,-1.5066387196366546,0.05337078651685393,0.5074842764749617,1.0,11/25,24.25%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;PARP4;SIRT1;SIRT5;PARP1;PARP2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.46872163955410867,1.5055324529050387,0.03905160390516039,0.5469513899681636,1.0,11/60,4.82%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;EPHA6
prerank,solute:proton symporter activity (GO:0015295),0.6060762333043064,1.5025645889890265,0.06292517006802721,0.5424345040310948,1.0,2/16,0.39%,SLC15A1;SLC2A13
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.627130509124755,-1.5017218885929906,0.06345733041575492,0.5006769540123924,1.0,3/10,4.03%,SLCO2A1;SLCO1C1;SLC22A6
prerank,rRNA binding (GO:0019843),-0.42458862674748016,-1.4912211939784221,0.026239067055393587,0.5129772652990751,1.0,22/42,31.19%,CAVIN1;RPS14;RPS9;DDX21;RPL5;ERI1;RPS5;RPL11;RPLP0;NGRN;MRPS7;UTP23;MRPL16;MRPS18A;RPL23;GTF3A;PTCD3;RPF2;FASTKD2;MRPL18;NOP53;MRPL11
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.609481094461293,1.4889709930034367,0.06239168110918544,0.5742556205366187,1.0,6/14,18.69%,CAPN5;CAPN3;CAPN6;CAPN15;CAPN10;CAPN2
prerank,voltage-gated potassium channel activity (GO:0005249),0.4532898202505788,1.4876293589203413,0.027522935779816515,0.5647220316827115,1.0,25/80,20.65%,KCNK2;KCNS2;KCNT2;KCNQ3;KCNMA1;KCNIP2;KCNG1;KCNH4;KCNC2;HCN2;HCN1;KCND2;HCN3;KCNE4;KCNK1;KCNN2;KCNH7;KCNJ8;KCNH8;KCNA6;KCNJ10;KCNJ3;KCNH1;KCNJ16;KCNS3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5868740214613053,1.4812847847970947,0.054635761589403975,0.5723668888283243,1.0,4/18,17.79%,HSD11B1;HSD17B8;RDH5;HSD17B2
prerank,pentosyltransferase activity (GO:0016763),-0.4312662030158044,-1.477751020528417,0.031446540880503145,0.5373389021801759,1.0,13/36,18.84%,UPP2;ART3;SIRT3;TNKS2;ZC3HAV1;LARGE1;LACC1;PARP10;PARP9;PARP4;SIRT1;QPRT;SIRT5
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5195215845206943,-1.4736222390208578,0.04895104895104895,0.5295580680810755,1.0,5/18,5.01%,TMOD3;BAIAP2L1;PDLIM5;S100A11;ANXA1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5928463513922597,-1.4721173322812526,0.060948081264108354,0.5143499190534154,1.0,5/12,14.67%,VEGFD;VEGFC;CCDC88A;ITGB3;CDH5
prerank,protein tyrosine kinase activity (GO:0004713),0.4213494129181188,1.4716479965582854,0.028683181225554105,0.5908074307863769,1.0,21/108,11.12%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;PEAK1;TXK;ERBB4;EPHB1;FGFR1;JAK1;EPHA6;CAMKK2;PTK2;EPHB6;AXL;FGR;EPHA3;FYN
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5885377379874178,-1.468519510171648,0.07476635514018691,0.5076814343135302,1.0,4/11,10.34%,SGMS1;SGMS2;AASDHPPT;GNPTAB
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6076156198032415,-1.4674263571492647,0.08924485125858124,0.4928579813937404,1.0,3/11,3.71%,MAP3K1;EGFR;MAP3K5
prerank,CCR chemokine receptor binding (GO:0048020),0.5241079924031574,1.464699341996142,0.05396825396825397,0.6013003208811043,1.0,5/28,10.56%,XCL1;MSMP;CCL15;CNIH4;CCL25
prerank,semaphorin receptor binding (GO:0030215),-0.4935859705607022,-1.461301632661481,0.05649717514124294,0.49487977189890175,1.0,10/23,18.21%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;PLXNB1;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,glucuronosyltransferase activity (GO:0015020),-0.5198929417795894,-1.458733862629426,0.06265060240963856,0.4856589037454442,1.0,3/19,8.22%,CSGALNACT1;EXT1;LARGE1
prerank,calcium ion binding (GO:0005509),0.3794917230125827,1.4567959770630563,0.0032119914346895075,0.6157441772988211,1.0,68/323,14.83%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;ITPR1;MASP1;NRXN1;FKBP9;TCHH;RYR2;LOXL2;KCNIP1;DCHS1;CEMIP2;CDH11;CAMKK2;CDH15;CDH3;CLEC3B;KCNIP2;ATP2A2;NOL3;CAPN3;RASGRP2;S100A7A;ENPP3;CALB1;MAN1C1;SYT3;AMY1B;AMY1C;AMY1A;KCNIP4;MICU3;PVALB;ITSN1;SYT7;MAN1B1;PPP3CB;RCN3;CABYR;S100A2;TRPM2;SYT5;S100A1;CDH10;HSP90B1;TESC;EML1;S100G;SPARCL1;BGLAP;RYR3;ASPH;MELK;PCLO;STIM1;HSPA5;NDUFAB1;FBN1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.6308937863301344,1.4474853519770747,0.10189982728842832,0.6340010741897352,1.0,4/12,10.16%,HDAC1;FOS;GTF2A1;TBPL1
prerank,actin binding (GO:0003779),-0.32670799547464874,-1.4392698119558534,0.0,0.5275180568456178,1.0,40/170,14.38%,SORBS1;PAWR;ABLIM1;SYNE2;MICAL2;CALD1;PDLIM5;VCL;MYRIP;ITGB1;EZR;NOS3;TPM1;PARVB;RDX;FXYD5;GSN;ANLN;PHACTR1;GIPC1;CAPZB;COBL;MAPT;EPS8L2;SSH1;DMD;CAP1;PHACTR4;COTL1;CCDC88A;DAG1;CEACAM1;SHROOM2;TMOD1;MYH10;LIMA1;TRPV4;MACF1;TLNRD1;TMSB4X
prerank,cytokine activity (GO:0005125),0.4012974843314199,1.4389220594588865,0.027093596059113302,0.6525819629360177,1.0,10/131,5.33%,IL33;IL34;XCL1;CXCL10;NRG1;WNT5A;CXCL1;IL16;TSLP;CCL15
prerank,frizzled binding (GO:0005109),-0.4290298482288021,-1.4388216582435984,0.04081632653061224,0.5125302849058208,1.0,13/34,18.76%,WNT5B;WNT9A;RNF43;WNT4;DVL1;FZD7;LRP6;WNT6;SFRP1;CCDC88C;WNT16;SDCBP;WNT11
prerank,GDP binding (GO:0019003),-0.3737583935176265,-1.4347274704179238,0.04220779220779221,0.5094522701726715,1.0,21/63,19.30%,MRAS;KRAS;RRAS2;RASL12;RAP1A;RAB21;RAB5A;RAB5C;RAB31;MIEF1;RRAGC;RAB35;RALB;RAN;RRAS;RAP2C;RAP2B;RERG;DYNC1LI1;RAB4A;RAB8B
prerank,histone demethylase activity (GO:0032452),-0.4553483981750868,-1.4301170698115468,0.05084745762711865,0.5087785596975635,1.0,12/27,25.64%,KDM4A;KDM4C;RIOX2;PHF8;FBXL19;JARID2;HR;KDM4B;KDM3B;PHF2;KDM2B;KDM1A
prerank,cholesterol binding (GO:0015485),0.4776650400614224,1.4290338672764151,0.0708092485549133,0.676160105639489,1.0,5/47,3.45%,APOD;VDAC2;GRAMD1B;OSBPL3;OSBPL6
prerank,death domain binding (GO:0070513),-0.5806468964320539,-1.4280658707185057,0.09490740740740741,0.5004778502003524,1.0,5/11,9.82%,BCL2L1;MCL1;CRADD;DAPL1;BAX
prerank,tau protein binding (GO:0048156),-0.41141488988773983,-1.4167782574376881,0.06853582554517133,0.519254599437493,1.0,15/40,25.27%,PICALM;ROCK2;MARK1;ACTB;MARK4;APOE;GSK3B;MARK3;PRKAA1;MARK2;HDAC6;TTBK1;BAG2;TAOK2;BRSK1
prerank,insulin-like growth factor binding (GO:0005520),-0.5429012524710064,-1.4144546752441365,0.09115281501340483,0.5116373797014532,1.0,10/15,14.34%,IGFBP6;IGF1R;IGFBP5;ITGA6;IGFBP3;INSR;IGFBP2;ITGB4;ITGB3;IGF2R
prerank,GTPase inhibitor activity (GO:0005095),-0.5488974384142266,-1.4142473287962258,0.0776255707762557,0.4987896157940971,1.0,7/13,21.30%,SLIT2;IQGAP1;CPEB2;ARL2;GPS1;RHOH;IQGAP2
prerank,copper ion binding (GO:0005507),0.4767760052391917,1.411460885789002,0.06340057636887608,0.7335629598578822,1.0,11/42,14.03%,PAM;TYR;LOXL3;LOXL2;CCS;ACR;COMMD1;TP53;P2RX4;HEPH;ATP7A
prerank,phospholipase inhibitor activity (GO:0004859),-0.58407178426983,-1.409722959978913,0.08685968819599109,0.49858487496173765,1.0,6/10,37.01%,ANXA5;ANXA1;ANXA4;ANXA9;APOC1;SNCB
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.590211609201787,-1.4095289886972757,0.10714285714285714,0.48667919556003547,1.0,6/10,22.73%,KDM4A;KDM4C;RIOX2;PHF8;KDM4B;KDM2B
prerank,tau-protein kinase activity (GO:0050321),-0.48486712662131104,-1.4056439157554321,0.08208955223880597,0.48628644271942395,1.0,13/20,29.28%,ROCK2;MARK1;MARK4;SIK3;GSK3B;MARK3;PRKAA1;MARK2;TTBK1;TAOK2;BRSK1;PHKG2;TTBK2
prerank,ion channel activity (GO:0005216),0.426796316634442,1.4050117048515969,0.05698778833107191,0.744088202457668,1.0,15/80,6.85%,GRIA3;NALCN;CHRNB4;GRID2;GRIN2B;GRID1;GRIK5;GRIK2;GRIA4;GRIA1;GRIK4;GRIN2A;TRPV3;GRIK1;TMC3
prerank,FAD binding (GO:0071949),-0.46588264387469425,-1.4042531849194388,0.07323943661971831,0.47830773290739526,1.0,10/24,17.98%,DDO;MICAL2;PRODH;CYB5R3;NQO2;MTHFR;CYB5R1;MICAL3;AIFM1;NDOR1
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5384237470848033,1.399573169185929,0.09136212624584718,0.75026871354302,1.0,10/22,18.58%,CPEB1;RBM24;RBMS3;ELAVL4;ZFP36L2;NUDT21;DHX36;EXOSC9;EXOSC8;ILF3
prerank,myosin V binding (GO:0031489),0.5834205539040157,1.3964364422312172,0.10175438596491228,0.7482391417457446,1.0,3/15,6.42%,NPC1L1;RAB8A;RAB3C
prerank,AMP binding (GO:0016208),-0.5717904151669098,-1.3928767683958354,0.10829493087557604,0.4981334928476056,1.0,5/11,20.07%,PRKAG2;MPPED2;PRKAG3;PFKL;APRT
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30378645377959346,-1.39054455753319,0.0,0.4938293038101158,1.0,65/196,21.91%,PDE5A;RAPGEF2;RHOBTB1;MRAS;KRAS;MPPED2;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;RAB5C;GBP2;GCH1;RAB31;PDE11A;MIEF1;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;NOA1;ARL1;TUBB2A;RAB6A;RAP2B;TSR1;RERG;DYNC1LI1;RAB4A;RAB8B;RRAGB;MFHAS1;ARL4C;TUBA1C;RAB1B;SCG5;RHOH;TUBA4A;TUBB2B;MTG2
prerank,phospholipase binding (GO:0043274),0.579954619889198,1.3891232839987693,0.12521440823327615,0.762375178982941,1.0,4/13,11.12%,ARHGAP6;PDPK1;DGKQ;FYN
prerank,chloride channel inhibitor activity (GO:0019869),-0.5728207949729482,-1.3889745723777174,0.0988235294117647,0.4870192928315659,1.0,4/10,9.42%,WNK4;WNK1;STX1A;STX7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3674903946795108,-1.3886604055383251,0.04225352112676056,0.47719568922289884,1.0,17/55,16.26%,SLC13A3;SLC16A2;SLC6A6;SLC38A11;SLC25A32;SLC22A4;SLC16A6;SLC16A11;SLC7A1;SLC16A1;SLC16A4;SLC38A5;SLC38A10;SLC7A5;SLC16A9;SLC36A4;PDPN
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5921072261064482,1.3875018337303622,0.1113013698630137,0.7536836692209453,1.0,3/12,5.40%,PIK3R1;GAB2;IRS1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.48069270483876275,1.382904518420214,0.08915304606240713,0.7578343018579787,1.0,13/34,14.84%,OGT;GAB2;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ARAP2;MYO1G;DAPP1;FERMT2
prerank,triglyceride lipase activity (GO:0004806),0.5385997791624496,1.375665887067093,0.10559006211180125,0.7736851681253456,1.0,3/20,5.09%,CEL;LIPC;LIPH
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5233771069203326,-1.369176870196776,0.10784313725490197,0.5203658145744453,1.0,7/15,22.27%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC4A8;SLC26A6;CFTR
prerank,nucleotide diphosphatase activity (GO:0004551),0.5701015629860123,1.3638278332992169,0.13074204946996468,0.807661761691642,1.0,3/14,10.38%,ENPP1;FHIT;NUDT13
prerank,hydro-lyase activity (GO:0016836),-0.3889852620744828,-1.3627407478145823,0.08385093167701864,0.5276239496847199,1.0,18/41,27.89%,HACD4;HACD1;CA4;ACO1;ECHDC1;L3HYPDH;ACO2;ENO1;PCBD2;HADHA;CDYL;AUH;CBS;FAHD2A;CYP2S1;ALAD;PARK7;HACD2
prerank,"DNA binding, bending (GO:0008301)",-0.515119390912139,-1.3583753873432851,0.11353711790393013,0.5296753971131705,1.0,6/14,17.69%,LEF1;FOXC1;FOXD1;FOXL1;HHEX;HMGB2
prerank,neuropeptide hormone activity (GO:0005184),0.5183457183807787,1.3561038902902052,0.12057877813504823,0.8264120854740513,1.0,3/22,8.90%,HCRT;SPX;NPY
prerank,transcription corepressor binding (GO:0001222),0.4949259573509665,1.3523184706990878,0.11290322580645161,0.8273549714622976,1.0,5/27,9.48%,RORA;PER3;ZBTB16;PER2;WIZ
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5648310784126338,-1.351734475061794,0.14035087719298245,0.5373300300774403,1.0,6/10,19.62%,SHANK3;GNAS;SQSTM1;SHANK1;SHISA7;IGSF11
prerank,nuclear export signal receptor activity (GO:0005049),0.6004816028575211,1.3512573377075567,0.14157706093189965,0.8171956556031658,1.0,6/11,19.94%,CSE1L;NUP214;NUP42;EIF4ENIF1;XPO6;XPO1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5851979551944768,1.3473873081163066,0.15357142857142858,0.8192594958389594,1.0,2/12,9.45%,GPR88;GPR52
prerank,voltage-gated cation channel activity (GO:0022843),0.3961450883252312,1.346338781381968,0.07142857142857142,0.8096862182439845,1.0,25/97,17.61%,KCNS2;CACNA1E;ITGAV;GRIN2B;CACNG3;KCNQ3;KCNMA1;GRIN2A;KCNG1;CATSPER3;KCNH4;KCNC2;CACNB4;HCN2;HCN1;CACNG4;KCND2;HCN3;KCNK1;KCNH7;KCNH8;CACNA2D1;NCS1;KCNA6;GRIN3A
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4652477522487365,-1.345158642954768,0.11658031088082901,0.54635452422471,1.0,8/18,22.98%,LTBP4;BMPR2;ACVR1;ACVRL1;ACVR2B;TGFBR3;TGFBR2;ACVR2A
prerank,voltage-gated sodium channel activity (GO:0005248),0.5055482136636634,1.3451507543320107,0.1297208538587849,0.8009799488085011,1.0,10/22,21.35%,SCN2B;CACNA1G;HCN2;HCN1;HCN3;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5657693098525363,1.3401926666424748,0.15135135135135136,0.8076835300416673,1.0,7/13,15.70%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GLRB
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.38294225049010777,-1.3398177324563367,0.09253731343283582,0.5513670615440044,1.0,9/42,5.01%,TMOD3;CD200;BAIAP2L1;PDLIM5;BSG;ESAM;SIRPA;S100A11;ANXA1
prerank,lipase activator activity (GO:0060229),0.5929012059114022,1.335065092754872,0.13381555153707053,0.815383158337991,1.0,3/10,11.12%,ARHGAP6;PDPK1;FYN
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3720179846710304,-1.33478095127116,0.0707395498392283,0.555306584201366,1.0,4/48,1.22%,TRPM3;TRPM6;SLC12A7;PIEZO2
prerank,MAP kinase activity (GO:0004707),-0.5058583147497098,-1.3347633594642196,0.13942307692307693,0.5450822762899482,1.0,3/14,6.47%,MAPK4;MAPK9;MAPK14
prerank,transforming growth factor beta binding (GO:0050431),-0.43778475846362985,-1.33159719903163,0.10554089709762533,0.5430501166775046,1.0,13/23,24.22%,LTBP4;THBS1;CD109;ACVR1;ACVRL1;LRRC32;TWSG1;TGFBR3;VASN;TGFBR2;NRROS;TSKU;HYAL2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.30405508169451656,-1.3308064831816993,0.012121212121212121,0.5356151793629782,1.0,44/147,14.85%,PLCE1;DOCK5;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;FNIP1;DOCK1;RAPGEF6;ARHGEF28;CYTH1;RASGRF1;RAP1A;RIN3;DENND3;RAPGEF1;NUCB1;ARHGEF15;LAMTOR5;EPS8L2;NGEF;MADD;SPATA13;GAPVD1;RGL2;RAB3IP;CCDC88A;DENND2C;DENND5B;ALS2;EIF2B4;HERC2;DENND6A;LAMTOR3;CCDC88C;BCR;EEF1D;DENND1A;DENND4C;ARHGEF11;RAPGEF3;MON1A
prerank,ADP binding (GO:0043531),-0.43100918317131715,-1.328987757543265,0.12244897959183673,0.5312428336952839,1.0,11/25,23.79%,PRKAG2;GCLC;PGK1;MIEF1;ME1;MYH10;ERN1;ATP5F1D;MYO18A;MYH9;COQ8A
prerank,cAMP binding (GO:0030552),0.5802028383935969,1.3270298426605538,0.15808170515097691,0.8340640492284407,1.0,5/11,14.27%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,BMP binding (GO:0036122),-0.5320657010853991,-1.3226446285901474,0.14482758620689656,0.5392464042683247,1.0,2/11,2.75%,NBL1;BMPR2
prerank,phospholipase activator activity (GO:0016004),0.583764973571484,1.3215609415798375,0.17122040072859745,0.8428413290334452,1.0,3/10,11.12%,ARHGAP6;PDPK1;FYN
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4542672290530282,1.3198103885454586,0.11861861861861862,0.8373158143075549,1.0,8/35,7.72%,ENPP1;PLCL1;GPLD1;PLCXD3;SMPD4;PLCXD1;ENPP3;ENPP6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.508489339199255,-1.3141296910888227,0.13,0.553438761152794,1.0,6/12,21.18%,LTBP4;BMPR2;ACVR1;ACVRL1;TGFBR3;TGFBR2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.5317220483447667,-1.309564065965485,0.15137614678899083,0.5568309118902368,1.0,6/11,24.60%,NUDT3;NUDT4;NUDT7;DCPS;NUDT16;NUDT16L1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5983631770599671,1.3091006797769447,0.16636851520572452,0.8683580482616571,1.0,1/10,1.38%,SLC6A13
prerank,protein tyrosine kinase binding (GO:1990782),-0.34437551364284114,-1.3071301777426818,0.06147540983606557,0.554736222978798,1.0,23/71,14.89%,EPHA4;DOCK4;PITPNM2;ITGB1;BMPR2;SIRPA;SQSTM1;PTPN14;GRB14;NEDD9;NCK1;TJP2;ACVR1;PTPN2;PTPN1;RNF41;CEACAM1;PCNA;NOX4;CPNE3;ELMO2;CDH5;TOB1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.413642428519005,-1.3042494345083973,0.10857142857142857,0.5538252724409136,1.0,9/27,12.89%,SLC9B2;ITPR2;ATP2B1;SLC41A1;MRS2;CNNM2;CNNM4;SLC4A8;ATP2A3
prerank,kinase activator activity (GO:0019209),-0.39973420989516645,-1.3042316254770159,0.125,0.5450681935871934,1.0,13/30,24.20%,PRKAG2;RPLP1;GPRC5C;WNK1;MADD;CAB39;WNT11;MARK2;RGCC;MOB1B;DUSP19;BCL10;MT3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.548913846291271,-1.301304988003293,0.1822125813449024,0.5442369620570865,1.0,3/10,3.33%,CD200;CXADR;SIRPA
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.5039817973988531,1.297836159980604,0.15728476821192053,0.9030380495175429,1.0,3/21,10.65%,CHRNB4;GRIA1;GRM5
prerank,mRNA methyltransferase activity (GO:0008174),-0.5203785674479082,-1.2977538573789889,0.1759465478841871,0.5451675091401602,1.0,3/12,8.66%,NSUN2;TRMT61B;CMTR1
prerank,anion:anion antiporter activity (GO:0015301),-0.4617944412140882,-1.2948966861681692,0.14148681055155876,0.5441986507043647,1.0,8/17,26.68%,SLC26A7;SLC26A2;SLC26A11;SLC4A3;SLC25A5;SLC26A6;SLC25A4;SLC25A11
prerank,gated channel activity (GO:0022836),-0.49505112428511344,-1.2948713381855352,0.12128712871287128,0.5361080634499193,1.0,7/14,21.46%,PIEZO2;TMC7;TMC6;TMEM266;PACC1;TMEM63B;PIEZO1
prerank,sequence-specific mRNA binding (GO:1990825),0.5845765819302292,1.2946596280682379,0.20825852782764812,0.9036844324503635,1.0,7/10,25.54%,RBM24;FMR1;LARP6;DHX9;SSB;ETF1;SHFL
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.49538298207868275,-1.2946492704277581,0.1716937354988399,0.528787760808269,1.0,5/13,11.40%,EIF5;SH3BP4;ARHGDIB;ITGB1BP1;CCDC88A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5490203930937262,-1.2907676779344772,0.1791767554479419,0.5311997928307542,1.0,3/10,4.65%,B4GALT1;B3GALT1;B4GALT5
prerank,ligand-gated anion channel activity (GO:0099095),0.5205693875194924,1.2901519076950627,0.18214285714285713,0.9102204551970415,1.0,8/17,15.70%,GABRA1;GABRG3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;GLRB
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5248114622958802,-1.2891846679562744,0.16173120728929385,0.5278698336748202,1.0,6/11,18.60%,ATP10A;ATP8A1;ABCA3;ATP8B1;ABCB4;ATP8A2
prerank,adenylate cyclase binding (GO:0008179),0.5824749955292408,1.2868729465210307,0.20437956204379562,0.9113584725001548,1.0,4/10,13.23%,ADCY5;AKAP5;ADCY2;AKAP6
prerank,N-acetyltransferase activity (GO:0008080),0.4877102764528329,1.2859277492474448,0.17755443886097153,0.9024630988160138,1.0,4/19,10.37%,NAA10;NAT10;NAA50;NAT8L
prerank,cytokine receptor activity (GO:0004896),0.3863159839574339,1.2857859445094149,0.12231182795698925,0.890906147362519,1.0,10/83,9.52%,GHR;IL15RA;IL2RA;IL1R2;IL18RAP;ACKR2;CCR9;IL17RD;IFNLR1;IL1RAP
prerank,ferrous iron binding (GO:0008198),0.49721007363442077,1.279454242662313,0.17560975609756097,0.9060289852143375,1.0,7/21,13.45%,HIF1AN;DNAJC24;EGLN2;FXN;HEPH;FTO;ALKBH3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.488585713315704,1.277983191731526,0.16802610114192496,0.8761252014617662,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,serotonin receptor activity (GO:0099589),0.488585713315704,1.277983191731526,0.16802610114192496,0.8761252014617662,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.488585713315704,1.277983191731526,0.16802610114192496,0.8761252014617662,1.0,7/22,20.18%,HTR2B;HTR5A;HTR1A;HTR2C;HTR4;HTR6;CHRM2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5269195420170201,-1.2758067289574053,0.16989247311827957,0.5553736377761201,1.0,3/10,9.45%,MECOM;ASH1L;PRDM16
prerank,dipeptidyl-peptidase activity (GO:0008239),0.577258560910184,1.2692910045213999,0.2137546468401487,0.900203403213735,1.0,3/10,3.37%,DPP6;FAP;DPP10
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.48616524213696827,-1.2691083375970027,0.17551963048498845,0.5658922861508389,1.0,7/14,22.94%,CASP8AP2;MAL;BAD;CTSH;ATP2A3;BCL2L13;APAF1
prerank,nuclease activity (GO:0004518),0.4153685204903556,1.2685536494065222,0.14685314685314685,0.8915418668724201,1.0,13/52,20.19%,ENPP1;ANKLE1;FEN1;ERCC5;PDE12;DIS3L2;NME1;RNASEH1;ISG20L2;RNASE12;WRN;REXO4;DDX1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4156003925463321,-1.2683424994908927,0.13648293963254593,0.5599925403911038,1.0,8/26,9.96%,ABCG2;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC16A1;SLC16A4;MPC1
prerank,phosphatidylglycerol binding (GO:1901611),-0.47888036521704236,-1.2683012001838048,0.1756440281030445,0.5524970095971881,1.0,3/13,6.69%,PITPNC1;PLTP;PITPNA
prerank,DNA polymerase binding (GO:0070182),0.5028729553553081,1.2676711660404532,0.19055374592833876,0.8840006441862194,1.0,2/18,2.23%,FANCI;NAT10
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4961038288207511,1.267613072610539,0.18896321070234115,0.8732893826259533,1.0,6/20,15.02%,CASK;MAGI3;DLG2;AK4;AK8;AK3
prerank,chloride channel regulator activity (GO:0017081),-0.4689798065730335,-1.2662337609178735,0.18427518427518427,0.5507375517314431,1.0,4/14,9.42%,WNK4;WNK1;STX1A;STX7
prerank,peptidase activator activity (GO:0016504),-0.42790904946359576,-1.2651084571372515,0.15844155844155844,0.5463627645678081,1.0,9/22,13.33%,CAV1;CASP8AP2;PCOLCE2;VCP;MAL;APH1A;CLPX;APH1B;PSME3
prerank,MAP kinase phosphatase activity (GO:0033549),0.5570191382051014,1.2639244480373562,0.21942446043165467,0.8767472232722738,1.0,5/12,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,ribonuclease P activity (GO:0004526),0.5616216987901888,1.2634336089264235,0.18914185639229422,0.8679262210575841,1.0,4/11,9.76%,RPP40;POP5;PRORP;POP7
prerank,retinoic acid receptor binding (GO:0042974),0.4992751215602679,1.2621016439661552,0.20408163265306123,0.8624598067376987,1.0,8/17,15.19%,NSD1;SNW1;CNOT1;NRIP1;MED1;MED25;ASXL1;PRMT2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.5409916817143144,1.261914125605021,0.2060931899641577,0.8529483444003431,1.0,2/12,2.74%,PDE7B;PDE4B
prerank,general transcription initiation factor binding (GO:0140296),0.4755487421449479,1.2617316161202403,0.18282988871224165,0.843691707707915,1.0,10/25,22.14%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;AR;THAP7;TAF11;GTF2B;GTF2A2
prerank,metalloendopeptidase activity (GO:0004222),0.38810297216966216,1.25888732752728,0.14624505928853754,0.8450637904096304,1.0,15/76,10.23%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP24;MMP28;MMP25;ADAM19;OMA1;ADAMTS12;MMP11;ADAMTS2;NRDC;PITRM1
prerank,GTPase activator activity (GO:0005096),-0.2622604431790129,-1.257558814626794,0.011494252873563218,0.5583755795431348,1.0,93/313,16.17%,RANBP3L;PLCE1;DOCK5;TBC1D4;PLCB1;RAPGEF2;RAPGEF5;ARHGEF18;DOCK4;DENND4A;FGD5;CHN2;RGS3;SIPA1L1;FNIP1;RGS6;DOCK1;RAPGEF6;ARHGEF28;RGS5;NRP1;CYTH1;SIPA1L2;RASGRF1;IQGAP1;TBC1D8;RAP1A;RIN3;RAP1GAP2;ARHGAP10;DENND3;ARHGAP42;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;SRGAP2;RAPGEF1;ERRFI1;BNIP2;NUCB1;ARFGAP2;ARHGEF15;RANGAP1;RUNDC1;RALBP1;LAMTOR5;EPS8L2;ELMOD3;NGEF;MADD;ARHGAP18;SGSM2;ELMOD2;SPATA13;GAPVD1;RGL2;RAB3IP;GMIP;GRTP1;CCDC88A;DENND2C;ARHGAP27;PGAM5;RP2;ARHGAP28;DENND5B;TBC1D7;ALS2;EIF2B4;HERC2;EVI5L;DENND6A;TBC1D22A;LAMTOR3;CCDC88C;BCR;TBC1D10B;EEF1D;DENND1A;ARHGAP15;DENND4C;ASAP2;ARHGEF11;RAPGEF3;MON1A;TBCK;RAP1GDS1;TBC1D13;RGS10;SBF1;ARHGAP44;LLGL2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.48271723722866244,-1.257299683770046,0.18993135011441648,0.5519266864857868,1.0,3/14,4.04%,SLC26A7;SLC26A2;SLC26A11
prerank,phosphatidate phosphatase activity (GO:0008195),0.5350927848534485,1.2534616339581703,0.22438162544169613,0.8560559135619219,1.0,5/13,15.43%,LPIN3;PLPPR3;PLPPR2;PLPP5;LPIN2
prerank,peptidoglycan binding (GO:0042834),-0.5348998639209785,-1.2524162188874042,0.18764302059496568,0.5573791853782759,1.0,7/10,39.86%,HK1;PGLYRP1;RNASE7;NOD2;JCHAIN;NLRP3;TLR2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.40289563009202695,1.2513957516785283,0.1688125894134478,0.8547019431550583,1.0,7/53,8.61%,SLC1A3;SLC1A5;SLC7A11;SLC43A1;SLC7A8;SLC66A1;SLC25A22
prerank,transcription coregulator binding (GO:0001221),0.4055647965676685,1.251007829576853,0.16204379562043797,0.8467262751646191,1.0,8/50,9.48%,RORA;PER3;PGR;PPARD;TEAD2;ZBTB16;PER2;WIZ
prerank,GTP binding (GO:0005525),-0.2780850331592726,-1.2490230489522929,0.012658227848101266,0.5593550251185083,1.0,63/172,24.20%,RHOBTB1;MRAS;KRAS;RRAS2;GBP7;RASL12;RAP1A;INSR;DRG1;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ARL6;RAB21;ADSS2;GBP4;RAB5A;RHOC;GBP2;GCH1;RAB31;DRG2;EEF1A1;RRAGC;RAB13;ARL2;RAB35;REM1;GBP6;RALB;TGM2;RAN;RAB38;RRAS;GNL1;RAP2C;ATL3;NOA1;ARL1;TUBB2A;RAB6A;RAP2B;TSR1;RERG;DYNC1LI1;RAB4A;RRAGB;MFHAS1;ARL4C;TUBA1C;RAB1B;SCG5;RHOH;TUBA4A;TUBB2B;MTG2;LANCL2;RAB9A;RAP1B;NUDT16;RHOU
prerank,GABA-A receptor activity (GO:0004890),0.48918357801579604,1.2483915780260464,0.20905923344947736,0.8469135482836829,1.0,5/18,13.82%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1
prerank,gamma-tubulin binding (GO:0043015),-0.4280587334523761,-1.247438310633522,0.17914438502673796,0.556773736117052,1.0,11/22,25.27%,MARK4;NDRG1;OFD1;TUBGCP5;GIT1;RAD51D;CDK5RAP2;DIXDC1;RAB11FIP5;CENPJ;BRSK1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.49562829476827336,-1.2466741845423321,0.20090293453724606,0.5518923965577657,1.0,7/12,28.57%,CASP8AP2;BAD;CTSH;ATP2A3;BCL2L13;APAF1;CASP1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5485918928934276,1.2454522786894426,0.21968365553602812,0.8482074769278409,1.0,6/12,16.72%,SDHB;CISD3;FXN;CISD2;AOX1;ISCA1
prerank,dynactin binding (GO:0034452),-0.4976943937718287,-1.2426511840294256,0.19111111111111112,0.5544144931620388,1.0,6/12,26.57%,GSK3B;MAPT;SNX6;BICD2;BICDL1;BICD1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5558338319832122,1.241762771408689,0.21390374331550802,0.8531431010109325,1.0,1/11,2.20%,CHRNB4
prerank,solute:anion antiporter activity (GO:0140323),-0.4767562091768026,-1.2392837224709141,0.21428571428571427,0.5560527017360021,1.0,4/14,6.46%,SLC26A7;SLC26A2;SLC26A11;SLC4A3
prerank,poly(A) binding (GO:0008143),0.467350133617439,1.2375415907603375,0.18225039619651348,0.8597889540130497,1.0,4/21,6.64%,RBMS1;EIF4A3;RBMS3;ELAVL4
prerank,histone methyltransferase binding (GO:1990226),-0.4978887143071128,-1.2335573835743225,0.19489559164733178,0.5647041202354666,1.0,5/11,22.23%,LCOR;CBX3;CBX1;LCORL;PHF1
prerank,phosphatase inhibitor activity (GO:0019212),0.4800116598388825,1.2323815324454663,0.19696969696969696,0.8712976867028654,1.0,2/20,4.56%,PTN;BOD1
prerank,phospholipase C activity (GO:0004629),-0.40239753247417687,-1.2321505719932428,0.18457300275482094,0.5615174454143271,1.0,7/25,15.34%,PLCE1;PLCB1;EDNRA;BDKRB2;PLCB4;PLCG2;PLCH1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.542447383204184,1.2306798004489021,0.2192513368983957,0.8682870052323237,1.0,1/11,0.86%,ROR2
prerank,poly-purine tract binding (GO:0070717),0.44458440347638895,1.2256705630889726,0.20602218700475436,0.8782384713666749,1.0,5/27,6.64%,RBMS1;EIF4A3;RBMS3;FMR1;ELAVL4
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.5618643995653585,1.2253684369074682,0.263254113345521,0.8616258469334458,1.0,5/10,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.5618643995653585,1.2253684369074682,0.263254113345521,0.8616258469334458,1.0,5/10,22.62%,DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,titin binding (GO:0031432),-0.48010569573115336,-1.223776281168026,0.22327790973871733,0.5754507021210177,1.0,4/13,13.14%,ACTN2;CAMK2D;CALM1;TRIM63
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4384218067194621,1.2235224375243057,0.20516962843295639,0.8594782091623102,1.0,8/30,17.97%,SLC25A37;SLC30A10;SLC30A5;SLC39A7;SLC30A3;ATP7A;SLC39A13;SLC39A14
prerank,death receptor activity (GO:0005035),0.5320578092841985,1.2211337763291972,0.241852487135506,0.8598547523541532,1.0,3/11,7.98%,EDA2R;NGFR;TNFRSF19
prerank,pyridoxal phosphate binding (GO:0030170),0.47589614682932535,1.2208027211015111,0.21870047543581617,0.8524738919310265,1.0,4/20,6.15%,THNSL2;GLDC;PDXK;ABAT
prerank,single-stranded DNA binding (GO:0003697),0.3591396695142767,1.2172081374538408,0.16429495472186287,0.8577593397871937,1.0,28/93,18.64%,RBMS1;ERCC1;MCM7;ERCC5;MSH3;RTF1;NEIL3;POLA1;RPA1;HMCES;ERCC4;WBP11;XPC;BRCA2;MCM4;DHX36;TOP3A;SPRTN;RAD52;LONP1;MCM10;SSBP2;DHX9;CRY2;MCMDC2;FBH1;SSBP1;REXO4
prerank,filamin binding (GO:0031005),-0.49311760062584387,-1.2160807917818348,0.23543123543123542,0.5885591643822459,1.0,2/11,0.72%,NEBL;DPYSL3
prerank,miRNA binding (GO:0035198),0.43564519873698293,1.214892044541648,0.20537124802527645,0.8575575708947033,1.0,9/30,11.21%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.43558390244955936,1.2130971847759302,0.21904761904761905,0.8560926383973385,1.0,11/28,17.55%,RPP40;POP5;FEN1;PRORP;MRPL44;POP7;DBR1;AGO3;EDC3;RNASEH1;RPP21
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5073899843526954,1.2109499304486018,0.25,0.8557376027832516,1.0,2/15,3.26%,ACKR2;CCR9
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2531840356031616,-1.2102029666867828,0.049019607843137254,0.5978441506731161,1.0,98/269,26.33%,SNCAIP;SMAD6;FOXO1;VCL;EGFR;NPLOC4;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;SQSTM1;TMBIM6;HSPA8;ARIH1;ACTG1;SKI;GABARAP;DBT;APC;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;GSK3B;PRR5L;SLC22A18;RNF8;VCP;TPI1;PCBP2;SMAD3;RPL11;CASP8;NFKBIA;UBE2A;PARP9;SUMO3;RALB;OTUB1;HERC2;PSMA3;SMG5;PRKAR2A;SLC25A5;PRKAR2B;PTPRN;UBE2N;CKB;USP25;UCHL1;TRAF3;CDKN1A;HSPBP1;UBE2L6;PER1;NEDD8;CUL3;FZD8;ISG15;LAPTM5;UBC;CBS;MAP1LC3A;AMBRA1;ERBB3;APBB1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;MID1;RFFL;UBA52;SMAD7;IKBKE;BCL10;AXIN2;HSPD1;RNF20;RPA2;IKBKG;SUMO1;DTX3L;NDUFS2;CHEK2;HSPA1A;BRCA1;ARRB2;RB1
prerank,TBP-class protein binding (GO:0017025),0.46804480402642473,1.2079082949615518,0.24549918166939444,0.858866907973719,1.0,8/21,22.14%,TAF12;THRA;GTF2A1;TAF1B;PSMC5;TAF11;GTF2B;GTF2A2
prerank,ubiquitin protein ligase binding (GO:0031625),-0.25598474523380566,-1.2075101212269141,0.058823529411764705,0.5984647326607178,1.0,94/254,26.33%,SNCAIP;SMAD6;FOXO1;VCL;EGFR;NPLOC4;TRIB2;KDM4A;BECN1;UBE2G1;LAPTM4B;NEK6;SQSTM1;TMBIM6;HSPA8;ARIH1;ACTG1;SKI;GABARAP;DBT;APC;RPL5;HLTF;CUL1;TXNIP;GABARAPL1;JKAMP;FZD4;UBB;GSK3B;PRR5L;SLC22A18;RNF8;VCP;TPI1;PCBP2;SMAD3;RPL11;CASP8;NFKBIA;UBE2A;RALB;OTUB1;HERC2;PSMA3;SMG5;PRKAR2A;SLC25A5;PRKAR2B;UBE2N;CKB;USP25;UCHL1;TRAF3;CDKN1A;HSPBP1;UBE2L6;PER1;NEDD8;CUL3;FZD8;ISG15;LAPTM5;UBC;CBS;MAP1LC3A;AMBRA1;ERBB3;APBB1;MFHAS1;HDAC6;RPL23;FAF2;MAP1LC3B;RTN4;TRAF1;MID1;RFFL;UBA52;SMAD7;IKBKE;BCL10;AXIN2;HSPD1;RNF20;RPA2;IKBKG;SUMO1;NDUFS2;CHEK2;HSPA1A;BRCA1;ARRB2;RB1
prerank,metal ion binding (GO:0046872),0.30810617198261653,1.2068526996819788,0.07921810699588477,0.854511685239368,1.0,85/477,14.56%,SCUBE1;ENPP1;ADGRL3;LRP1;PLSCR4;CLEC4E;HRG;S100A3;CDH6;PLA2G2C;PAM;ADGRV1;ASTN2;ITPR1;MASP1;PDXK;NRXN1;FKBP9;TCHH;RYR2;FAN1;FEN1;LOXL2;KCNIP1;CISD3;DCHS1;CEMIP2;CDH11;CAMKK2;CDH15;CDH3;LRRK2;CLEC3B;KCNIP2;ATP2A2;NOL3;CAPN3;CLYBL;RASGRP2;S100A7A;ENPP3;CALB1;ADCY2;CDC42BPA;PRKACB;MAN1C1;SYT3;PIF1;AMY1B;AMY1C;AMY1A;PINK1;KCNIP4;MICU3;PVALB;OPA1;ITSN1;SYT7;MAN1B1;PPP3CB;DHX36;RCN3;CABYR;S100A2;TRPM2;SYT5;S100A1;CDH10;HSP90B1;FIGNL1;YDJC;DIS3L2;TESC;EML1;S100G;SPARCL1;BGLAP;RYR3;ASPH;MELK;PCLO;NME1;STIM1;HSPA5;NDUFAB1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4591621439364874,-1.2064709051750222,0.21852731591448932,0.5948481645990845,1.0,7/15,14.14%,HS3ST3A1;HS3ST4;HS3ST1;NDST1;NDST3;HS3ST2;HS3ST3B1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.46679323861459276,1.2062732809531447,0.22750424448217318,0.8488566665824255,1.0,4/21,15.70%,CHRNB4;GRIK2;P2RX4;GLRB
prerank,manganese ion binding (GO:0030145),-0.338492055368665,-1.2060159253205396,0.16507936507936508,0.5895049375473783,1.0,12/48,14.15%,B4GALT1;MPPED2;XPNPEP3;SOD2;ADPRM;MGAT1;LARGE1;GYG1;DYRK2;ME1;PRIMPOL;GALNT1
prerank,semaphorin receptor activity (GO:0017154),-0.4935970393252031,-1.2053361060908956,0.24663677130044842,0.5848375644546892,1.0,4/11,2.72%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,clathrin adaptor activity (GO:0035615),-0.4457927388590892,-1.2039988762710168,0.21158690176322417,0.5819684104622741,1.0,9/15,35.49%,HIP1R;DAB2;AP2A1;HIP1;AP2S1;AP2B1;AP1M1;AP1G1;AP1G2
prerank,single-stranded DNA helicase activity (GO:0017116),0.4755715514520829,1.2023498852795986,0.21475409836065573,0.855705358314763,1.0,7/19,21.65%,MCM7;POLQ;PIF1;RFC3;DHX9;HELQ;RFC4
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5089835326068768,-1.2011941311982401,0.23695652173913043,0.5831605110927739,1.0,3/10,6.91%,SLC24A3;SLC8A3;SLC3A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3819583924920371,-1.2009928357676034,0.20887728459530025,0.577640428856531,1.0,8/27,16.42%,SLC9A2;SLC8A3;SLC9B2;SLC3A2;SLC41A1;CNNM4;SLC4A8;SLC9A5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.43695216025791445,-1.1996877044722174,0.21428571428571427,0.5749781120485332,1.0,8/15,30.24%,PLA2G4A;SH3PXD2B;JPH2;SNX3;PLA2G4E;LANCL2;RUBCNL;VEPH1
prerank,GABA receptor activity (GO:0016917),0.45681481410580904,1.199402171082984,0.252129471890971,0.8581837207490685,1.0,6/21,15.97%,GABRA1;GABRD;GABRG3;GABRG2;GABRB1;GABBR2
prerank,R-SMAD binding (GO:0070412),-0.43172544092297704,-1.1982385248164267,0.21927710843373494,0.5726960422146585,1.0,4/18,8.34%,SMAD6;DDX5;DROSHA;SMAD3
prerank,FMN binding (GO:0010181),0.5368996978314198,1.1971849087824669,0.2512998266897747,0.8587242023851623,1.0,3/11,6.89%,POR;MTRR;DUS2
prerank,low-density lipoprotein particle binding (GO:0030169),0.49943359543780286,1.1964562533067082,0.24019607843137256,0.8534453627611769,1.0,3/16,5.25%,COLEC12;LIPC;SORL1
prerank,protein homodimerization activity (GO:0042803),0.29991560646492527,1.1920207791021824,0.07026476578411406,0.861840075140043,1.0,127/590,18.07%,TBX18;ENPP1;HSD11B1;PDGFRA;ECE1;GHR;XCL1;TENM3;PTPRT;ACOX2;TIMM10;NTRK2;HIF1AN;NR2F2;GLDC;ERBB4;PIP4K2A;ABCD2;MASP1;PDXK;FAP;ODC1;CIP2A;PHETA2;FGFR1;RABL3;TPST1;EPRS1;TYR;JUP;POU3F3;TENM4;SOX6;KMT2A;RNF40;ERCC5;KYNU;MTCL1;CPQ;FMR1;ZBTB16;GRHPR;MSH3;LRRK2;PEX7;MTMR1;ACTN1;ADCY8;MTHFD1L;TENM2;SRF;DSCAML1;TRIM37;PTPRO;SYNDIG1;QTRT2;GLIPR2;TERF1;CIDEA;UXS1;TRIM8;APPL2;CPOX;TENM1;COMMD1;CR2;IRAK1;NUDT21;HOGA1;EIF2AK1;PRPS1L1;PRPS1;PTPA;PYCARD;ACOT7;SLK;BCL2L2;HMGCS1;PDK2;SLC4A1;ACSL6;S100A1;ZNF318;GALE;KCNN2;CISD2;RAB11FIP3;CADM3;PEX11A;TESC;SYNE1;AXIN1;SDCBP2;NECTIN3;TSG101;RDH5;SNF8;BAK1;RIPK1;TFAP4;ABCB7;PRMT2;GDNF;PHETA1;CENPF;ZHX3;FGFR2;AOX1;CRPPA;MMAA;ZDHHC2;CYP2R1;HARS1;SLC39A13;RRAGA;MMUT;SARS1;ADRA2A;VPS4B;GOLGA5;LDB1;GNPTG;TOP2A;CAMK2A;MSH6;DPYD;WRN
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.45541784992382817,1.1904896210604192,0.25,0.8596856845232645,1.0,7/21,13.23%,AKAP5;AKAP7;RYR2;WASF3;PRKACA;ACBD3;AKAP6
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4398449809965703,1.1838725756644455,0.2544570502431118,0.8760428511989639,1.0,3/26,7.43%,PTN;BOD1;PPP1R14A
prerank,Toll-like receptor binding (GO:0035325),0.5196827616061994,1.1822185136370975,0.2703180212014134,0.8743971438651947,1.0,4/11,17.67%,UNC93B1;TLR6;TIRAP;MYD88
prerank,endopeptidase activator activity (GO:0061133),-0.5018053684714022,-1.180949908651577,0.273542600896861,0.6103038816323492,1.0,8/10,34.19%,APH1A;APH1B;PSME3;PSME2;ADRM1;VSIR;PSME1;NLRC4
prerank,metallopeptidase activity (GO:0008237),0.3420525506450688,1.1787855196259593,0.1935483870967742,0.8792252387533787,1.0,28/113,17.31%,ECE1;ECE2;ADAMTS14;ADAMTS6;MBTPS2;MMP24;MMP28;MMP25;EIF3H;ADAM11;ADAM19;METAP1D;OMA1;ADAMTS12;MMP11;ADAMTS2;NRDC;ADAM12;PITRM1;SPRTN;ADAMTS20;ADAMTS10;ADAM2;ADAMTS19;DPEP1;PSMD14;RNPEP;ADAM8
prerank,ATPase activator activity (GO:0001671),0.4563391767471664,1.1785629053798479,0.2694136291600634,0.8726387969658628,1.0,5/20,13.75%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15
prerank,neuropeptide receptor activity (GO:0008188),0.41951424421046557,1.1762378560005387,0.26291079812206575,0.8734164318540326,1.0,2/29,2.03%,SORCS3;NPFFR1
prerank,voltage-gated ion channel activity (GO:0005244),0.491203269869496,1.1746591327959799,0.26666666666666666,0.8715361145898685,1.0,4/14,10.52%,VDAC2;CACNA1E;HCN1;KCND2
prerank,NF-kappaB binding (GO:0051059),0.4361741262006391,1.1725970459719426,0.2680577849117175,0.8717648113997699,1.0,4/24,7.08%,HDAC1;HIF1AN;CDKN2A;BRMS1
prerank,NADP binding (GO:0050661),0.4137412166872245,1.1709399498231676,0.262992125984252,0.8707514460266604,1.0,5/32,8.28%,HSD11B1;GRHPR;MTRR;DUS2;KCNAB1
prerank,G protein-coupled receptor activity (GO:0004930),0.3110540955482916,1.1666078786314902,0.17600896860986548,0.8784073443913549,1.0,29/239,10.95%,ADGRL3;GPR88;RXFP3;ADGRV1;CALCRL;PDGFRL;GPR3;NPFFR1;C5AR1;P2RY1;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;MRGPRE;GPR22;LPAR3;ADGRB3;TRHR;GPR183;GPR176;ADGRL1;NPY;TAPT1;GPR52;LPAR1;GRM5;GPR26
prerank,sulfotransferase activity (GO:0008146),0.4064329429608997,1.1648723271722323,0.2546583850931677,0.8777041022949698,1.0,2/33,3.16%,CHST8;TPST1
prerank,GTPase regulator activity (GO:0030695),-0.25482912021189486,-1.1630013037237543,0.09333333333333334,0.6508539078407799,1.0,61/212,15.41%,RANBP3L;TBC1D4;PLCB1;RAPGEF2;CHN2;SLIT2;RGS3;SIPA1L1;RGS6;DOCK1;RGS5;RGS12;NRP1;SIPA1L2;SIRPA;IQGAP1;TBC1D8;ARL2BP;RAP1GAP2;EIF5;ARHGAP10;ARHGAP42;SH3BP4;TBC1D22B;ARHGAP17;ARAP3;RASGRP3;SRGAP2;ERRFI1;BNIP2;ARFGAP2;RANGAP1;RUNDC1;RALBP1;ITGB1BP1;ELMOD3;ARHGAP18;SGSM2;CPEB2;ELMOD2;ARL2;GMIP;GRTP1;CCDC88A;ARHGAP27;PGAM5;RP2;ARHGAP28;TBC1D7;ALS2;EVI5L;TBC1D22A;BCR;IPO7;TBC1D10B;ARHGAP15;ASAP2;TBCK;RAP1GDS1;TBC1D13;RGS10
prerank,leak channel activity (GO:0022840),0.46619256127528685,1.162950306513467,0.2652388797364086,0.877746519479876,1.0,5/18,15.93%,KCNK2;NALCN;TMEM175;KCNK1;KCNK13
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.45343032148294954,1.1628073800374163,0.277504105090312,0.8645288064986227,1.0,8/21,17.24%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.45343032148294954,1.1628073800374163,0.277504105090312,0.8645288064986227,1.0,8/21,17.24%,CDK14;CDK8;CDKL3;CDK13;CDKL1;CDK10;CCNK;CDK5
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.44763765364339575,1.1580235255309823,0.28187919463087246,0.8744396829187409,1.0,6/20,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;SLC39A13;SLC39A14
prerank,protein kinase activator activity (GO:0030295),-0.3043948653954199,-1.1573817004919649,0.1709090909090909,0.6599474090687792,1.0,19/60,19.39%,PRKAG2;AFAP1L2;RICTOR;IQGAP1;RPLP1;GPRC5C;WNK1;CALM1;MADD;CAB39;MAP2K2;ALS2;ETAA1;CDKN1A;PAK2;ERBB3;WNT11;MARK2;RGCC
prerank,CoA-ligase activity (GO:0016405),0.4817653002118784,1.155643779288312,0.28987993138936535,0.8759222839052379,1.0,1/14,1.09%,ACSS3
prerank,growth factor activity (GO:0008083),0.35562347221071433,1.1547936187002723,0.2524137931034483,0.8718630116151077,1.0,13/74,16.73%,PTN;NRG1;CXCL1;AMELX;NRG3;IL12A;ENDOU;IGF2;CLEC11A;FGF5;AREG;GDNF;JAG1
prerank,nuclear localization sequence binding (GO:0008139),0.45017245554009366,1.15424537676494,0.28183361629881154,0.8673101976425842,1.0,9/18,22.51%,NUP214;POM121;TNPO1;KPNA1;CABP1;TNPO2;KPNB1;KPNA2;IPO4
prerank,calcium channel regulator activity (GO:0005246),0.39824721224758075,1.152821245117407,0.27191679049034173,0.8656164513082147,1.0,9/37,15.57%,ITPR1;NRXN2;NRXN1;STIMATE;NPY;CACNG4;STIM1;PACSIN3;SGK1
prerank,protein kinase C activity (GO:0004697),0.47489670988953964,1.1523230070242843,0.30103806228373703,0.860796911671352,1.0,5/14,9.17%,PRKD3;PRKCI;PRKD1;PRKCA;PRKCB
prerank,endodeoxyribonuclease activity (GO:0004520),0.45819714898161656,1.1502075610202478,0.28733766233766234,0.8613473502648696,1.0,5/20,13.74%,ERCC1;FEN1;ERCC5;ERCC4;MBD4
prerank,nucleotidase activity (GO:0008252),-0.4232248750655555,-1.147807581766852,0.25925925925925924,0.67974919829608,1.0,8/15,32.64%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;BPNT1;NT5C2
prerank,3'-5' DNA helicase activity (GO:0043138),0.4656677554383566,1.1473079965349242,0.2996632996632997,0.8650015163947513,1.0,7/16,18.20%,MCM7;NAV2;RECQL;DHX9;HELQ;WRN;FBH1
prerank,steroid hydroxylase activity (GO:0008395),0.46960777641820917,1.1446334635105404,0.3104026845637584,0.8680816217577965,1.0,1/16,0.29%,CYP7B1
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.31354377016488255,-1.1378050265528585,0.23920265780730898,0.70006575620401,1.0,24/51,32.05%,SLC16A2;SLCO2A1;SLCO1C1;SLC22A4;SLC22A6;SLC25A3;SLC22A8;SLC35D2;SLC7A5;SLC20A1;MFSD2A;SLC35E4;TMEM241;SLCO5A1;SLC35C2;MCU;SLCO4A1;SLC25A11;SLC5A6;SLCO4C1;SLCO1B1;SLC5A5;SLC35E2A;SLC35E2B
prerank,monocarboxylic acid binding (GO:0033293),0.4564746237652707,1.137779623128949,0.29173989455184535,0.885123421202697,1.0,2/18,2.85%,NR2F2;NR1H4
prerank,tumor necrosis factor receptor binding (GO:0005164),0.492993395230335,1.136343143847271,0.3368055555555556,0.8834856006620044,1.0,2/12,7.21%,TRAF4;TRIM37
prerank,vinculin binding (GO:0017166),0.5133268920666973,1.135671614880857,0.32783882783882784,0.8792476471275312,1.0,3/11,6.32%,UTRN;CORO2B;ACTN1
prerank,pyrophosphatase activity (GO:0016462),0.36773866317201304,1.1350855441291994,0.2857142857142857,0.8748646942964502,1.0,11/50,14.93%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA;NUDT9;TRPM2;ENTPD7;BNIPL;PLPP5;DHX9
prerank,MHC class II protein complex binding (GO:0023026),-0.46744847539192813,-1.1333573659301093,0.3184855233853007,0.7057314121014132,1.0,4/11,17.21%,HSPA8;ANXA11;PKM;CD74
prerank,lipoprotein particle binding (GO:0071813),0.4477198398406592,1.1329803378502337,0.3022151898734177,0.8755333308948202,1.0,3/20,5.25%,COLEC12;LIPC;SORL1
prerank,water transmembrane transporter activity (GO:0005372),-0.44346819555106776,-1.1328860026712124,0.3363431151241535,0.7003485806274142,1.0,8/11,55.32%,PDPN;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7;SLC5A1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.41418836087357014,-1.1300356467152095,0.28361858190709044,0.7019775082552755,1.0,6/16,22.27%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,organic cation transmembrane transporter activity (GO:0015101),0.4600725730219668,1.1284834151504792,0.3130287648054145,0.8843632497699992,1.0,5/16,18.50%,SLC18A3;SLC7A8;SLC25A26;SLC25A17;SLC44A1
prerank,Tat protein binding (GO:0030957),-0.46274451489453217,-1.1280300146313147,0.31403118040089084,0.7014566340029774,1.0,3/10,6.18%,ACTB;SMARCA4;GABARAPL1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.4929138193459195,1.125192610581518,0.3213644524236984,0.889053752009328,1.0,2/11,9.94%,HCN2;HCN1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.47019797199359636,1.1229705355983741,0.32597623089983024,0.8901891153344204,1.0,4/14,9.76%,RPP40;POP5;PRORP;POP7
prerank,beta-tubulin binding (GO:0048487),0.39774358550951205,1.1202422431637564,0.3111455108359133,0.8928606129185964,1.0,5/31,10.91%,DLEC1;CCT5;LRPPRC;ARL8B;IFT74
prerank,hexosyltransferase activity (GO:0016758),-0.2658037089028879,-1.1196273139813036,0.17982456140350878,0.7181178533094704,1.0,24/101,16.13%,B4GALT1;TMTC2;CSGALNACT1;B3GALT1;TMTC1;ALG9;B4GALT5;EXT1;GBE1;TMTC4;LARGE1;GYG1;HEXB;HYAL1;MGAT4B;ALG12;MTAP;B3GALNT1;FUT9;LFNG;DPY19L4;GCNT1;MFNG;B3GLCT
prerank,androgen receptor binding (GO:0050681),-0.3590817345987301,-1.119524458548388,0.2857142857142857,0.7117933373420742,1.0,5/25,7.64%,FOXP1;DDX5;KDM4C;SMARCA4;TMF1
prerank,ribonuclease P RNA binding (GO:0033204),0.5075876387042442,1.119273607778191,0.3350877192982456,0.8899804802780448,1.0,3/10,9.76%,RPP40;POP5;POP7
prerank,carboxylic acid binding (GO:0031406),0.38346259089961776,1.1181213837952582,0.3074626865671642,0.8877320146366999,1.0,11/38,17.61%,THNSL2;HIF1AN;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,hormone activity (GO:0005179),0.36099474547837285,1.1152565585702046,0.3100558659217877,0.8915825704136701,1.0,7/54,11.19%,HCRT;EDN3;SPX;TRH;NPY;CCL25;ERFE
prerank,alanine transmembrane transporter activity (GO:0022858),-0.43673331158619255,-1.114699564635603,0.3219178082191781,0.718901645334979,1.0,5/12,21.01%,SLC6A6;SLC3A2;SLC38A5;SLC36A4;SLC38A7
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4465722736612289,-1.1144329096104229,0.3273942093541203,0.7131156392295773,1.0,8/12,47.46%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A3;SLC2A6
prerank,damaged DNA binding (GO:0003684),0.3701602013276149,1.1141457408263018,0.2832369942196532,0.8891991594045557,1.0,11/44,15.54%,ERCC1;FEN1;POLQ;ERCC5;NEIL3;RPA1;ERCC4;XPC;XRCC1;ERCC2;CRY2
prerank,5'-nucleotidase activity (GO:0008253),-0.4245435648029021,-1.1133342863043398,0.31683168316831684,0.7096953408593438,1.0,7/13,32.64%,NT5DC3;NT5E;NT5C3B;NT5C1A;NT5M;ACP3;NT5C2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4587890132505789,-1.1125480512231298,0.32207207207207206,0.705412251945483,1.0,4/10,13.12%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5046950759991184,1.1101937666019361,0.3262411347517731,0.8965386603244669,1.0,4/10,16.89%,STAMBPL1;ATXN3;YOD1;STAMBP
prerank,thyroid hormone receptor binding (GO:0046966),0.40543180358791286,1.1097301214305175,0.3203732503888025,0.8922830308143644,1.0,10/28,20.81%,MED12;NCOA3;BRD8;NSD1;HMGN3;MED1;GTF2H1;PRMT2;TAF11;GTF2B
prerank,sequence-specific DNA binding (GO:0043565),0.281015818568574,1.107425685210674,0.19837232960325535,0.8938545903670944,1.0,97/590,16.31%,TBX18;RORA;ZBTB20;ISL2;MSC;ATF5;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;TEAD1;ETV5;TEF;NR2F2;TCF7L2;TCF4;SMAD5;NR1H4;ZIC4;MEIS2;NFATC3;ZNF740;POU3F3;PPARD;TEAD2;TBX3;FOS;ZIC1;KMT2A;HOXC9;ZNF423;FOXN2;CXXC1;MYCN;DMRTA2;EPAS1;HLF;LIN28B;E2F4;GLIS1;MBD3;ZCWPW1;SRF;CSRNP3;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;TERF1;CSRNP2;ZKSCAN3;PIF1;ERH;SOX2;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;TFEB;HOXB4;DMRTA1;PRDM5;NFIX;HOXC4;ZFP1;RFX4;SREBF1;CUX2;MYRF;ARNT2;LONP1;ELK1;BPTF;CREB3L1;ZBTB32;HNRNPD;TFAP4;SAFB2;ATF2;FOXJ3;KLF11;HOXA9;MAFB;KDM2A;ZBTB7A;ONECUT2
prerank,protein phosphatase binding (GO:0019903),-0.25962525020514293,-1.1072458177522109,0.23076923076923078,0.7134104504954423,1.0,37/117,17.80%,FOXO1;EGFR;SIRPA;IQGAP1;SHOC2;MAP3K5;VRK3;FBXL2;PPP1R16A;MAPK14;AKAP11;MVP;PPP1R3B;MTMR9;SH3RF2;ITGA1;PPP6R1;VCP;PPP1R16B;MAPT;MAP2K7;CTTNBP2NL;BAD;PHACTR4;AP3B1;KCNQ1;CEACAM1;SMG5;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;PPP1R11
prerank,amino acid binding (GO:0016597),0.39235974871589807,1.105050948668272,0.32238805970149254,0.8957688151329177,1.0,10/31,17.61%,THNSL2;GLDC;GRIN2B;GLRA3;GLRA1;GLRA2;GLRB;GRM7;CASTOR1;GRIN3A
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4402132926646849,-1.1050179502631672,0.3395348837209302,0.7129467460870198,1.0,5/12,21.46%,PIEZO2;TMC7;TMC6;TMEM63B;PIEZO1
prerank,protein kinase binding (GO:0019901),-0.21495165870072855,-1.1033188811406873,0.09433962264150944,0.7109950165002267,1.0,100/480,14.67%,PRKAG2;EPHA4;MAP3K1;MAPK4;RHOBTB1;SLC12A7;IL31RA;CAV1;PDLIM5;PTPRJ;BCL2L1;ACTB;TRIB2;ITGB1;PTPRK;EZR;BMPR2;BECN1;ELAVL1;RICTOR;SIRPA;IQGAP1;NEK6;CSPG4;SQSTM1;CCND2;CAVIN2;ATG13;RHOBTB2;MAPK8IP3;SKI;APC;RAC1;NEDD9;DVL1;MAVS;ACE;CAV2;TFRC;ADAM10;SYN1;CDC42;RPS7;WNK1;TRIM5;ERRFI1;TJP2;PARN;RPS19;TRIM14;CALM1;SIK1;MVP;PFKFB2;GSK3B;ACVR1;RHOC;ACVRL1;GCH1;MAPT;SMAD3;ANK2;YWHAG;MAP2K7;AP2A1;EXOC2;FRMD5;BAD;EEF1A1;CAVIN3;PPM1D;PPEF2;ADCY6;PTPN2;SPAG9;PTPN1;KCNQ1;CCDC88A;MAPKAP1;HSPB1;CEACAM1;ACTA2;SPRED3;PLCG2;SMAD1;NR3C1;NOX4;PRKAG3;PRKAR2A;CYLD;TRPV4;IRAK4;GATA6;NBEAL2;HINT1;PRKAR2B;CCND1;GRB2;TICAM1;CDH5
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.40126915306331734,-1.1016826843284537,0.3471882640586797,0.7094861314770718,1.0,3/16,19.42%,PIR;ETHE1;ALOX12
prerank,acid-thiol ligase activity (GO:0016878),0.4645940625299114,1.1004249252458995,0.3401015228426396,0.9053456775475236,1.0,1/13,1.09%,ACSS3
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.28610829197527,-1.0993785326348704,0.2830188679245283,0.7095095744951649,1.0,17/70,20.29%,B4GALT1;CSGALNACT1;B3GALT1;GXYLT2;EXT1;LARGE1;HEXB;HYAL1;MGAT4B;B3GALNT1;LFNG;GCNT1;MFNG;B3GLCT;B3GNT2;HAS1;GXYLT1
prerank,receptor ligand activity (GO:0048018),0.2950785599498693,1.099012564719796,0.27497194163860833,0.9044673684796577,1.0,12/245,2.18%,IL33;PTN;IL34;EPHA7;CXCL10;NRG1;EDN3;EDA;WNT5A;CXCL1;SEMA5A;IL16
prerank,NAD+ binding (GO:0070403),-0.436088426522119,-1.098718616900538,0.3538083538083538,0.7053545341238642,1.0,7/12,18.84%,SIRT3;ZC3HAV1;PARP9;CRYL1;HADH;SIRT1;SIRT5
prerank,receptor tyrosine kinase binding (GO:0030971),0.35230558240413784,1.0980229116724296,0.31058495821727017,0.9022064002085866,1.0,10/56,11.42%,PIK3R1;NRG1;CBLB;FLT3LG;GAB2;PIK3R2;IRS1;FIZ1;TP53;NRG3
prerank,cytokine receptor binding (GO:0005126),0.3330864752910994,1.0949779357103793,0.31592689295039167,0.9062829368858595,1.0,11/83,12.10%,IL34;IL1RN;XCL1;JAK1;TSLP;SPRED1;SPRED2;IL1RAP;CCL25;PYCARD;IL12A
prerank,adrenergic receptor binding (GO:0031690),-0.3958686741308003,-1.093426012504367,0.32524271844660196,0.7137517929743741,1.0,4/16,3.34%,RAPGEF2;ARRDC3;GNAS;MAGI2
prerank,regulatory RNA binding (GO:0061980),0.37570712029077663,1.0933939796274026,0.3202511773940345,0.9058215301585862,1.0,9/38,11.21%,AGO4;SPOUT1;FMR1;DND1;ZC3H7B;ZNF346;HNRNPA2B1;SOX2;AGO3
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.3205041238129741,-1.0932512789326538,0.2891566265060241,0.7082489629065869,1.0,10/38,11.76%,SORBS1;SHANK3;MAGI2;MAPK8IP3;NCK1;SHANK1;SPAG9;FRS2;SH2B1;DLG5
prerank,tubulin binding (GO:0015631),0.2874429263962738,1.093058701980909,0.2650862068965517,0.9013591540888933,1.0,60/296,14.84%,DLEC1;ATF5;CCDC61;REEP2;MDM1;MAP4K4;GJA1;EFHC1;IRAG2;MTCL1;FMR1;CCT5;NEFH;LRRK2;CENPE;STARD9;CEP295;SUN2;CLIP3;LRPPRC;TTLL6;IFT81;UNC5C;SNPH;TERF1;HAUS8;FAM161A;GOLGA2;STMN2;NAV3;PHF6;OPA1;BRCA2;CCSAP;CAPN6;STMN4;ARL8B;IFT74;KATNA1;TBCE;FYN;NUSAP1;GAS8;AGBL4;RMDN1;DNM1;TUBGCP4;SYBU;POLB;KIF5C;CLIP2;KIF9;EML1;TPGS1;MAP9;STMN1;CLASP2;KIF3C;TUBGCP6;KIFC2
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4573964422011758,-1.0927908734561342,0.3583690987124464,0.7036217424263389,1.0,3/10,8.51%,ANO6;ANO1;CLCN5
prerank,mRNA binding (GO:0003729),0.2910569067419529,1.0897951311557064,0.28896473265073946,0.9070595246617514,1.0,58/249,18.68%,RBFOX1;EIF4G3;RBMS1;CPEB1;GNL3;TRA2B;EIF4A3;NANOS3;NOVA1;MYEF2;RBM46;RBM24;LSM14A;SNRNP35;RNF40;SF3B6;ZC3H12D;RBMS3;FMR1;DND1;LARP6;CCT5;BOLL;KHDRBS3;ELAVL4;PCBP3;HNRNPA2B1;CELF4;NUDT21;LUC7L2;TP53;RBFOX3;DHX36;EDC3;CSDC2;RBM20;HDLBP;EIF4ENIF1;RBM4B;SLBP;DHX9;RC3H2;SNRNP70;FYTTD1;HNRNPLL;SRRM2;IGF2BP3;RBM5;PPP1R8;THOC5;HNRNPL;SRRM3;CALR;SRSF6;DXO;LSM14B;KHDRBS1;YTHDF1
prerank,ephrin receptor activity (GO:0005003),0.43020137769308975,1.0889228779208313,0.3764705882352941,0.8986209553591994,1.0,5/17,10.40%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.43020137769308975,1.0889228779208313,0.3764705882352941,0.8986209553591994,1.0,5/17,10.40%,EPHA7;EPHB1;EPHA6;EPHB6;EPHA3
prerank,snoRNA binding (GO:0030515),-0.3340697866337178,-1.0888161789453845,0.3198757763975155,0.7082015353386474,1.0,12/30,30.39%,PRKDC;DDX21;NUDT4;NUDT7;IMP3;NUFIP1;TSR1;NUDT16;NUDT16L1;NHP2;BMS1;RRP9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4433772755806654,-1.0885950886494662,0.35180722891566263,0.703013972892565,1.0,10/11,55.69%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,adenyl nucleotide binding (GO:0030554),-0.4429373336829549,-1.0862438564531027,0.3959731543624161,0.6979218492886928,1.0,6/11,30.00%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4429373336829549,-1.0862438564531027,0.3959731543624161,0.6979218492886928,1.0,6/11,30.00%,HSPH1;BAG3;HSPBP1;BAG2;SIL1;BAG4
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.4454730306628552,1.0859110918516357,0.3663865546218487,0.8973863772019507,1.0,6/16,10.69%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.4454730306628552,1.0859110918516357,0.3663865546218487,0.8973863772019507,1.0,6/16,10.69%,PTPRT;PTPRR;PTPRN2;PTPRU;PTPRO;PTPRA
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.47798197680254345,1.0850027023010622,0.3621908127208481,0.8949189750888158,1.0,2/11,15.28%,RDH11;AKR1B1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.27266698046008403,1.084720701106968,0.2199798183652876,0.8904376165153043,1.0,147/830,17.30%,TBX18;RORA;GBX1;ZNF367;ZEB1;ZBTB20;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;ETV5;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;GTF2A1;HOXC9;ZNF423;ZBTB16;MYCN;DMRTA2;ZFP37;EPAS1;HLF;FOXS1;E2F4;ZBTB46;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;ZKSCAN3;TWIST1;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;ZBTB43;HOXC8;TBPL1;SOX10;TP53;NFXL1;DHX36;ZBTB39;ZNF25;MED8;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TWIST2;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;PEG3;SREBF1;CUX2;ARNT2;ELK1;BPTF;ZSCAN18;ZBTB32;MYNN;FOXM1;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZNF3;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,transcription cis-regulatory region binding (GO:0000976),0.28051177884677,1.084062834975861,0.28465608465608466,0.8871400437887889,1.0,63/406,15.75%,TBX18;RORA;GBX1;ZBTB20;ISL2;BHLHA9;TRPS1;MSC;ATF5;HOXC10;TEAD1;ETV5;HDAC1;TCF7L2;BASP1;ERBB4;THRA;NR1H4;PER3;REST;FOS;SOX6;FOXN2;ZFP37;EPAS1;CREB3L2;PRDX5;BCOR;ZBTB46;ALX4;PER2;TWIST1;SOX2;MXI1;GLI1;GLI3;ZBTB43;HOXC8;SOX10;TP53;NFXL1;DHX36;ZNF25;MSX1;SOX9;TWIST2;TFEB;PRDM5;CARM1;PEG3;SREBF1;CUX2;LONP1;ELK1;CREB3L1;FOXM1;TFAP4;PBX2;AR;ATF2;MYC;CRY2;KLF11
prerank,CoA hydrolase activity (GO:0016289),-0.40015260700021227,-1.0831977835842943,0.33665835411471323,0.700557998179499,1.0,5/16,15.36%,ACOT8;NUDT7;ACOT13;ACAA2;ACOT6
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.30581191928182244,-1.0827734209835682,0.30434782608695654,0.6962909402843391,1.0,19/49,24.52%,SQSTM1;ABRAXAS2;VCP;PARP10;OPTN;MINDY1;RNF169;BRCC3;TAB2;PSMD4;RAD23B;TNFAIP3;HDAC6;ZFAND2B;IKBKE;ZRANB3;ZFAND6;IKBKG;ATRIP
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.3900891361434596,-1.0821722607377213,0.3281653746770026,0.6922963662961331,1.0,6/18,22.48%,SMAD6;TGFB2;SMAD3;TGFBR3;TGFBR2;SMAD7
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.42258183519471854,-1.0814465852217663,0.36818181818181817,0.6888382460234348,1.0,7/13,11.86%,PDGFD;PTPRJ;IL1R1;VEGFD;PDGFA;PDGFC;ITGB3
prerank,NADPH binding (GO:0070402),0.46327825427071767,1.0809972468342959,0.35543278084714547,0.8916279368372306,1.0,4/13,8.28%,GRHPR;MTRR;DUS2;KCNAB1
prerank,alkali metal ion binding (GO:0031420),0.4585083005869163,1.0794433086175295,0.3615257048092869,0.8911408230558779,1.0,3/13,6.54%,ATP1A2;PDXK;CAPN3
prerank,kinase activity (GO:0016301),0.31303751479351183,1.0781686908351098,0.33248730964467005,0.8900956480733205,1.0,26/109,14.06%,PDXK;MAP4K4;PKMYT1;PRKD3;CDC7;CDKL5;SCYL3;PSTK;LRRK2;IPMK;NADK;COASY;PI4KA;DGKQ;PAPSS2;PINK1;PRKD1;MTOR;CKM;IRAK1;CHKA;GK;DGKI;AGK;IP6K1;LYN
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3173647061159931,-1.0778155374430516,0.3465909090909091,0.6930236487671395,1.0,11/37,21.20%,SLCO2A1;SLCO1C1;SLC22A4;SLC22A6;SLC22A8;COX15;COX5B;COX4I1;COX6B1;SLCO5A1;UQCRQ
prerank,protein serine/threonine kinase activity (GO:0004674),-0.2224707845889652,-1.0754528307522668,0.1566265060240964,0.6938387616617704,1.0,105/335,23.57%,DAPK1;MAP3K1;MAPK4;ROCK2;PRKCH;MARK1;EGFR;MYLK;BMPR2;IRAK2;CSNK1D;MARK4;NEK6;CAMK2D;SQSTM1;PRKDC;MAP3K5;TOP1;SIK3;MINK1;WNK4;VRK3;PRKAA2;TLK1;MAPK9;CDK6;SNRK;WNK1;HIPK3;MAPK14;NRBP2;SIK1;GSK3B;HIPK1;ACVR1;CDC42BPB;RIOK1;ACVRL1;TLK2;NEK7;STK38L;MAST3;DYRK2;RPS6KA5;CDK19;CAMK2B;STK19;MAP3K8;ATR;CDKL2;CAMK2G;RPS6KA1;RIOK3;FASTK;SRPK1;GAK;PRKCZ;HIPK2;ATM;CSNK1G3;IRAK4;BCR;PTK2B;MAP3K4;CPNE3;STK17B;CDC42BPG;ERN1;MARK3;PRKCD;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;ACVR2B;STK32B;CDK9;AKT1;CSNK2B;NUAK2;CSNK1A1;SBK1;VRK2;MARK2;MAP4K3;ULK3;MKNK1;ALPK1;PKN3;PIM2;TGFBR2;NEK10;CDKL4;TTBK1;PASK;STK39;IKBKE;ACVR2A;BRD2;CDK16;PLK4;IKBKB;PAK4
prerank,symporter activity (GO:0015293),-0.4588538070428723,-1.0733898482174,0.4117647058823529,0.6939932199370097,1.0,10/10,54.15%,MFSD2A;SLC5A6;SLC5A5;SLC4A4;SLC46A2;SLC28A2;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.48979872846146205,1.0731259854494826,0.3954305799648506,0.9009167946387447,1.0,3/10,13.55%,CDKN2A;CDKN2D;CDKN2C
prerank,zinc ion binding (GO:0008270),0.28401996590220907,1.0714774249824266,0.3401506996770721,0.9007967934373884,1.0,62/293,18.02%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;HIF1AN;CBLB;PDXK;GRIN2B;EPRS1;DUSP12;MYT1;SLC30A5;DNAJC24;KMT2A;CHD4;ZFP37;DHX58;SIRT6;GRIN2A;ACR;TARS1;ENPP3;CALB1;MDM4;TRIM8;DPYS;BIRC2;NSD1;SLU7;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;ZFPM2;P2RX4;USP33;PTGR2;KDM1B;TRIM2;HDAC10;RABIF;KDM5C;ZBTB32;TMEM163;ZKSCAN5;KDM2A;ZNF3;USP16;DPEP1;SEC24A;CALR;RNPEP;SEC23A;ADAM8;PEX12;SUV39H2;MBD1
prerank,phosphatase binding (GO:0019902),-0.25744563008012056,-1.0712292755554516,0.30414746543778803,0.6944790698632699,1.0,35/105,18.81%,CTSC;EGFR;SIRPA;MAGI2;IQGAP1;CNST;SHOC2;MAP3K5;VRK3;WNK1;FBXL2;MAPK14;MVP;MTMR9;SH3RF2;ITGA1;PPP6R1;VCP;SMAD3;MAP2K7;BAD;PPP3R1;AP3B1;CEACAM1;FLT4;PPP1R3C;CDH5;TRAF3;MET;TBK1;SKAP1;ERBB2;DLG1;CHCHD3;SNX3
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.35373465663889814,-1.0707412532537712,0.36962750716332377,0.6906517948185121,1.0,11/24,27.64%,DAPK1;CAMK2D;CAMK2B;CAMK2G;EEF2K;PTK2B;MKNK1;CAMK1G;CAMKK1;PHKA2;PHKG2
prerank,methylation-dependent protein binding (GO:0140034),0.34028251442472857,1.0697781281799856,0.3649025069637883,0.9009164081002806,1.0,21/57,22.66%,KMT2E;L3MBTL1;PYGO1;FMR1;RRP8;CXXC1;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;BPTF;CHD8;MBTD1;MSH6;THAP7;ING3;RBBP5;KDM5A;ATRX;ZMYND8
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.3882542401050345,-1.0682797523155694,0.33649289099526064,0.6866774381789684,1.0,2/16,2.46%,ANO6;ANO1
prerank,intracellular chloride channel activity (GO:0061778),-0.3882542401050345,-1.0682797523155694,0.33649289099526064,0.6866774381789684,1.0,2/16,2.46%,ANO6;ANO1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4339324549555728,1.0671492393496307,0.35494880546075086,0.9037118962403271,1.0,4/16,15.03%,SLC1A5;SLC25A22;SLC25A30;SLC25A14
prerank,deoxyribonuclease activity (GO:0004536),0.4614877732609163,1.0671397982112265,0.37457627118644066,0.8986155115373016,1.0,4/14,14.14%,ERCC5;ERCC4;MBD4;NME1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4403971471020448,1.066939620365916,0.37099494097807756,0.8941431470042954,1.0,7/15,21.55%,KMT2A;CXXC1;WDR5;ASH2L;SETD4;KMT2C;RBBP5
prerank,fibroblast growth factor binding (GO:0017134),0.4072825144754506,1.0658566539897516,0.38925081433224756,0.8925047969146886,1.0,3/21,3.03%,ITGAV;FGFBP3;FGFR1
prerank,voltage-gated calcium channel activity (GO:0005245),0.3617834592702821,1.0623434477705218,0.36795252225519287,0.898187660326951,1.0,9/37,15.95%,CACNA1E;ITGAV;CACNG3;CACNA1G;CATSPER3;CACNB4;CACNG4;CACNA2D1;NCS1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28910425184881716,-1.0617271615107637,0.31833910034602075,0.6981187622106915,1.0,6/49,5.01%,ANXA3;ANXA5;MCTP1;SYT9;PLA2G4A;ANXA1
prerank,poly(U) RNA binding (GO:0008266),0.4078739024132396,1.0599922957777843,0.3963210702341137,0.9003690180965274,1.0,3/20,4.99%,RBMS1;RBMS3;FMR1
prerank,potassium channel regulator activity (GO:0015459),0.34018182559432303,1.058134554825155,0.3748211731044349,0.9012267002507294,1.0,10/49,15.57%,DPP6;DPP10;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNE4;KCNAB3;WNK2;SGK1
prerank,methylated histone binding (GO:0035064),0.33431785462621755,1.0577848675555657,0.36488340192043894,0.8972601195291416,1.0,22/62,22.66%,KMT2E;L3MBTL1;PYGO1;FMR1;RRP8;CXXC1;ZCWPW1;SPIN1;WDR5;MORC4;MPHOSPH8;DPF2;BPTF;CHD8;MBTD1;MSH6;THAP7;ING3;RBBP5;KDM5A;ATRX;ZMYND8
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.267426818933725,-1.055014115257076,0.3333333333333333,0.7100618280013785,1.0,15/72,11.60%,PICALM;PLCB1;MARK1;ACTN2;SNX18;HIP1R;PARD3;GSN;SNX21;FZD7;VILL;KCNJ2;RAB35;KCNQ1;MAPKAP1
prerank,C-C chemokine receptor activity (GO:0016493),0.39991647820418974,1.0547597901401091,0.39872408293460926,0.9021553652651437,1.0,2/21,3.26%,ACKR2;CCR9
prerank,protein kinase regulator activity (GO:0019887),-0.25179586337100535,-1.0545551082755564,0.3116883116883117,0.7059937728537367,1.0,31/95,21.10%,PRKAG2;CCNYL1;RPLP1;CCND2;GPRC5C;APC;WNK1;YWHAB;NCK1;CCNG1;MADD;CAB39;PRKAG3;PRKAR2A;PRKAR2B;CCND1;MAPK8IP1;CDKN1A;KIDINS220;CCNE2;CCNL2;CSNK2B;WNT11;GSKIP;MARK2;HEXIM1;RGCC;NPM1;DNAJC3;ELP3;DUSP19
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.42846618631102096,1.0532984719268508,0.38209982788296043,0.9018943462131731,1.0,4/16,6.30%,PTEN;SACM1L;MTMR4;MTMR1
prerank,alpha-actinin binding (GO:0051393),-0.3414798854999698,-1.05314843603603,0.39577836411609496,0.7042637397871769,1.0,14/24,38.65%,CACNA1C;PDLIM5;DAG1;PDLIM3;MAGI1;PKD2L1;TTN;PPARG;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN;KCNA5
prerank,GTPase activity (GO:0003924),-0.229119646420576,-1.053063417122916,0.3053435114503817,0.6995515551889072,1.0,55/192,19.47%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;RASL12;RAP1A;DRG1;RAB23;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;RAB21;ARHGDIB;GBP4;RAB5A;RHOC;RAB5C;DNM3;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;RAB35;NKIRAS1;GBP6;RALB;RAN;RAB38;RRAS;GNL1;RAP2C;GNAZ;ATL3;GPN3;GNA14;ARL1;RAB1A;RAB6A;GTPBP1;RAP2B;GNG11;TSR1;RERG;GSPT2;RAB4A;RAB8B;RRAGB
prerank,retinoic acid binding (GO:0001972),-0.4153883862350051,-1.0530227584883227,0.36637931034482757,0.6947340374832693,1.0,2/12,6.38%,CYP26B1;RXRA
prerank,C-C chemokine binding (GO:0019957),0.3944500052389056,1.0527691011241067,0.3746031746031746,0.8985095751627798,1.0,2/22,3.26%,ACKR2;CCR9
prerank,alpha-tubulin binding (GO:0043014),0.38195165183104,1.0523162438236289,0.4009508716323296,0.8949124183568805,1.0,5/31,11.12%,DLEC1;EFHC1;ARL8B;TBCE;FYN
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4836087013736129,1.0507426687031152,0.4247787610619469,0.8948335101667585,1.0,2/10,9.92%,NAA10;NAA50
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.4702747629031233,1.0485789459390444,0.4293785310734463,0.8965501724115871,1.0,3/10,10.51%,GABRA1;GABRG3;GABRG2
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.41782682947808925,-1.0478493063826415,0.39903846153846156,0.7029884536723309,1.0,5/12,8.58%,IGF1;GNAS;INSR;SOCS2;YWHAG
prerank,mRNA 3'-UTR binding (GO:0003730),0.31686994959458425,1.047304188456303,0.3917808219178082,0.8958717559594643,1.0,17/79,12.15%,RBMS1;CPEB1;RBM24;RNF40;RBMS3;FMR1;DND1;CCT5;BOLL;ELAVL4;ZFP36L2;HNRNPA2B1;NUDT21;TP53;DHX36;CSDC2;EXOSC9
prerank,N-acyltransferase activity (GO:0016410),0.36384683787891703,1.0430321287907873,0.4034003091190108,0.9041304143976213,1.0,8/32,16.38%,NAA10;NAT10;CERS4;TLCD3B;NAA50;NAT8L;CERS6;GNPNAT1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.32130308843263433,1.0427178642098425,0.3755047106325707,0.9002648762693936,1.0,12/73,16.07%,RXFP3;SORCS3;CALCRL;NPFFR1;GPR37L1;CRHR2;CCKBR;F2R;S1PR2;LGR5;LHCGR;GPR37
prerank,phosphatase activator activity (GO:0019211),-0.39576417225717303,-1.0421390226902971,0.3787128712871287,0.7122670924717619,1.0,7/14,30.22%,CALM1;PHACTR4;FRS2;PPP2R5D;PPP2R5B;PPP2R5C;PPP1R15A
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.47288753410874806,1.0417427255887024,0.42057761732851984,0.8984630565209589,1.0,3/10,11.25%,FAN1;DAXX;FAAP20
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2883571408267231,1.0412059270212841,0.39622641509433965,0.8953262748116524,1.0,27/173,15.40%,TBX18;ZEB1;ZBTB20;ZFHX3;TRPS1;PPARA;NFATC3;PPARD;REST;TBX3;ZBTB16;ZFP37;ZBTB2;BCL6;ZKSCAN3;MXI1;ZBTB39;ZNF25;ZBTB26;MYT1L;HIC2;PRDM5;PEG3;CREB3L1;ZBTB32;ZBTB25;MYC
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.3788318773045787,-1.0387698113986614,0.40786240786240785,0.7161901627988106,1.0,5/17,15.36%,ACOT8;PLA2G6;ACOT13;ACAA2;ACOT6
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.2617431042511094,1.037613027540797,0.37487335359675783,0.9015490400633811,1.0,127/731,17.30%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;ISL2;ZFHX3;MSC;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;HOXC9;ZNF423;ZBTB16;FOXN2;MYCN;DMRTA2;HLF;FOXS1;E2F4;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;NR2C1;ZKSCAN3;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;SOX10;TP53;DHX36;ZBTB39;MED8;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;ARNT2;ELK1;BPTF;ZSCAN18;ZBTB32;MYNN;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,small GTPase binding (GO:0031267),-0.2312679943053469,-1.0359205590094889,0.3765432098765432,0.7181840420124185,1.0,38/170,14.29%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;AFDN;RNF152;RAPGEF6;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;EXOC5;SH3BP4;SRGAP2;ARHGDIB;RANGAP1;PPP6R1;RALBP1;RUSC2;EXOC2;SGSM2;OPTN;STK19;RNF41;MYO1C;MAPKAP1;TBC1D7;ALS2;GOLGA4;EVI5L;CCDC186;FLNA;LSM2;BICD2
prerank,calcium channel activity (GO:0005262),0.3124683283258695,1.03434920266658,0.39659685863874344,0.9064819375763108,1.0,14/84,12.51%,SLC24A5;CACNA1E;ITGAV;CACNG3;RYR2;TRPV3;CATSPER3;TRPC3;CACNB4;CACNG4;P2RX4;TRPM2;TRPC7;CUL5
prerank,endopeptidase inhibitor activity (GO:0004866),-0.261148012057267,-1.0295198754536719,0.3776978417266187,0.7298263646253154,1.0,15/82,14.01%,SPOCK2;APP;CST3;COL4A3;PSMF1;SERPIND1;PTTG1;RENBP;NGF;SERPINE1;SERPINI1;SERPINA2;GAPDH;SERPINE2;FURIN
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.39980000016838474,-1.029266164685584,0.4212962962962963,0.7254998265154914,1.0,6/13,30.74%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2590024216254258,1.0282329176601752,0.40161453077699294,0.9201637043860973,1.0,128/730,17.30%,TBX18;RORA;ZNF367;ZEB1;ZBTB20;ZFHX3;MSC;ETV1;PKNOX2;RUNX2;PPARA;HOXC10;MEIS1;TEAD1;TEF;HDAC1;NR2F2;TCF7L2;TCF4;SALL1;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;MEIS2;PGR;NFATC3;ZNF740;MYT1;POU3F3;PPARD;NR1H2;TEAD2;REST;TBX3;FOS;ZBTB24;SOX6;ZIC1;FOXO6;HOXC9;ZNF423;ZBTB16;MYCN;DMRTA2;HLF;CREB3L2;FOXS1;E2F4;GLIS1;SRF;NPAS2;PAX9;ZBTB2;BCL6;NR2C1;ZKSCAN3;TWIST1;CHD2;SOX2;MXI1;GLI1;OLIG2;WIZ;BHLHE22;NSD1;GLI3;SOX10;TP53;DHX36;ZBTB39;MED8;HOXB9;ZBTB26;RFX2;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TFEB;HOXB4;ST18;HIVEP3;HIC2;DMRTA1;ZNF628;PRDM5;NRIP1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;ARNT2;ELK1;BPTF;ZSCAN18;CREB3L1;ZBTB32;MYNN;HOXC5;TFAP4;DHX9;PBX2;ZBTB25;AR;ATF2;MYC;FOXJ3;KLF11;HOXA9;MAFB;ZKSCAN5;ZBTB7A;ZNF467;ONECUT2;ZFP62;ZIC5;CIART;MAZ;NR1D2;ZBTB12;DNMT3A;SARS1;ZBTB11
prerank,chemokine binding (GO:0019956),0.3626374146236315,1.026925655045875,0.4227129337539432,0.9195446718652577,1.0,4/30,8.42%,ITGAV;ACKR2;CCR9;PLP2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.21886240842001667,-1.0263055322612629,0.38,0.7282789739936067,1.0,55/254,17.72%,NFIB;MECOM;FOXO1;MEF2C;RBPJ;LEF1;ELK3;ERG;FOXC1;ELF1;MEF2A;KLF4;NFKB1;FOXC2;KLF7;RUNX1;MLXIP;ATF6;NFYC;PRDM2;SIX1;ELF4;SOX4;PLAG1;IRF2;SOX17;PLAGL1;SMAD3;PRDM16;IRF1;MYBL1;NR4A1;NR4A2;ETS1;CASZ1;MZF1;ZNF76;RLF;SMAD1;NR3C1;ZIC3;GTF2I;CDC5L;ZNF585A;ZNF585B;ELK4;NFYB;CREB1;NFKB2;CLOCK;ESR1;UBP1;CREB3;HHEX;SOX18
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.43124862952626203,1.0261447027900643,0.4471947194719472,0.917325180648686,1.0,3/15,8.98%,PIK3R1;PIK3R2;CCKBR
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.3221102473309736,-1.024451190377798,0.4175531914893617,0.7284548648992307,1.0,9/27,22.04%,CRCP;POLR2B;POLR2G;PRIMPOL;POLR2C;POLR1H;POLRMT;POLR1C;POLR3K
prerank,bHLH transcription factor binding (GO:0043425),-0.3486355120923356,-1.023722651100259,0.3925925925925926,0.7255255402572595,1.0,8/19,25.64%,LMO2;PSMD9;SMAD3;SIRT1;MAP3K10;BHLHE40;BHLHE41;KDM1A
prerank,GTPase binding (GO:0051020),-0.2326790403693849,-1.0218334027029086,0.38524590163934425,0.7255918750191988,1.0,44/195,14.29%,PLCE1;PICALM;ERC1;DOCK4;FGD5;CAV1;FNBP1L;AFDN;RNF152;RAPGEF6;BECN1;IQGAP1;EXOC4;RIN3;YBX3;NDRG1;UNC13B;RASIP1;EXOC5;SH3BP4;SRGAP2;ARHGDIB;RANGAP1;PPP6R1;RALBP1;RUSC2;EXOC2;SGSM2;RRAGC;OPTN;STK19;RNF41;MYO1C;MAPKAP1;TBC1D7;ALS2;GOLGA4;EVI5L;ENO1;CCDC186;FLNA;YBX1;LSM2;BICD2
prerank,microtubule minus-end binding (GO:0051011),-0.38319315445350194,-1.019596404639376,0.4221698113207547,0.7261481944940162,1.0,5/13,19.65%,CEP290;TUBGCP5;MACF1;CAMSAP2;NUMA1
prerank,nuclear import signal receptor activity (GO:0061608),0.41771202015888703,1.019330181998013,0.4359430604982206,0.9332022897190226,1.0,7/15,22.51%,TNPO1;KPNA1;TNPO2;IPO9;KPNB1;KPNA2;IPO4
prerank,DNA binding (GO:0003677),0.2577612941474694,1.0190645793289084,0.4316109422492401,0.9293364206220677,1.0,152/694,19.87%,RORA;C1D;ISL2;RBMS1;ATF5;ARID3A;PPARA;MEIS1;TEAD1;ETV5;NR2F2;TCF7L2;TCF4;POLG;TAF12;ERCC1;NR1H4;MBD6;ZIC4;MEIS2;TIPIN;PGR;MCM7;POU3F3;PPARD;NR1H2;FAN1;FEN1;POLQ;TBX3;SOX6;ERCC5;GTF2A1;ZNF423;ZBTB16;CHD4;MYCN;MSH3;RTF1;EPAS1;HLF;FOXS1;TLR8;E2F4;NEIL3;MBD3;ACR;POLA1;CSRNP3;HP1BP3;NPAS2;RPA1;LYAR;BCL6;ALX4;HMCES;NR2C1;ERCC4;TERF1;CSRNP2;ZKSCAN3;POLL;WBP11;SPTY2D1;CHD2;SOX2;GLI1;APLP2;XPC;SRRT;BRCA2;RFC3;CR2;SOX10;TP53;MCM4;SMARCA1;DHX36;TOP3A;ZNF292;GTF3C4;RFX2;ESR2;SOX9;CENPC;CDT1;POLG2;SPRTN;HIC2;RAD52;PRDM5;TSG101;MBD4;SREBF1;CUX2;MYRF;LONP1;MCM10;ERCC2;SSBP2;BPTF;ZBTB32;CHD8;TFAP4;DHX9;SAFB2;MLF1;AIFM2;RC3H2;MYC;CRY2;FOXJ3;WDR76;MAFB;ZBTB7A;ZNF3;ZCCHC3;RBM5;NHEJ1;CALR;TRIM26;DNMT3A;TOP2A;SAFB;MCMDC2;SMC1A;MSH6;MBD1;WRN;FBH1;HDGFL2;ILF3;SSBP1;REXO4;KHDRBS1;ATAD5;HIF1A;DEDD2;ZNF711;CARF;RBM6;CREBZF;ARNT;CBFB;GTF3C3;NR2C2;SP1;CNBP;HIVEP2;LRRFIP1;HOXB2;POLE
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.4452933926014758,1.0168231258154266,0.4491682070240296,0.9312931794624074,1.0,4/12,13.82%,GABRA1;GABRG3;GABRG2;GABRB1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.2761229643770631,-1.0139797904547492,0.43272727272727274,0.7353656662225501,1.0,17/53,17.98%,DDO;MICAL2;NOS3;PRODH;CYB5R3;XDH;ETFDH;NQO2;PPOX;MTHFR;NOS1;NOX4;CYB5R1;SDHA;MICAL3;AIFM1;NDOR1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.31330477078938723,1.013760623069638,0.44640434192673,0.9356310869559739,1.0,15/71,11.70%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP1;PTPN22;DUSP22;PALD1;PTPRU;PTPRO;PTPN13;TNS2;PTPRA;UBASH3B
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4396019827067436,1.0132455994515879,0.4265975820379965,0.9326414421090145,1.0,2/13,4.12%,FAN1;FEN1
prerank,potassium ion leak channel activity (GO:0022841),0.42004214260836675,1.0127523905277682,0.4478114478114478,0.9295629669505441,1.0,4/15,15.93%,KCNK2;TMEM175;KCNK1;KCNK13
prerank,nucleoside-diphosphatase activity (GO:0017110),0.44801305603215974,1.0119079814674796,0.47227191413237923,0.9276431425893505,1.0,2/12,4.54%,ENTPD2;ENTPD5
prerank,RNA stem-loop binding (GO:0035613),0.44151079215526756,1.0114509251823451,0.4647887323943662,0.9244409889187856,1.0,5/12,15.33%,EPRS1;FMR1;LARP6;DHX9;RC3H2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3790316443684229,-1.0110440454439473,0.45,0.7335657978525072,1.0,6/16,22.24%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3790316443684229,-1.0110440454439473,0.45,0.7335657978525072,1.0,6/16,22.24%,ATP6V0A4;ATP5F1B;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,calcium activated cation channel activity (GO:0005227),-0.36662810603658574,-1.0104655067800605,0.4225,0.7304727866983894,1.0,2/17,2.46%,ANO6;ANO1
prerank,cell adhesion mediator activity (GO:0098631),0.37838017659088874,1.0094540124673892,0.4539363484087102,0.925493795308931,1.0,8/24,10.71%,DSCAM;CNTN4;DSCAML1;JAM3;PALLD;NEXN;CNTN6;LRRC4C
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3732750356692228,1.009185657725366,0.43585780525502316,0.9218044040645066,1.0,7/25,13.62%,GAB2;FCHSD2;ADAP2;PLEKHA1;COMMD1;MYO1G;DAPP1
prerank,protein phosphatase activator activity (GO:0072542),-0.38933675226636466,-1.0087856391941643,0.4606205250596659,0.7300903560555148,1.0,5/13,18.57%,IGFBP3;CALM1;PHACTR4;PPP2R5D;PPP2R5B
prerank,syntaxin-1 binding (GO:0017075),0.3782524429613298,1.008143695584945,0.4396694214876033,0.920304387741865,1.0,9/22,18.61%,VAMP2;LRRK2;SNPH;SYP;SYNPR;UNC13A;STXBP5;UNC13C;SYT1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.256746869824873,1.0069395759130704,0.4673469387755102,0.9194567513043269,1.0,113/597,18.42%,TBX18;ZBTB20;ISL2;MSC;ATF5;ETV1;PKNOX2;RUNX2;HOXC10;TEAD1;ETV5;TEF;TCF7L2;TCF4;BASP1;ERBB4;THRA;SMAD5;ZIC4;PER3;MEIS2;MCM7;NFATC3;ZNF740;PPARD;TEAD2;REST;TBX3;FOS;SOX6;ZIC1;HOXC9;FOXN2;MYCN;DMRTA2;HLF;CREB3L2;LIN28B;BCOR;E2F4;GLIS1;POLA1;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;PER2;SOX2;GLI1;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;TP53;MCM4;DHX36;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;CENPC;TFEB;HOXB4;DMRTA1;PRDM5;NFIX;CARM1;HOXC4;ZFP1;RFX4;MBD4;SREBF1;CUX2;ARNT2;MCM10;ELK1;TSPYL2;CREB3L1;ZBTB32;TFAP4;DHX9;AR;ATF2;CRY2;ORC2;FOXJ3;KLF11;HOXA9;ZBTB7A;ONECUT2;NONO;HNRNPL;ATMIN;ZIC5;NR1D2;ZBTB12;MBD2;ASH2L;ZNF32;MCMDC2;SUV39H2;KAT7;NFAT5;SKOR2;HEY1;BRD7
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.32468080511029107,-1.005450274363092,0.43958868894601544,0.7334456430216696,1.0,4/25,4.46%,MICAL2;CYP26B1;NOS3;FMO2
prerank,aspartic-type peptidase activity (GO:0070001),-0.42090314749473634,-1.0051578436005064,0.4468599033816425,0.7294918400331653,1.0,1/10,2.50%,DDI2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.44662910372247905,1.0050167774301382,0.46265938069216755,0.9206183047628926,1.0,3/11,7.80%,RPA1;HNRNPA2B1;TERF1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3587112686896456,1.0010015788967943,0.4442793462109955,0.9281396630402045,1.0,11/33,20.81%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;AR;AGO1;LLPH;CDC73;GTF2B
prerank,SH2 domain binding (GO:0042169),0.3492007362153287,0.9995928248326549,0.44642857142857145,0.9276066259160035,1.0,5/31,7.70%,DLC1;PAG1;IRS1;RUFY1;PTK2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.29399633743147485,0.9994212551748878,0.4619289340101523,0.9237585337781071,1.0,21/100,14.84%,ZFYVE28;OGT;GAB2;WDR45B;MYO10;GBF1;MYO1B;FCHSD2;ADAP2;CYTH3;COMMD1;ZFYVE26;ARAP2;GSDMD;MYO1G;PLEKHA5;ARFIP1;DAPP1;CLVS1;SNX12;FERMT2
prerank,lipoprotein particle receptor binding (GO:0070325),0.3701385263362741,0.9994172437153162,0.47384615384615386,0.9194664663043934,1.0,7/27,18.61%,LRP1;HSPG2;RELN;HSP90B1;CLU;LDLRAP1;SYT1
prerank,poly-pyrimidine tract binding (GO:0008187),0.37836799322842457,0.999358711969073,0.47333333333333333,0.9154149791398623,1.0,3/23,4.99%,RBMS1;RBMS3;FMR1
prerank,5'-3' exonuclease activity (GO:0008409),0.4242106016343121,0.9986297080905533,0.47297297297297297,0.9134132946180827,1.0,5/14,23.44%,FAN1;FEN1;DXO;TRIR;DCP2
prerank,DNA replication origin binding (GO:0003688),0.37746001179316996,0.9983566477969431,0.4566929133858268,0.9098954909423685,1.0,9/23,20.91%,MCM7;POLA1;MCM4;MCM10;DHX9;ORC2;MCMDC2;KAT7;ORC5
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.324774645462239,-0.9980390852034338,0.46089385474860334,0.7420298131638365,1.0,8/24,22.42%,OSBPL8;PLA2G4A;CERT1;GOLPH3L;JPH2;SNX3;PLA2G4E;LANCL2
prerank,amyloid-beta binding (GO:0001540),0.3013538766339151,0.9977404781054783,0.4528043775649795,0.9073518305100535,1.0,12/79,7.19%,LRP1;HSPG2;GRIA3;GRIN2B;GRIA4;GRIA1;NGFR;TLR6;SORL1;ATP1A3;GRIN2A;C1QA
prerank,RNA polymerase core enzyme binding (GO:0043175),0.35384291429779074,0.994351892298289,0.45209580838323354,0.9125435097009817,1.0,16/33,27.62%,NCOA3;ERCC5;SPTY2D1;UVSSA;ELP4;ZNF326;DHX9;AGO1;CDC73;GTF2B;MAF1;RRN3;RPRD2;ELP2;CTR9;WDR43
prerank,RNA polymerase II complex binding (GO:0000993),0.35320739552741964,0.9921922569847612,0.47723935389133626,0.9144253449924183,1.0,10/32,20.81%,NCOA3;ERCC5;UVSSA;ELP4;ZNF326;DHX9;SCAF1;AGO1;CDC73;GTF2B
prerank,double-stranded DNA binding (GO:0003690),0.2536613350410176,0.9920158544315801,0.5232198142414861,0.91083609247183,1.0,91/531,18.37%,TBX18;ZBTB20;ISL2;RBMS1;MSC;ETV1;PKNOX2;RUNX2;HOXC10;TEAD1;ETV5;TEF;TCF4;SMAD5;ZIC4;MEIS2;NFATC3;ZNF740;PPARD;FEN1;TEAD2;TBX3;FOS;ZIC1;ERCC5;HOXC9;FOXN2;MYCN;MSH3;DMRTA2;HLF;LIN28B;E2F4;GLIS1;NEIL3;SRF;NPAS2;PAX9;ZBTB2;BCL6;ALX4;NR2C1;TERF1;OLIG2;BHLHE22;GLI3;ZBTB43;HOXC8;SOX10;MSX1;HOXB9;ZBTB26;RFX2;FOXJ2;SOX9;POLG2;SPRTN;TFEB;HOXB4;DMRTA1;NFIX;HOXC4;ZFP1;RFX4;SREBF1;CUX2;ARNT2;ELK1;CREB3L1;ZBTB32;TFAP4;DHX9;ATF2;FOXJ3;KLF11;HOXA9;ZBTB7A;ONECUT2;ZCCHC3;ZIC5;NR1D2;ZBTB12;SAFB;ZNF32;MSH6;MBD1;NFAT5;FBH1;SKOR2;HDGFL2;HEY1
prerank,carboxy-lyase activity (GO:0016831),0.3739707750213057,0.9903602675928719,0.44462025316455694,0.9110702934148135,1.0,3/23,9.38%,ODC1;UXS1;GGCX
prerank,receptor antagonist activity (GO:0048019),0.3998531656985695,0.9891684880332416,0.4813008130081301,0.9103340726566118,1.0,1/17,0.62%,IL1RN
prerank,syntaxin binding (GO:0019905),0.3103388364671541,0.9890001549516101,0.44755244755244755,0.906772299191714,1.0,24/61,23.47%,VAMP2;LRRK2;NAPB;SNAP23;SNPH;SYT3;SYP;GOLGA2;SNAP29;SYNPR;SCFD1;SYT5;UNC13A;VPS52;STXBP5;TMED9;UNC13C;SYT6;SYT1;NAPG;CACNA1A;ABL1;BLOC1S6;STXBP4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.34621355513969504,0.987855238434011,0.46865671641791046,0.9059379087643908,1.0,3/32,4.87%,SLC1A5;SLC43A1;SLC7A8
prerank,potassium ion antiporter activity (GO:0022821),0.3995613996533013,0.9869607282482612,0.459866220735786,0.9044823412236801,1.0,3/15,6.00%,SLC24A5;SLC9A9;SLC9A1
prerank,ribosome binding (GO:0043022),0.32787563626206395,0.9853280040683347,0.45454545454545453,0.9052086024110869,1.0,18/46,27.73%,CPEB1;NAA10;FMR1;SEC61B;EIF2S1;BAG6;EFL1;EIF3C;YTHDF1;MRPS27;NAA16;GEMIN5;CCDC47;ETF1;SHFL;SEC61A1;IGHMBP2;MAIP1
prerank,solute:sodium symporter activity (GO:0015370),-0.3174649988146465,-0.9838742048921559,0.468586387434555,0.7723824035264533,1.0,22/27,56.38%,SLC4A10;SLC20A1;SLC4A8;SLC4A7;SLC5A6;SLC4A9;SLC4A5;SLC4A4;SLC34A3;SLC5A3;SLC28A2;SLC13A5;SLC28A3;SLC5A10;SLC5A8;SLC17A7;SLC28A1;SLC5A1;SLC34A2;SLC5A2;SLC5A9;SLC17A1
prerank,lysine N-methyltransferase activity (GO:0016278),0.3876787837551277,0.9834117680560954,0.48653198653198654,0.9062232014268922,1.0,7/20,23.36%,EEF1AKMT4;VCPKMT;SETD4;EHMT2;ATPSCKMT;EHMT1;ANTKMT
prerank,tRNA binding (GO:0000049),0.3308537085330245,0.9822920171948412,0.49782293178519593,0.9051961384473506,1.0,20/43,27.23%,NAT10;CTU1;ELP1;PSTK;CARS1;TRNAU1AP;PTCD1;SARS1;SARS2;SEPSECS;MRPS27;TRMT10A;AIMP1;AARS1;TRMT10C;SSB;NSUN6;YARS2;IGHMBP2;ALKBH8
prerank,nuclear receptor coactivator activity (GO:0030374),0.31921101330312157,0.9818974484882895,0.4908062234794908,0.9022040078843339,1.0,11/52,14.22%,NCOA2;MED12;NCOA3;ACTN1;BRD8;NCOA1;PRKCB;ENY2;CARM1;MED1;ELK1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.20042559642649066,-0.9802239735105482,0.5319148936170213,0.7768586269470288,1.0,129/431,23.32%,PRKAG2;DAPK1;RHOBTB1;MARK1;MRAS;KRAS;RRAS2;GBP7;MARK4;ABCD3;NEK6;RASL12;MAP3K5;RAP1A;INSR;DRG1;ABCD4;HSPA8;TOP1;RHOQ;RHOBTB2;SIK3;MINK1;WNK4;RAC1;TLK1;CDK6;SYN1;GBP5;SNRK;PEX1;CDC42;WNK1;PRAG1;ARL6;RAB21;SIK1;PGK1;ADSS2;ACVR1;ABCC6;GBP4;RAB5A;CDC42BPB;RHOC;ACVRL1;GBP2;GCH1;RAB31;TLK2;STK38L;ABCF1;DYRK2;DRG2;RPS6KA5;EEF1A1;RRAGC;RAB13;TAP2;ABCF2;SMARCA5;ARL2;RAB35;REM1;GBP6;RALB;RTEL1;SRPK1;SYN3;TGM2;CLPX;PSMA6;MYH10;GUK1;PMVK;RAN;RAB38;PFKL;RRAS;GNL1;P2RX7;TBCK;RAP2C;STK17B;ABCB8;CDC42BPG;ERN1;ATL3;NOA1;ARL1;TUBB2A;RAB6A;ATP5F1D;AKT1;RAP2B;NUAK2;TSR1;RERG;DYNC1LI1;MARK2;MCM6;MAP4K3;CLP1;RAB4A;RRAGB;MLKL;TRNT1;MKNK1;MFHAS1;ARL4C;TUBA1C;ABCB9;RAB1B;SCG5;RHOH;TWF2;TUBA4A;TUBB2B;AK6;MTG2;MYO18A;LANCL2;NDUFA13;DDX25;CAD;RAB9A;MYH9;RAP1B;PRPS2
prerank,chemorepellent activity (GO:0045499),0.371514572433194,0.979283236229457,0.48484848484848486,0.9052088211104811,1.0,3/25,1.98%,EPHA7;NRG1;SEMA5A
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4094603851741464,0.975377773832922,0.48856209150326796,0.9114647060184294,1.0,6/17,15.02%,AK4;NME6;NOL9;AK8;NME1;AK3
prerank,chloride channel activity (GO:0005254),0.30813313325228675,0.9748230758773679,0.4971671388101983,0.9090279574162531,1.0,14/59,15.70%,ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;CLCN6;GLRA2;GABRB1;GLRB
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.2672411072274198,0.9733003274498953,0.5304449648711944,0.9093645516524775,1.0,44/181,20.70%,PPARA;PTPRT;MIER2;HDAC1;HIF1AN;TCF7L2;CDKN2A;NR1H4;NCOA2;JUP;PPARD;TBX3;FOS;NCOA3;MDFIC;CHD4;BRMS1;FIZ1;PIAS2;NCOA1;TP53;ZFPM2;SNW1;ATN1;NRIP1;MED1;ARNT2;ELK1;DHX9;DMAP1;AR;ATF2;TRIP4;LDB2;LDB1;BBS1;HIF1A;ARNT;SP1;DDRGK1;MTA3;MTA1;RERE;BBS4
prerank,estrogen receptor binding (GO:0030331),0.33608071328655964,0.9707245742760048,0.4733637747336377,0.9123575371715568,1.0,12/32,18.17%,PPID;DNAAF4;NCOA1;NSD1;CNOT1;NRIP1;MED1;PRMT2;DCAF1;MMS19;TRIP4;TAF10
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.38631146988613596,0.969010113110672,0.5050505050505051,0.9127260535804754,1.0,5/17,18.06%,BLVRB;DHCR24;PTGR2;PECR;DPYD
prerank,mannosyltransferase activity (GO:0000030),-0.31997855404922243,-0.9664516125236116,0.4786096256684492,0.8078259244988657,1.0,5/21,10.16%,TMTC2;TMTC1;ALG9;TMTC4;ALG12
prerank,phosphatase activity (GO:0016791),0.29672482415398554,0.9654076873445488,0.5079787234042553,0.918012871194233,1.0,13/73,15.60%,LPIN3;ATP1A2;SACM1L;DUSP12;PTPN22;PLPPR3;PTPRO;PLPPR2;PLPP6;DUSP8;PLPP5;LPIN2;ACP2
prerank,endoribonuclease activity (GO:0004521),-0.29087709377029614,-0.9651262535879588,0.47863247863247865,0.8064420708226686,1.0,10/32,22.60%,KHNYN;SMG6;NYNRIN;DICER1;RNASEL;ENDOV;ERN1;AGO2;LACTB2;YBEY
prerank,nuclear receptor binding (GO:0016922),0.280502372797045,0.9643322093854779,0.5249376558603491,0.9170154909190655,1.0,28/111,17.04%,PPID;TCF7L2;NR1H4;NCOA2;GRIP1;DNAAF4;MED12;JUP;NCOA3;BRD8;NCOA1;PRKCB;DAXX;NSD1;HMGN3;SNW1;CNOT1;NRIP1;MED1;MED25;ASXL1;GTF2H1;PRMT2;DCAF1;MMS19;ZBTB7A;TRIP4;CALR
prerank,ubiquitin binding (GO:0043130),-0.25129407737595777,-0.9640858240376158,0.5059288537549407,0.8043735222437338,1.0,25/73,22.98%,NPLOC4;DDI2;MARK4;SQSTM1;RNF185;ASCC2;TOLLIP;SMAD3;HSPB1;OTUB1;UBE2N;USP25;UCHL1;RAE1;UBE2L6;RAD23B;BUB3;TNFAIP3;FAF2;VPS28;MVB12B;ILRUN;WDR48;ADRM1;VPS36
prerank,growth factor receptor binding (GO:0070851),-0.23680342923174716,-0.9622580986874543,0.5480769230769231,0.8039772754654408,1.0,22/95,18.62%,PDGFD;PTPRJ;FER;IL1R1;ERAP1;VEGFD;VEGFC;IL6ST;PDGFA;FGF1;PDGFC;FRS2;CCDC88A;ITGB3;TRIP6;HIP1;GRB2;ERN1;ESM1;EGF;SDCBP;EFEMP1
prerank,vitamin D receptor binding (GO:0042809),0.4056530516996738,0.9617164128875864,0.513986013986014,0.9202761741945609,1.0,5/14,20.83%,MED12;SNW1;MED1;TAF11;MED14
prerank,histone deacetylase activity (GO:0004407),0.3682329956832356,0.9594873121689529,0.5097087378640777,0.9222017613183606,1.0,3/19,5.74%,MIER2;HDAC1;SIRT6
prerank,phosphoric ester hydrolase activity (GO:0042578),0.31600879902087264,0.9563313722354572,0.5251798561151079,0.9263541913643343,1.0,8/49,7.72%,ATP1A2;SACM1L;DUSP12;PTPN22;PLCXD3;PLCXD1;PTPRO;ENPP6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.38927542653784786,0.9554535405756441,0.5103806228373703,0.924843003824639,1.0,2/15,5.02%,ALDH1A1;ALDH3B1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3071915571102095,-0.9552055244607165,0.5401662049861495,0.8166135346541135,1.0,11/25,28.29%,FER;CCDC88A;HIP1;GRB2;EGF;EFEMP1;LINGO1;CNOT9;FAM83B;ARF4;SNX2
prerank,translation initiation factor activity (GO:0003743),0.3304280177104454,0.9532742627675143,0.5451807228915663,0.9266155731409279,1.0,8/36,18.71%,EIF4G3;EIF3H;EIF2B1;EIF4A2;EIF2S1;EIF5B;EIF3C;EIF3G
prerank,endopeptidase activity (GO:0004175),0.25477466370431034,0.9528173474950594,0.5820224719101124,0.9239391486270546,1.0,51/257,19.87%,ECE1;ECE2;ADAMTS14;MASP1;ADAMTS6;MBTPS2;FAP;MMP24;MMP28;MMP25;PCSK2;HTRA3;USP1;CASP6;ADAM19;CASP4;OMA1;ACR;ADAMTS12;PSMA5;USP42;MMP11;PSMB5;PLAU;LGMN;ADAMTS2;RHBDL3;NRDC;PITRM1;PSMA4;USP33;HTRA2;SPRTN;PSMB9;ADAMTS20;ADAMTS10;USP34;PSMA7;ADAMTS19;USP16;USP13;USP49;PSMA2;USP14;EEF1AKMT4-ECE2;RHBDD1;TASP1;CTSK;USP46;PLAT;PRTN3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3983619447541733,0.9520936773389639,0.5086206896551724,0.9219036554299224,1.0,3/14,6.30%,PTEN;MTMR4;MTMR1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3875835041168065,0.9514836372989194,0.5487603305785124,0.9196855938642889,1.0,3/18,8.98%,PIK3R1;PIK3R2;CCKBR
prerank,transition metal ion binding (GO:0046914),0.2488439209406693,0.9512327958581703,0.6031746031746031,0.9165758138373032,1.0,79/397,18.07%,ENPP1;ECE1;ZEB1;HRG;ADH1A;TIMM10;MYCBP2;PAM;HIF1AN;CBLB;PDXK;GRIN2B;EPRS1;TYR;DUSP12;MYT1;FEN1;LOXL3;LOXL2;SLC30A5;DNAJC24;KMT2A;CHD4;ZFP37;DHX58;SIRT6;GRIN2A;CCS;ACR;TARS1;ENPP3;CALB1;ADCY2;MDM4;TRIM8;DPYS;COMMD1;BIRC2;AGMO;NSD1;SLU7;SEC24B;PITRM1;PGGT1B;TP53;GLRA1;ZFPM2;P2RX4;USP33;ENDOU;PTGR2;HEPH;KDM1B;TRIM2;HDAC10;B4GALT7;PIM1;ATP7A;RABIF;KDM5C;ZBTB32;TMEM163;AOX1;ZKSCAN5;KDM2A;ZNF3;CYP2R1;USP16;DPEP1;SEC24A;CALR;RNPEP;GALNT2;SEC23A;ADAM8;PEX12;SUV39H2;MBD1;WRN
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.328588081137352,0.9505708380469695,0.5107361963190185,0.9145208559924484,1.0,12/34,23.36%,EEF1AKMT4;KMT2E;VCPKMT;DOT1L;N6AMT1;SETD4;EHMT2;ATPSCKMT;MEN1;CAMKMT;EHMT1;ANTKMT
prerank,microtubule binding (GO:0008017),0.255644091111239,0.9497203424496988,0.59375,0.9131108833685082,1.0,54/222,19.15%,CCDC61;REEP2;MDM1;MAP4K4;IRAG2;MTCL1;FMR1;NEFH;LRRK2;CENPE;STARD9;CEP295;SUN2;CLIP3;LRPPRC;SNPH;TERF1;HAUS8;FAM161A;GOLGA2;NAV3;OPA1;CCSAP;CAPN6;KATNA1;NUSAP1;GAS8;RMDN1;DNM1;TUBGCP4;SYBU;POLB;KIF5C;CLIP2;KIF9;EML1;TPGS1;MAP9;CLASP2;STIM1;KIF3C;TUBGCP6;KIFC2;KIF2A;CLASP1;CEP44;CDK5;ALMS1;MAST1;KIF21A;SPEF1;PEX14;KIF13B;SVBP
prerank,muscle alpha-actinin binding (GO:0051371),-0.3534664745531405,-0.9493358706828224,0.5278450363196125,0.8265772796859049,1.0,9/15,37.65%,PDLIM5;PDLIM3;PKD2L1;TTN;SYNPO2;PDLIM2;PDLIM1;NRAP;MYPN
prerank,omega peptidase activity (GO:0008242),0.2805747022496472,0.9472222544569816,0.5260416666666666,0.9156143422418179,1.0,31/89,25.21%,GGT5;STAMBPL1;GGT7;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3281939152386726,-0.9454947852668938,0.5426997245179064,0.8318857087096743,1.0,5/20,20.68%,LPGAT1;AGPAT4;LCLAT1;PNPLA3;AGPAT2
prerank,protein phosphorylated amino acid binding (GO:0045309),0.31563929083010295,0.944704168783952,0.5532544378698225,0.9179716907721666,1.0,16/42,25.27%,PIK3R1;PIK3R2;NEDD4;IRS1;FGR;CRK;LDLRAP1;PIK3R3;SH3BP2;PTPN11;BCAR3;NCK2;ABL1;VAV2;YWHAE;CRKL
prerank,histone deacetylase binding (GO:0042826),0.28011340428397596,0.944296264904809,0.5725490196078431,0.915349285312345,1.0,24/88,21.00%,MIER2;HDAC1;TOP2B;CHD4;BCOR;GMNN;BRMS1L;BRMS1;PHF6;KAT2A;GLI3;NUDT21;TP53;DHX36;ZMYND15;HDAC10;TFAP4;TOP2A;THAP7;NACC1;SP1;MTA3;MTA1;MEF2B
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.31377441033877984,-0.9432329481312449,0.554016620498615,0.832706676845304,1.0,5/22,13.08%,PICALM;MESD;APOE;AP2A1;SNX17
prerank,protein tyrosine kinase activator activity (GO:0030296),0.37520789863190107,0.9387651985790396,0.5317073170731708,0.9257277338306679,1.0,4/19,11.42%,NRG1;DGKQ;GRM5;NRG3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3633688494961689,-0.9373597878491607,0.5495495495495496,0.8424107702877413,1.0,5/12,26.30%,AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,amino acid transmembrane transporter activity (GO:0015171),0.3074926717831924,0.9372652792811021,0.5574229691876751,0.9258930487466478,1.0,6/47,7.31%,SLC1A5;SLC6A13;SLC7A11;SLC43A1;SLC7A8;SLC66A1
prerank,phosphotyrosine residue binding (GO:0001784),0.3222786533593982,0.9368891175024218,0.5310136157337367,0.9232666660660268,1.0,11/37,20.63%,PIK3R1;PIK3R2;IRS1;FGR;CRK;LDLRAP1;PIK3R3;SH3BP2;PTPN11;BCAR3;NCK2
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23305591094225261,-0.9364604293033332,0.6059322033898306,0.8397353458849799,1.0,26/85,24.52%,PLA2G4A;MGLL;PON3;NDST3;GDPD3;PAFAH2;LIPA;LIPE;ENPP2;ABHD2;PLA2G6;TARS2;PAFAH1B2;PTRH2;PLAAT3;DDHD2;ESD;PLA2G4E;PNPLA3;PLA2G4C;MRPL58;LYPLA1;FAAH;GDPD1;AOAH;PGLS
prerank,channel activity (GO:0015267),0.3123462821802123,0.9350586027730765,0.5619596541786743,0.9245843492757313,1.0,3/41,6.19%,TRPA1;SLC14A1;TRPV3
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.34431385936631925,0.934351343403047,0.5329052969502408,0.9228390659429027,1.0,6/28,17.67%,EDA;TRAF4;TRIM37;RIPK1;FEM1B;MYD88
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.3682596885043816,-0.934025593518805,0.5327102803738317,0.8407042319496322,1.0,5/12,15.23%,PIK3C2B;PIK3CB;PIK3CD;ATM;PIK3R6
prerank,galactosyltransferase activity (GO:0008378),0.4097595890028669,0.933608564587841,0.5464098073555166,0.9212561441693524,1.0,5/11,13.63%,B4GALT2;A3GALT2;B4GALT3;B4GALT4;B4GALT7
prerank,ATPase binding (GO:0051117),-0.2399152419412992,-0.9317977490125446,0.5943775100401606,0.841559272209115,1.0,24/71,23.66%,CAV1;EGFR;EZR;PTPN3;ATP6V0A4;RDX;SNTA1;ATP1B3;TMTC4;ANK2;RALB;PEX26;USP25;ESR1;CHMP4A;NUFIP1;ATP6V0A2;CLPP;SELENOS;TOR1AIP1;ATP6V0A1;ATP6V1G1;PLN;DNAJB1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.19746227640886643,-0.9315187219680323,0.7346938775510204,0.8374964233138712,1.0,67/248,19.47%,RHOBTB1;MRAS;KRAS;RRAS2;GNAS;GBP7;MYL6;RASL12;RAP1A;DRG1;RAB23;RHOQ;RHOBTB2;RAC1;GBP5;CDC42;ATP2B1;RAB21;ARHGDIB;ABCA3;VCP;GBP4;RAB5A;RHOC;RAB5C;DNM3;GBP2;GCH1;GPN1;RAB31;DRG2;EEF1A1;RRAGC;ARL2;RAB35;NKIRAS1;MYO1E;GBP6;RALB;CLPX;RAN;RAB38;RRAS;GNL1;SMCHD1;TOR1A;RAP2C;GNAZ;ATL3;GPN3;CHD3;GNA14;ARL1;RAB1A;RAB6A;DYNC1I1;GTPBP1;KIF1C;RAP2B;ABCB10;GNG11;TSR1;RERG;GSPT2;RAB4A;RAB8B;RRAGB
prerank,ion channel inhibitor activity (GO:0008200),-0.2755483573261191,-0.9314843172935371,0.5676567656765676,0.8328631615421035,1.0,7/35,9.42%,CAMK2D;WNK4;WNK1;STX1A;CALM1;MCUB;STX7
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4138357034004603,0.9307096651677231,0.5634057971014492,0.9249022675250965,1.0,5/11,22.77%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.29885791443887544,0.9304653169084901,0.5568181818181818,0.9218830704235272,1.0,8/55,12.51%,SLC24A5;ITPR1;RYR2;ATP2A2;TRPV3;TRPC3;TRPM2;CUL5
prerank,phospholipase activity (GO:0004620),0.28591793442968594,0.9265653738578471,0.5770804911323328,0.9280893303652785,1.0,10/67,12.04%,PLCL1;GPLD1;PRDX6;LIPC;LIPH;SMPD4;PNPLA7;ABHD16A;LYPLA2;ABHD12
prerank,exopeptidase activity (GO:0008238),0.3011665335443237,0.926557001596071,0.5528571428571428,0.9245861321072653,1.0,7/50,6.96%,DPP6;FAP;DPP10;METAP1D;BLMH;DPEP3;CPM
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2930726671326814,-0.9261441363290955,0.5463917525773195,0.8409563837652245,1.0,3/26,3.07%,AEBP1;CPE;CPD
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.38177206124417506,0.9260853514897577,0.5663265306122449,0.9222487777832609,1.0,1/15,1.30%,PLA2G2C
prerank,double-stranded RNA binding (GO:0003725),0.28441307411916206,0.9257686135435022,0.5702592087312415,0.9195616422847268,1.0,26/70,22.26%,AGO4;ADARB2;FMR1;DHX58;ZNF346;ACTN1;TLR8;DUS2;MRPL44;DHX30;STAU2;EIF2AK2;DHX36;AGO3;DHX9;RC3H2;ADAR;PRKRIP1;AGO1;ILF3;FXR1;LRRFIP1;EIF4A1;DHX15;DHX33;EIF4B
prerank,protease binding (GO:0002020),0.27103001003634564,0.9222439442897515,0.5976863753213367,0.9246612886708394,1.0,22/99,17.51%,SLC2A13;NTRK2;PTEN;ITGAV;POLG;ITGA3;FAP;BFAR;NOL3;COL1A2;PINK1;BRCA2;TP53;PYCARD;ATP9A;STIM1;BAG6;SERPINC1;TRIP4;DVL3;COL3A1;A2M
prerank,histone methyltransferase activity (GO:0042054),-0.2857739552424315,-0.9221419345513167,0.5934718100890207,0.8460969494809651,1.0,6/32,10.66%,SMYD3;KMT5B;NTMT1;PRMT7;SMYD2;PRMT8
prerank,ubiquitin-dependent protein binding (GO:0140036),0.41681837300920754,0.9218570110809952,0.5504424778761062,0.9221766070576344,1.0,5/10,25.27%,FAN1;FAAP20;ANKRD13B;IDE;DNAJC2
prerank,cyclic nucleotide binding (GO:0030551),0.35613695834381554,0.9215956331865242,0.5702479338842975,0.9192967995724611,1.0,5/21,14.27%,RAPGEF4;PDE4B;CNBD2;HCN1;PDE4A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3840554808231097,0.9208354085499703,0.5563380281690141,0.9175636986705293,1.0,4/14,18.56%,KCNIP2;KCNE4;KCNJ8;KCNJ3
prerank,phospholipase A2 activity (GO:0004623),0.3340349983087756,0.9197817921389204,0.5607476635514018,0.9164539859418578,1.0,3/26,8.18%,PLA2G2C;PRDX6;PLA2G7
prerank,anion channel activity (GO:0005253),0.28660278316071597,0.9177682553950652,0.5957446808510638,0.9177073922276147,1.0,13/61,13.84%,VDAC2;ANO4;GABRA1;GABRD;CLCC1;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;LRRC8A
prerank,nucleosomal DNA binding (GO:0031492),0.3458228405550573,0.9166025705424519,0.5521885521885522,0.9168144196487662,1.0,4/21,11.15%,HDAC1;CHD4;MBD3;RCC1
prerank,MHC class I protein binding (GO:0042288),-0.35884551045015234,-0.9154378452336351,0.572463768115942,0.8577980275606355,1.0,3/13,10.49%,ATP5F1B;TAPBP;TAP2
prerank,sterol transfer activity (GO:0120015),0.3731971356239125,0.9143647600466491,0.5627062706270627,0.9188412571876807,1.0,4/17,19.35%,GRAMD1B;MTTP;OSBP;NPC2
prerank,exoribonuclease activity (GO:0004532),0.4025288998141697,0.9140712316975288,0.5658119658119658,0.9161387160373318,1.0,5/12,15.88%,EXOSC9;EXOSC10;CNOT7;EXOSC8;EXOSC5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3434059376571315,-0.9139525268430406,0.5819477434679335,0.8565771452112731,1.0,7/13,23.01%,PIK3C2B;PIK3CB;PIK3CD;PIP4K2C;PIP5K1A;PIP5K1B;PIK3C2A
prerank,chemokine receptor activity (GO:0004950),0.3423111934254044,0.9123794709174158,0.5739837398373984,0.9165337048017672,1.0,2/24,3.26%,ACKR2;CCR9
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4040919935379623,0.9103071366146707,0.5621621621621622,0.9180505294134143,1.0,4/11,12.28%,CASP6;CASP4;PYCARD;CASP12
prerank,G protein-coupled receptor binding (GO:0001664),0.25760841662649475,0.909154630616476,0.6372315035799523,0.9175691842558389,1.0,15/132,11.54%,XCL1;NPB;RTP4;WNT5A;REEP2;PTCH2;PDYN;TUB;CALCA;NPY;GNA11;WNT3;CCL25;USP33;PSMC5
prerank,calcium-activated potassium channel activity (GO:0015269),0.4086625677619845,0.9083176931341679,0.5693160813308688,0.9162521131030514,1.0,2/11,12.30%,KCNMA1;KCNN2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.2820195729332737,-0.9065155844229905,0.6118598382749326,0.8694718858587587,1.0,5/29,9.86%,PTPRJ;ACE;MAPK14;GCH1;PPM1D
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.28486386342830455,-0.9062696742700868,0.6102150537634409,0.8653308967245,1.0,9/27,22.04%,CRCP;POLR2B;TERT;POLR2G;POLR2C;POLR1H;POLRMT;POLR1C;POLR3K
prerank,transferrin receptor binding (GO:1990459),0.41030853886101104,0.9061751207390739,0.5591985428051002,0.917853840577869,1.0,2/10,12.94%,RGMA;CD81
prerank,organic anion transmembrane transporter activity (GO:0008514),0.254437926088111,0.9049811780878789,0.6206060606060606,0.9171889927173493,1.0,9/134,4.87%,SLC1A3;SLC1A5;SLC6A13;SLC6A8;SLC16A12;SLC25A21;SLC35B3;GJA1;SLC7A8
prerank,metalloexopeptidase activity (GO:0008235),-0.24898535892521262,-0.9045230677298888,0.6319218241042345,0.8648257185692062,1.0,6/51,5.43%,AEBP1;CPE;CPD;XPNPEP3;ERAP1;ACE
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.38193512799033097,-0.9039315203096034,0.579064587973274,0.8615441389341907,1.0,1/10,0.82%,CACNA1C
prerank,acetylcholine receptor activity (GO:0015464),0.3447879878268904,0.9031728301122525,0.5537720706260032,0.9181996281681409,1.0,1/22,2.20%,CHRNB4
prerank,cation channel activity (GO:0005261),0.2632483911412986,0.9027870654378635,0.6121673003802282,0.9158939539067394,1.0,14/94,12.51%,TRPA1;SLC24A5;CACNA1E;NALCN;RYR2;TRPV3;KCNG1;TRPC3;TMEM38B;TMEM175;HCN1;TRPM2;KCNK1;CUL5
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3645598727403535,-0.9014738775573772,0.6009070294784581,0.8628295454626633,1.0,3/12,8.82%,PARN;PAN3;CNOT8
prerank,adenyl ribonucleotide binding (GO:0032559),0.23621390270501066,0.9008264124037282,0.7116022099447514,0.9170621265787477,1.0,52/291,14.93%,ENPP1;RAPGEF4;ATP1A2;PEAK1;ABCD2;EIF4A3;PDE4B;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;CNBD2;MTHFD1L;CARS1;TARS1;RHOBTB3;MYO6;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;HCN1;GCK;NOL9;PRPS1L1;PRPS1;PTPA;DHX36;P2RX4;HSPA13;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;MAP4K1;LONP1;PIM1;ATP7A;NME1;WNK2;PDE4A;HSPA5;SYN2;HSPA4;CHD8;DHX9
prerank,MAP-kinase scaffold activity (GO:0005078),0.3998315437291241,0.8996440593409737,0.5598591549295775,0.91630759666735,1.0,1/11,0.33%,SH3RF1
prerank,methyl-CpG binding (GO:0008327),0.3350517744481428,0.8993674095252128,0.5737704918032787,0.913708106507826,1.0,6/22,19.18%,MBD3;ZCWPW1;ERH;MBD2;MBD1;CHTOP
prerank,motor activity (GO:0003774),0.28625260495281385,0.8991498516545575,0.6143057503506312,0.9109279219128736,1.0,20/60,23.59%,GPR88;CENPE;STARD9;MYO6;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;SMC3;KIF3A;KIF7;KIF11;KIF1B;KIF15;KIF14;KIF23
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.2615097035907829,-0.8991150258429632,0.643646408839779,0.8634500273591791,1.0,11/38,23.10%,APP;SERPIND1;SERPINE1;SERPINI1;SERPINA2;SERPINE2;FURIN;SPINT2;AGT;SERPINB8;TFPI
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.397753580392258,0.8982900298362009,0.5948275862068966,0.9095946774374573,1.0,3/11,11.67%,ITPR1;TRPC3;TRPC7
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2480150228182309,0.8982522959018635,0.6793981481481481,0.9065133508469897,1.0,33/188,16.89%,TBX18;ZBTB20;ATF5;ETV5;TCF7L2;BASP1;ERBB4;THRA;PER3;REST;FOS;SOX6;CREB3L2;BCOR;PER2;SOX2;GLI1;SOX10;TP53;DHX36;TFEB;PRDM5;CARM1;ELK1;CREB3L1;TFAP4;DHX9;AR;CRY2;KLF11;NONO;HNRNPL;ATMIN
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.39983645550261276,0.8981991651079043,0.578397212543554,0.9035067200491033,1.0,4/11,15.19%,PRMT3;NDUFAF7;CARM1;PRMT2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.26651932821620505,-0.8950177454235888,0.6371428571428571,0.8683281857038785,1.0,7/34,12.85%,RICTOR;IQGAP1;CALM1;CAB39;MAP2K2;ALS2;ETAA1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3959472740864033,0.8945492948561979,0.5873873873873874,0.9087615927694563,1.0,5/12,21.60%,CDK8;CDK13;CCNK;MAPK1;CDK7
prerank,cholesterol transfer activity (GO:0120020),0.3691585937260347,0.8931054991848086,0.5752066115702479,0.9086434169359735,1.0,1/16,1.24%,GRAMD1B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.28404323373689794,0.8924786840592028,0.6305555555555555,0.9067696726952085,1.0,10/54,13.60%,MIER2;HDAC1;NIT1;SIRT6;ASPA;ACR;ACY1;AGA;PIGL;HDAC10
prerank,E-box binding (GO:0070888),0.31556559771463777,0.8875561607535626,0.601823708206687,0.9145753093687828,1.0,6/34,16.99%,ZEB1;TCF4;TWIST1;TFAP4;MYC;CIART
prerank,ubiquitin protein ligase activity (GO:0061630),-0.18733407530135066,-0.8857200630952267,0.8349514563106796,0.8849334118240113,1.0,41/228,13.77%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;SMURF2;UBR1;RC3H1;RNF125;RNF11;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.38661801960895403,0.8845991122857682,0.5906735751295337,0.9178061011124753,1.0,3/11,18.56%,KCNE4;KCNJ8;KCNJ3
prerank,metalloaminopeptidase activity (GO:0070006),-0.3268702137324633,-0.8814763110954908,0.6309226932668329,0.8896981783875599,1.0,4/16,20.36%,XPNPEP3;ERAP1;MMP15;TRHDE
prerank,myosin II binding (GO:0045159),-0.3735920092203685,-0.880656583359368,0.6034063260340633,0.8867833036134759,1.0,4/10,16.17%,SHROOM4;GSN;SHROOM1;LLGL2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.2726218205334126,-0.8803023383990122,0.6376811594202898,0.882955341800087,1.0,7/32,9.18%,KDM4A;KDM4C;TET3;EGLN3;RIOX2;PHF8;ALKBH5
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.27023705365965006,0.8802248668737525,0.6487935656836461,0.9241031432462242,1.0,9/75,9.56%,ADH1A;RDH10;RDH11;MDH1;H6PD;GRHPR;KCNAB1;PRXL2B;HSD17B8
prerank,WW domain binding (GO:0050699),0.32176352790843415,0.8793101717707386,0.6287878787878788,0.9229678502863012,1.0,4/26,10.46%,TRAF4;WBP11;TCEAL5;NDFIP2
prerank,single-stranded RNA binding (GO:0003727),0.29197889588499376,0.8785836891037955,0.6588579795021962,0.9214117459836213,1.0,14/43,19.77%,AGO4;ADARB2;FMR1;DHX58;TLR8;AGO3;LONP1;DHX9;EXOSC10;SRA1;AGO1;ILF3;FXR1;CNBP
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.29862931052972996,-0.8739849473649496,0.6276346604215457,0.8927329288480801,1.0,10/22,24.52%,SQSTM1;PARP10;OPTN;RNF169;TAB2;TNFAIP3;IKBKE;ZRANB3;IKBKG;ATRIP
prerank,NAD binding (GO:0051287),0.3230866022152936,0.8739149936248958,0.6324921135646687,0.9283029384635876,1.0,5/26,9.56%,ALDH1A1;GRHPR;SIRT6;UXS1;HSD17B8
prerank,iron ion binding (GO:0005506),0.28739815787213985,0.8734015834604448,0.6516220028208745,0.9263331543190597,1.0,11/48,18.49%,HIF1AN;DNAJC24;EGLN2;FXN;AGMO;HEPH;FTO;ALKBH3;AOX1;CYP2R1;ALOX5
prerank,neuropeptide binding (GO:0042923),0.3478024754188541,0.8715827726305736,0.6224137931034482,0.9269954418944781,1.0,2/18,16.07%,SORL1;GPR37
prerank,cardiolipin binding (GO:1901612),0.38990178882436954,0.8712529322272803,0.6120996441281139,0.9246491519443246,1.0,3/10,19.67%,OPA1;GSDMD;GSDME
prerank,sodium:proton antiporter activity (GO:0015385),-0.3647320052994736,-0.871018546466342,0.6433408577878104,0.8943243350126753,1.0,2/11,3.16%,SLC9A2;SLC9B2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3955176961869963,0.8708072966436468,0.6324324324324324,0.9225226974358939,1.0,3/11,17.46%,NEIL3;HMCES;APEX2
prerank,mRNA 5'-UTR binding (GO:0048027),0.33033520761933644,0.8690631403697564,0.6309904153354633,0.923232364365249,1.0,4/24,5.48%,GNL3;FMR1;LARP6;CCT5
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.25741733594237903,0.8668913201007055,0.703989703989704,0.9247364900196777,1.0,22/91,17.76%,SVIL;STXBP6;WDR45B;GBF1;MYO1B;GRAMD2A;SLC9A1;ADAP2;COMMD1;SYT7;GSDMD;EXOC1;MYO1G;PLEKHA5;SDCBP2;CLVS1;AMER2;TIRAP;LDLRAP1;FCHO2;SYTL2;WIPI2
prerank,deubiquitinase activity (GO:0101005),0.25704567238572484,0.8646739319397972,0.6910039113428944,0.9263287356200456,1.0,32/88,25.21%,STAMBPL1;EIF3H;USP1;UCHL3;USP42;MINDY4;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;MINDY2;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,I-SMAD binding (GO:0070411),-0.33026643747317985,-0.8636748083648155,0.6272727272727273,0.905557419888155,1.0,7/13,26.15%,SMAD6;SMAD3;SMAD1;TGFB1I1;SMAD7;SMURF1;SMAD4
prerank,MAP kinase kinase activity (GO:0004708),-0.32882039396297136,-0.8633799851535924,0.6547619047619048,0.9016848614724184,1.0,5/15,15.14%,MAP2K4;MAPK14;MAP2K7;MAP2K2;MAP2K5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.258835491575194,0.8630716580203851,0.7004048582995951,0.926511790213937,1.0,21/78,19.75%,CAPN5;USP1;CASP6;CASP4;CAPN3;USP42;LGMN;CAPN6;PYCARD;USP33;CASP12;USP34;CAPN15;USP16;USP13;USP49;CAPN10;USP14;CAPN2;CTSK;USP46
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.36763231905355587,0.8627575769491898,0.6719022687609075,0.9240433632513354,1.0,2/14,4.16%,RSAD1;SDHB
prerank,histone acetyltransferase activity (GO:0004402),0.3099942520117301,0.8624440384834019,0.6593059936908517,0.9217599827436957,1.0,12/30,24.32%,NCOA3;BRCA2;KAT2A;NAA50;EPC1;ATF2;KAT7;TAF10;MCM3AP;CREBBP;SRCAP;USP22
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.2904056706798078,0.8620651151679546,0.6495726495726496,0.9194539434589006,1.0,12/42,22.78%,CDKN2A;CCNJ;CDKN2D;CCNB2;CDKN2C;CCNA2;CCNK;CCNE1;CDK5R1;CCND3;CCNT2;CCNQ
prerank,carboxypeptidase activity (GO:0004180),-0.2562285177037438,-0.8618897005274222,0.7023809523809523,0.9002549530949031,1.0,9/35,19.43%,AEBP1;CPE;CPD;MINDY1;SCPEP1;AGBL1;CTSZ;ACE2;VASH1
prerank,histone acetyltransferase binding (GO:0035035),0.33596109948550684,0.8615212894358562,0.6332819722650231,0.9176665636617793,1.0,9/21,23.88%,EPAS1;GLI3;KANSL1;TP53;ZBTB7A;TRIP4;HIF1A;TRIM68;STAT1
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.18373602102461647,-0.8601066818075235,0.9387755102040817,0.8995402671885349,1.0,41/232,13.77%,WWP1;RNF152;XIAP;MGRN1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;SMURF2;UBR1;RC3H1;RNF125;RNF11;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.34978353801065365,-0.8594781679740829,0.6658823529411765,0.896330795169798,1.0,2/11,9.80%,LEF1;GATA2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.38419335716492303,0.8590891339254314,0.6164874551971327,0.9196909902163954,1.0,4/12,19.65%,SULF1;GNS;ARSK;ARSJ
prerank,protein heterodimerization activity (GO:0046982),0.23384576402011814,0.8578168210404925,0.7668997668997669,0.9193881570804838,1.0,40/178,19.24%,BHLHA9;TENM3;ATP1A2;TCF4;ITGA3;PIK3R2;TOP2B;TENM4;GTF2A1;FMR1;TLR6;EPAS1;ADCY8;TENM2;QTRT2;TENM1;TLR4;CYBA;IRAK1;SAE1;TP53;KATNA1;RCC1;BCL2L2;IL12A;SDCBP2;ARNT2;BAK1;HEXA;ZHX3;MTTP;GABBR2;RRAGA;ADRA2A;TOP2A;SMC1A;RRAGD;HIF1A;ARNT;FXR1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.30585419300900774,0.8577121010334411,0.6597774244833068,0.9166356122201028,1.0,5/29,15.03%,SLC1A5;SLC25A21;SLC25A22;SLC25A30;SLC25A14
prerank,ATP binding (GO:0005524),0.22656324192705013,0.8567640252580804,0.7843575418994413,0.9156168130393896,1.0,79/266,24.36%,ENPP1;ATP1A2;PEAK1;ABCD2;EIF4A3;PDXK;P2RY1;MAP4K4;MYO1B;CDKL5;ATP1A3;PRKCI;MTHFD1L;CARS1;TARS1;RHOBTB3;CDC42BPA;PRKACB;PIF1;PINK1;PFKM;ABCB6;GCK;NOL9;PRPS1L1;PRPS1;PTPA;DHX36;P2RX4;HSPA13;TGFBR1;MTREX;PDK2;ACLY;KCNJ8;MAP4K1;LONP1;PIM1;ATP7A;NME1;WNK2;HSPA5;SYN2;HSPA4;CHD8;DHX9;BRSK2;HARS1;SARS2;MAST1;MSH6;NVL;PEX6;STK26;KSR1;ABCA2;PDK3;PPIP5K1;TRIP13;LATS2;PXK;HSPA9;PI4K2A;BMPR1B;MYO9B;BCKDK;BMPR1A;NLK;ABL1;TDG;BTK;MVK;KIF14;AARS1;DAPK3;UBA2;MAP4K5;PIP4K2B;MTHFS
prerank,antiporter activity (GO:0015297),0.3360397444307888,0.8561669992480877,0.6433333333333333,0.9138730461195216,1.0,8/20,22.00%,ATP1A3;CLCN3;SLC25A30;SLC35E1;SLC25A14;SLC35E3;SLC25A16;SLC35A1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.31890025490224216,-0.8560777053240092,0.6635071090047393,0.8989214491685862,1.0,6/15,30.74%,AGPAT4;LCLAT1;PNPLA3;AGPAT2;AGPAT5;LPCAT2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3895694219638882,0.8557866891394679,0.6092362344582594,0.9117345701876012,1.0,2/11,9.92%,NAA10;NAA50
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.26177732630964917,0.8555516175981285,0.6922043010752689,0.9092507370763772,1.0,14/74,12.14%,PDXK;ADK;IPMK;NADK;COASY;PI4KA;DGKQ;PAPSS2;CHKA;GK;NOL9;FGGY;DGKI;AGK
prerank,protein kinase C binding (GO:0005080),-0.24316790360330784,-0.8547288817442941,0.7589285714285714,0.8972331143707863,1.0,14/43,21.45%,PDLIM5;SQSTM1;CAVIN2;YWHAG;CAVIN3;ADCY6;CCDC88A;HSPB1;TRPV4;HINT1;DACT2;PKP2;ADAM9;TWF2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.34159807709732143,-0.8539787897088305,0.656319290465632,0.8943236895243367,1.0,2/12,3.16%,SLC9A2;SLC9B2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.29530359206784645,0.8504582909085752,0.6682027649769585,0.9161984615432345,1.0,7/35,14.06%,PEAK1;TXK;PTK2;FGR;FYN;MELK;LYN
prerank,acylglycerol lipase activity (GO:0047372),-0.34953315302984583,-0.850093883595001,0.636568848758465,0.8981229599223842,1.0,3/11,9.86%,MGLL;LIPE;ABHD2
prerank,cysteine-type peptidase activity (GO:0008234),0.2560219393579243,0.8442101644575092,0.7170068027210884,0.9252482664838969,1.0,19/73,19.75%,ATG4A;USP1;CASP6;BLMH;CASP4;CAPN3;OTULINL;USP42;LGMN;USP33;USP34;USP21;USP16;USP13;USP49;USP14;CAPN2;CTSK;USP46
prerank,RNA methyltransferase activity (GO:0008173),-0.2922619293770631,-0.8424715227674924,0.705,0.9092857963057365,1.0,8/19,29.30%,TRMT9B;FTSJ1;TRDMT1;TRMT5;MEPCE;MRM2;TRMT12;TGS1
prerank,serine-type peptidase activity (GO:0008236),0.24766680230397978,0.8411086379310736,0.7334235453315291,0.9283549207042804,1.0,9/96,12.25%,MASP1;FAP;PCSK2;HTRA3;ACR;PLAU;RHBDL3;HTRA2;ENDOU
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.30827344972048143,-0.8397420308537189,0.6803874092009685,0.9103139181764242,1.0,4/15,13.12%,PIK3C2B;PIK3CB;PIK3CD;ATM
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.32913056131367957,-0.8379316114791283,0.6928571428571428,0.9095268264675764,1.0,5/13,18.07%,FTSJ1;TRMT5;THUMPD2;TRMT11;TRMT10B
prerank,pseudouridine synthase activity (GO:0009982),-0.3280457262917808,-0.8374963373434184,0.6872246696035242,0.9059423535449124,1.0,7/13,34.72%,PUS10;PUS1;PUS7L;RPUSD1;PUSL1;RPUSD2;RPUSD3
prerank,protein phosphatase regulator activity (GO:0019888),0.27303856785189307,0.8351920640307168,0.7292263610315186,0.9368750061002483,1.0,23/53,27.24%,PTN;BOD1;PPP6R2;PPP2R2A;PPP2R3A;EIF2AK2;PTPA;RCAN3;ANKLE2;PPP6R3;RCAN1;PPP4R2;B3GAT3;PPP2R2D;BOD1L1;PPP2R1B;PPP2R5A;STYXL1;CALM2;IGBP1;PPME1;SAG;PPP2R2B
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.1705631393221372,-0.8340478909424915,1.0,0.9085304882844955,1.0,95/346,24.48%,WWP1;RNF152;XIAP;LMO7;MGRN1;RNF146;KLHL13;UBE2G1;ASB2;RNF43;RNF185;KCMF1;PELI1;WWP2;ARIH1;CDC23;UBE2D3;TRIM24;HLTF;TRIP12;TRIM25;CUL1;CDC42;TRIM5;TRIM11;VPS18;TRIM14;SH3RF2;RNF8;MSL2;UBE2H;MIB1;SMURF2;UBR1;TRIM36;FBXO25;TSPAN17;RC3H1;UBE2A;RNF125;KLHL20;RNF11;ZFP91;RNF144B;RNF41;NEURL2;RNF114;UBR2;RCHY1;HERC2;VPS11;TRIM63;UBE3D;RING1;AMFR;UBE2N;TRAF3;TRIM35;SIAH3;TRIM27;UBE2L6;HECTD3;FBXL14;SIAH2;CUL3;ANAPC11;PPP1R11;CHFR;ANKIB1;RNF141;CDC34;TNFAIP3;MAEA;RNF166;PRPF19;IRF2BPL;RNF5;TNFAIP1;TRAF1;FBXO3;MEX3C;RFFL;FBXO22;BIRC3;MKRN1;FBXW2;FBXO10;RFWD3;SMURF1;RLIM;RNF111;RNF20;TRIM39;RNF2;RNFT2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.25516723828142596,-0.8318376503128315,0.723943661971831,0.9083613664792393,1.0,15/33,26.84%,RNF185;ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;SIAH2;DCUN1D3;ANKIB1;RNF5;RNF19A;FOXL2;PARK7;DCUN1D1
prerank,Hsp70 protein binding (GO:0030544),0.30433970450081177,0.8306347564557951,0.7179878048780488,0.9423692563658718,1.0,8/31,18.22%,PPID;DNAJB12;DNAJC10;GPR37;TSC1;DNAJB14;DNAJC8;SACS
prerank,Notch binding (GO:0005112),-0.2765138707823093,-0.8305050667214876,0.7487046632124352,0.906639758069735,1.0,4/22,11.59%,SNED1;CCN3;DNER;GALNT11
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.2626325814375123,-0.8304023301986515,0.7393939393939394,0.9025690551800617,1.0,11/30,26.60%,XIAP;CST3;PTTG1;RPS6KA1;TNFAIP8;PRDX3;CAST;BIRC3;MT3;CD27;RPS6KA3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.26206467729157434,0.8281716573869544,0.7333333333333333,0.9441972240495753,1.0,8/60,12.08%,CDC14B;PTEN;DUSP1;LRRK2;PPP6C;PPP3CB;PDP1;LRRC39
prerank,cation:chloride symporter activity (GO:0015377),-0.34443925463712616,-0.8266434774889926,0.6824034334763949,0.9051894023124805,1.0,2/10,10.68%,SLC12A7;SLC12A8
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2644953234972934,-0.8232196368591674,0.7426273458445041,0.9074121344033806,1.0,2/26,1.41%,CSGALNACT1;B3GALT1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.32478099092626633,-0.8231423266362881,0.7278761061946902,0.9033104577590786,1.0,2/13,3.16%,SLC9A2;SLC9B2
prerank,phosphate ion binding (GO:0042301),-0.3481011095511676,-0.822400610957941,0.7133182844243793,0.9005775750125603,1.0,5/10,37.21%,ADSS2;PNP;RELA;CHST14;MTHFD2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.32272640002107916,-0.8223369842330117,0.6959619952494062,0.8965402912731024,1.0,5/13,13.96%,EZR;GSK3B;KCNQ1;PRKAR2A;PRKAR2B
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.29759480377378333,-0.8218526405083332,0.7032710280373832,0.893228652238988,1.0,11/16,36.99%,CD38;OARD1;SARM1;MACROD1;NEIL1;ADPRH;NTHL1;SMUG1;RPS3;NEIL2;BST1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3598508922321504,0.8215839675618961,0.6981757877280266,0.9538243113476631,1.0,4/14,14.14%,AK4;NME6;AK8;NME1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.27232039641978395,0.8199408637468428,0.7329462989840348,0.9540069820915191,1.0,16/44,21.55%,KMT2E;KMT2A;CXXC1;SETD5;WDR5;NSD1;SMYD5;DOT1L;N6AMT1;ASH2L;SUV39H2;SETD4;EHMT2;MEN1;KMT2C;RBBP5
prerank,sodium channel regulator activity (GO:0017080),0.28135784317115375,0.819814482197425,0.7292899408284024,0.9513141941938312,1.0,8/37,15.57%,GPLD1;SCN2B;NEDD4;COMMD1;FXYD4;FGF12;FGF14;SGK1
prerank,methyltransferase activity (GO:0008168),0.2716491044085223,0.8188554380226519,0.7303206997084548,0.9502151065505099,1.0,8/46,15.53%,EEF1AKMT4;PRMT3;RRP8;COQ3;GAMT;NDUFAF7;AMT;N6AMT1
prerank,lipid phosphatase activity (GO:0042577),0.34172359283011866,0.8163567259012027,0.702054794520548,0.9519060545099325,1.0,3/14,10.68%,PLPPR3;PLPPR2;PLPP6
prerank,potassium:proton antiporter activity (GO:0015386),0.3696464095842855,0.8159022338644594,0.6985559566787004,0.949815590449824,1.0,2/10,6.00%,SLC9A9;SLC9A1
prerank,3'-5' exonuclease activity (GO:0008408),0.271540980313626,0.8142744836492785,0.7306590257879656,0.9499462939259683,1.0,13/45,21.29%,POLG;PDE12;REV3L;EXOSC9;DIS3L2;EXOSC10;CNOT7;EXOSC5;WRN;REXO4;TRIR;REXO2;PNLDC1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3516136621391832,0.8129627861097264,0.7014134275618374,0.9495053639121703,1.0,5/12,22.77%,SLC35B3;LRRC8A;SLC25A17;SLC19A1;SLC25A24
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.33124170243230344,0.8126881971173576,0.7058823529411765,0.9470838660280454,1.0,5/18,18.57%,ALDH1A1;ALDH3B1;AKR1B1;ALDH9A1;ALDH3A2
prerank,heme binding (GO:0020037),0.25610652667942474,0.8122412923565676,0.7642163661581137,0.9450648384272426,1.0,5/65,4.27%,SLC48A1;HRG;PGRMC2;RSAD1;PTGES2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2368604506124717,-0.8119288910461057,0.7946428571428571,0.9066705624620155,1.0,14/35,26.05%,TRMT9B;FTSJ1;TRDMT1;TARS2;PTRH2;TRMT5;MTFMT;ELAC2;MRPL58;GATC;PUS10;DUS1L;TRMT12;TRPT1
prerank,RNA binding (GO:0003723),0.20259227160796045,0.8115446774257369,0.9839679358717435,0.9434533250317355,1.0,292/1321,20.73%,DCN;C1D;LRP1;RBFOX1;EIF4G3;RBMS1;GNL3;TEP1;TRA2B;NAT10;FNDC3A;EIF4A3;BICC1;NANOS3;AGO4;CDKN2A;ISY1;RPP40;NOVA1;SPOUT1;CTU1;FNDC3B;ARL6IP4;EPRS1;ELP1;HTATSF1;WDR36;MYEF2;AFF2;SPTBN1;POP5;RBM46;EIF3H;BZW1;FSCN1;GTPBP10;YWHAZ;ADARB2;LRRC59;EIF1AX;SPATS2L;LSM14A;SNRNP35;SF3B6;MTCL1;ZMAT3;ZC3H12D;RBMS3;FMR1;DND1;RRP8;LARP6;ADK;PSTK;ZC3H7B;CAPRIN1;IFIT2;RTF1;DHX58;TBL2;RRBP1;NOL3;LIN28B;KHDRBS3;ZNF346;LSM4;ACTN1;TLR8;LRPPRC;TRIM56;CARS1;TAF15;SRF;DUS2;STAU1;KRR1;ZFP36L2;PCBP3;UTP11;LYAR;HNRNPA2B1;MRPL44;SEC63;EIF4A2;SRSF11;MPHOSPH10;TRNAU1AP;RALYL;WBP11;ERH;DDX19B;SNUPN;TENT4B;DHX30;NMD3;CDK13;CHD2;PNO1;MRM3;NOC2L;EDF1;PHF6;ALG13;GPATCH8;CELF4;MRPS31;CFAP65;DDX19A;DDX17;SRRT;MRPS24;RP9;CWC22;STAU2;DDX41;POP7;TENT5A;SRPRA;FAM32A;NUDT21;LUC7L2;NOC3L;DBR1;EIF2AK2;SEC61B;ZC3H8;RBFOX3;DHX36;NUP42;RCAN3;NTPCR;RIMS1;RPL37;NAP1L1;AGO3;TEFM;MKI67;SNW1;EDC3;MTREX;MRPS26;NUSAP1;PRPF38B;CASC3;CSDC2;TNPO1;R3HDM2;DNM1;SRSF10;DNAJC21;EXOSC9;UTP15;NDUFV3;ENDOU;SYF2;HSP90B1;CISD2;RBM20;SSRP1;PPAN;MRPL28;FAM98B;CLNS1A;PPIL4;HDLBP;DDX18;CNOT1;MRPS30;LGALS1;EIF2S1;SYNE1;MRPL10;RBM18;DIMT1;PRR3;MRTO4;TDRD9;DAP3;DDX31;EIF4ENIF1;LONP1;CDC42EP4;NME1;ZNF326;RBM4B;SLBP;PUS7;RRS1;HNRNPUL1;DUS3L;HNRNPD;DHX9;UTP6;RNASEH1;SNRPF;ERAL1;ISG20L2;DDX59;SAFB2;YARS1;ZCCHC9;CSNK1E;EXOSC10;RC3H2;SNRNP70;ADAR;TNRC6B;FYTTD1;PTCD1;HNRNPLL;SRRM2;NOL4;HEATR6;SRSF9;IGF2BP3;ZCCHC3;RBM5;NONO;CHERP;PPP1R8;THOC5;HNRNPL;SRRM3;ZCCHC24;EIF5B;SF3A3;MRPS23;PRKRIP1;MRPL3;MAZ;SUGP2;CALR;MTIF2;SARS1;SARS2;AGO1;SRSF6;RPP21;EIF3C;DMGDH;RPS17;TOP2A;SAFB;HABP4;DXO;SMC1A;RRP1B;SEPSECS;ILF3;LSM14B;SSBP1;MRPS5;REXO4;KHDRBS1;YTHDF1;PPIG;EIF3G;KPNB1;FKBP3;NVL;ZCRB1;RBM6;LLPH;CHTOP;FXR1;BYSL;CANX;RBM28;HSPE1;DHX29;RO60;SUMO2;CNBP;ZC3H14;LRRFIP1;NOL12;ZC3H7A;URB1;NOL10;DDX1;CCDC86;LUC7L3;PRPF8;MRPS27;UTP20;KMT2C;ZNFX1;TRMT10A;FLNB;DDX39B;HEATR1;RPL35
prerank,voltage-gated anion channel activity (GO:0008308),0.3320341160344776,0.8109135573671368,0.695575221238938,0.9417392026109546,1.0,4/15,12.66%,VDAC2;CLCN3;CLCN2;CLCN6
prerank,endonuclease activity (GO:0004519),0.2651902750159352,0.810320946085543,0.7464985994397759,0.9400668437052571,1.0,11/49,19.33%,ANKLE1;FEN1;ERCC5;ZC3H12D;ERCC4;AGO3;ENDOU;MBD4;AGO1;REXO4;NOB1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.2345829669868154,-0.8099285125179867,0.7993527508090615,0.9062369011514657,1.0,13/38,22.42%,PARD3;PLA2G4A;SNX21;SH3PXD2B;ATG2B;HIP1;DENND1A;JPH2;ATG2A;SNX3;PLA2G4E;WDR45;LANCL2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.30679098541193983,0.8072976075740043,0.7184,0.9426610034618309,1.0,6/22,22.62%,DUSP12;DUSP1;DUSP8;DUSP10;DUSP6;DUSP7
prerank,ion gated channel activity (GO:0022839),0.30462014455555897,0.8065040012320323,0.7238689547581904,0.9413238102776557,1.0,2/24,3.06%,KCNT2;ANO4
prerank,ephrin receptor binding (GO:0046875),0.3114664881582668,0.8030031770804562,0.6970684039087948,0.9445615481714906,1.0,10/21,22.80%,CHN1;ANKS1B;FYN;CRK;LYN;EFNA1;PIK3CG;EFNB3;CBL;ABL1
prerank,acetylation-dependent protein binding (GO:0140033),0.31406940200880334,0.8028607053365844,0.7214983713355049,0.9392477624179186,1.0,11/20,26.17%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;BRD9;ZMYND8;BRDT;YEATS4
prerank,lysine-acetylated histone binding (GO:0070577),0.31406940200880334,0.8028607053365844,0.7214983713355049,0.9392477624179186,1.0,11/20,26.17%,PHIP;KMT2A;DPF2;CARM1;BRD7;THAP7;ATAD2B;BRD9;ZMYND8;BRDT;YEATS4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.35594496900337314,0.8024131253408218,0.6883365200764818,0.9372709541997507,1.0,2/10,11.00%,ADARB2;DCTD
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2713199718773245,-0.7996971277791188,0.7885117493472585,0.9196139226257148,1.0,7/22,22.24%,ATP6V0A4;ATP5F1B;ATP2A3;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.30454541781968725,-0.7976484621403945,0.7670588235294118,0.9188908739204453,1.0,4/15,18.80%,COX15;COX5B;COX4I1;COX6B1
prerank,disordered domain specific binding (GO:0097718),0.3011282018534378,0.7972342782576641,0.7338582677165354,0.9434956856012442,1.0,5/23,11.49%,TEAD2;NCOA3;TP53;FYN;BCL2L2
prerank,DNA-binding transcription factor binding (GO:0140297),0.21862006127258565,0.7953064871802169,0.872791519434629,0.9440037540687892,1.0,43/189,20.70%,PPARA;MIER2;HDAC1;TCF7L2;PPARD;YWHAZ;TBX3;FOS;RUNX1T1;CHD4;TLE2;CRTC2;SRF;LYAR;FIZ1;DGKQ;PIAS2;TWIST1;NOC2L;TLE1;TP53;ZFPM2;PSMC5;PRDM5;ATN1;ELK1;DHX9;DMAP1;AR;ATF2;MYC;ZBTB7A;LDB2;LDB1;BBS1;SP1;DDRGK1;CRTC3;MTA3;MTA1;RERE;FHL2;BBS4
prerank,chemoattractant activity (GO:0042056),0.2985836153393745,0.7950458286722047,0.7418300653594772,0.9416950362895814,1.0,2/26,5.33%,CXCL10;CCL15
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3159940210812968,-0.7945774006653736,0.75,0.9199503219126048,1.0,8/12,46.79%,DDI2;BACE2;SPPL3;CTSE;HM13;NAPSA;PSEN1;SPPL2A
prerank,kinesin binding (GO:0019894),-0.25474868165108716,-0.7935269458424408,0.797752808988764,0.9176304958122327,1.0,7/27,15.39%,ACTB;NEK6;MAPK8IP3;SPAG9;TOR1A;MAPK8IP1;CROCC
prerank,kinase inhibitor activity (GO:0019210),-0.2377383163944734,-0.7934636338711012,0.8270893371757925,0.9136420420274544,1.0,13/33,23.69%,YWHAB;NCK1;LRP6;MAPK8IP1;CDKN1A;GSKIP;HEXIM1;NPM1;DNAJC3;DUSP19;RHOH;SOCS3;QARS1
prerank,kinase binding (GO:0019900),0.20351445570385623,0.7912571998236403,0.9272918861959958,0.945278556247939,1.0,55/435,11.89%,PTN;GHR;IL15RA;UTRN;ATF5;RND3;TCF7L2;ERCC6L2;PTPRR;CDKN2A;DLG3;YWHAZ;SPRED1;FBXO5;RAC3;PTPN22;DLG2;MYCN;NEFH;DCTN2;SGO1;TBL2;MTCP1;LLGL1;CADPS;SIKE1;POLA1;TEX14;CEP68;CDKN2D;RHOBTB3;UNC5C;DGKQ;PTK2;LRRC14;SPRED2;GOLGA2;PFKM;PRKACA;JTB;CEP192;SP100;RB1CC1;DAXX;CNKSR2;CACUL1;TNS2;IRAK1;FGR;TP53;TTC28;DLG4;WDCP;FBXW5;DNM1
prerank,myosin binding (GO:0017022),0.25259268393101314,0.7900887301734602,0.7917847025495751,0.9444824644120738,1.0,8/55,12.75%,NPC1L1;LARP6;RAB8A;LLGL1;RAB3C;NKD2;PYCARD;TRIOBP
prerank,pre-mRNA binding (GO:0036002),0.2907710908894672,0.7895880235720342,0.7387820512820513,0.9426576660787904,1.0,8/28,17.43%,TRA2B;RBM24;ZRSR2;CELF4;SLU7;SLBP;HNRNPL;SRSF6
prerank,carbohydrate:cation symporter activity (GO:0005402),0.34293785310734465,0.7883775775988984,0.7068345323741008,0.9419482269676884,1.0,11/11,65.73%,SLC2A9;SLC5A11;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC5A3;SLC23A1;SLC23A2;SLC17A5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.33701828655591376,0.7871734289423254,0.7495462794918331,0.9412814028715518,1.0,5/13,24.18%,BMP7;PYCARD;BMP2;BMP5;BMP4
prerank,delayed rectifier potassium channel activity (GO:0005251),0.27939946457561304,0.7868185088843553,0.776416539050536,0.9391050483193889,1.0,7/32,20.65%,KCNQ3;KCNG1;KCNC2;KCNE4;KCNA6;KCNH1;KCNS3
prerank,peptidase inhibitor activity (GO:0030414),-0.24064406236812053,-0.7846017120735922,0.8283378746594006,0.9236612683896488,1.0,5/33,6.59%,CST3;PSMF1;GPC3;SERPIND1;RENBP
prerank,BMP receptor binding (GO:0070700),0.3370334609364262,0.7815456105267663,0.740608228980322,0.9452284045579553,1.0,5/12,24.18%,BMP7;PYCARD;BMP2;BMP5;BMP4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3204726514216362,-0.7812718967198244,0.7665903890160183,0.9248920871674218,1.0,4/11,24.21%,PPP1R1A;PABIR1;PPP1R11;PPP1R2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3532243258908624,0.7796653296126086,0.7275862068965517,0.9457158799317489,1.0,3/10,14.87%,DSE;GALE;GNE
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23199004092493117,-0.7773824322452635,0.8264705882352941,0.9267051393142066,1.0,7/34,15.97%,UBE2G1;UBE2D3;UBE2F;UBE2H;UBE2A;UBE2N;UBE2L6
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.3088051688270249,-0.7740134858679087,0.7808219178082192,0.9277538459188737,1.0,7/12,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1
prerank,SUMO binding (GO:0032183),-0.2985030430310676,-0.7730867467513485,0.7660550458715596,0.9251365840342279,1.0,5/13,23.64%,CASP8AP2;HERC2;USP25;SERBP1;RNF111
prerank,cation transmembrane transporter activity (GO:0008324),-0.2091174743299717,-0.7709802213831616,0.9090909090909091,0.9241873542056922,1.0,22/48,30.78%,SLC6A6;SLC7A1;SLC3A2;SLC41A1;SLC38A5;SLC7A5;SLC1A1;SFXN1;SLC6A7;SLC36A4;SLC22A2;SLC38A6;SLC38A7;SLC38A2;MMGT1;PKD2L1;MFSD12;SLC39A1;PKD1L3;SLC8B1;SLC7A2;SLC36A2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.23160055932708515,0.7708982353717438,0.8539176626826029,0.9571507489030656,1.0,29/83,25.21%,STAMBPL1;USP1;UCHL3;USP42;USP33;JOSD1;USP19;ATXN3;YOD1;USP34;USP4;USP21;USP16;USP13;STAMBP;PSMD14;USP49;USP14;USP46;USP45;USP48;USP31;UFD1;USP24;USP22;OTUD7A;JOSD2;USP2;USP36
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2779566860015515,-0.7705827067385769,0.7546728971962616,0.9208233055423759,1.0,13/17,55.95%,SLC2A1;SLC2A4;SLC2A2;PPBP;SLC5A3;SLC2A5;SLC2A3;SLC2A6;SLC2A10;SLC5A10;SLC5A1;SLC5A2;SLC5A9
prerank,serine-type endopeptidase activity (GO:0004252),0.2321904192207936,0.7705195075317991,0.8367626886145405,0.9550682681628013,1.0,7/80,12.13%,MASP1;FAP;PCSK2;ACR;PLAU;RHBDL3;HTRA2
prerank,lysophospholipase activity (GO:0004622),-0.2632391322798737,-0.7687891623828544,0.7904040404040404,0.9194666498209789,1.0,5/20,11.58%,PLA2G4A;MGLL;GDPD3;ENPP2;PLA2G6
prerank,MHC protein binding (GO:0042287),-0.2651400914140009,-0.7675287792273331,0.8260869565217391,0.9173526738772116,1.0,5/20,20.39%,ATP5F1B;TAPBP;TAP2;CD74;ABCB9
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.34815950192197265,0.7675269720605173,0.7513513513513513,0.957029610624178,1.0,3/10,12.28%,CASP6;CASP4;CASP12
prerank,ribosomal small subunit binding (GO:0043024),0.308238492018633,0.7642615772370358,0.7773851590106007,0.9593823181488619,1.0,6/17,22.26%,PIM1;NME1;ERAL1;MTIF2;DHX29;EIF4B
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.26599727907413995,0.7641422520939923,0.8057228915662651,0.9568667408431691,1.0,6/31,11.98%,SLC12A6;KCNG1;TMEM38B;TMEM175;HCN1;KCNK1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.29439768403946437,0.7639806537024454,0.7964743589743589,0.9544618491198725,1.0,6/23,17.76%,WDR45B;GBF1;COMMD1;PLEKHA5;CLVS1;WIPI2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.30925888989950023,0.7622784946163926,0.7465753424657534,0.9544723516726192,1.0,2/15,11.17%,P2RY1;P2RX4
prerank,ATP hydrolysis activity (GO:0140603),0.2604150493210301,0.7612943104403831,0.8155619596541787,0.9533211569413792,1.0,9/41,17.34%,ABCD2;VWA8;RHOBTB3;ABCB6;ABCA4;TDRD9;DHX9;CLU;VPS4B
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.3225946789260609,0.7591531591251761,0.7547826086956522,0.9538354074218999,1.0,3/14,9.13%,RECK;SPOCK3;LXN
prerank,neurexin family protein binding (GO:0042043),0.34100135145327826,0.758812825888799,0.7577413479052824,0.9517574960362891,1.0,1/10,2.79%,CEL
prerank,magnesium ion binding (GO:0000287),-0.17266263717056304,-0.7558356744950409,0.9732620320855615,0.9298446913330789,1.0,22/135,15.33%,EYA2;MARK1;NEK6;MAP3K5;GCLC;SIK3;SNRK;NUDT3;AASDHPPT;SIK1;CDC42BPB;MAP2K7;STK38L;DYRK2;RRAGC;RP2;SRPK1;RAN;PGP;CDC42BPG;ENDOV;ERN1
prerank,SH3 domain binding (GO:0017124),0.23843387716258496,0.7525128014182304,0.8741355463347165,0.9583778378159092,1.0,9/62,11.25%,WIPF1;AKAP5;CBLB;ELMO1;PTPN22;RUFY1;CYBA;ADAM12;CABYR
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.2582531338395537,0.7519803518670758,0.8044117647058824,0.9565761900467211,1.0,6/35,10.80%,HDAC1;FOS;GTF2A1;TBPL1;TP53;TAF1B
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3181897725306152,0.7518081574306849,0.7722602739726028,0.9541891138879954,1.0,2/14,7.03%,BLVRB;PYCR1
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.3130064545960968,-0.750735506250631,0.7806603773584906,0.9328790464524476,1.0,3/10,16.91%,ECHDC1;HADHA;AUH
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.25853139844502426,0.749721713485577,0.8197932053175776,0.9548095713863826,1.0,8/37,17.22%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS1;SARS2
prerank,microtubule motor activity (GO:0003777),0.24545306587754548,0.7486937137478157,0.8229461756373938,0.95369245621507,1.0,18/51,23.59%,CENPE;STARD9;KIF5C;KIF9;KIF3C;KIFC2;KIF2A;KIF21A;KIF13B;KIF6;SMC3;KIF3A;KIF7;KIF11;KIF1B;KIF15;KIF14;KIF23
prerank,death receptor binding (GO:0005123),-0.2748123120078461,-0.7483026289818394,0.8254716981132075,0.9325635643011079,1.0,4/15,12.21%,CASP8AP2;NGF;MADD;BID
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.241633910834964,0.7458400096880418,0.8361581920903954,0.955073758174554,1.0,8/46,15.26%,OGT;PIGQ;GCNT2;B3GNT8;PIGP;PIGA;B3GALT5;HEXA
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2383855657170282,-0.7457436955277169,0.8823529411764706,0.9317899803619152,1.0,8/28,17.85%,PRKAA2;MAP2K4;MAPK14;MAP2K7;RPS6KA1;MAP2K2;MAP2K5;AKT1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.33184544805147187,0.7391744156463737,0.7811387900355872,0.9619243087888563,1.0,5/10,20.89%,CXCL10;PKIG;PRKAR1A;PKIB;PRKAR1B
prerank,transaminase activity (GO:0008483),-0.30252744518751473,-0.7373092827638974,0.8472222222222222,0.9385734376959214,1.0,4/11,20.21%,GOT2;OAT;PSAT1;AGXT
prerank,translation elongation factor activity (GO:0003746),-0.2730120830634593,-0.7365163545180825,0.8272506082725061,0.9355188729528381,1.0,5/14,30.99%,EEF1A1;EEFSEC;GTPBP1;GTPBP2;TUFM
prerank,SUMO transferase activity (GO:0019789),-0.2657854854222216,-0.7296030208608146,0.8541176470588235,0.9403177233764732,1.0,1/16,1.93%,HDAC4
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3272969220824135,0.7287994933492715,0.7833935018050542,0.973589245323635,1.0,3/10,15.32%,BRCA2;NAA50;ATF2
prerank,telomerase RNA binding (GO:0070034),0.28426015737261895,0.7262345470321454,0.8051750380517504,0.9744135424131525,1.0,4/22,15.30%,TEP1;TENT4B;DHX36;EXOSC10
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.2798341606737067,-0.7261715536609278,0.828009828009828,0.9405103472811387,1.0,4/13,29.81%,SREBF2;MIF;EBP;DDT
prerank,glutamate receptor binding (GO:0035254),0.29106408447262744,0.7255509108963946,0.8198347107438017,0.9726618196924354,1.0,7/17,21.37%,AKAP5;SYNDIG1;SHISA6;DLG4;CAMK2A;HOMER3;HOMER2
prerank,Hsp90 protein binding (GO:0051879),-0.2178480963703947,-0.72395715665742,0.9241573033707865,0.9391328856659288,1.0,8/33,17.04%,PTGES3;KDR;MAPT;PPEF2;HDAC8;NR3C1;ERN1;UNC45B
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2833323428299321,0.7208050600260648,0.82574568288854,0.9760360245141512,1.0,4/20,16.65%,EIF3H;OTULINL;YOD1;USP21
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.22864651189363658,-0.720661531180127,0.8975741239892183,0.9391193467761035,1.0,9/27,18.71%,ARIH1;TOLLIP;RNF125;RNF144B;UBE3D;SIAH3;SIAH2;DCUN1D3;ANKIB1
prerank,microtubule plus-end binding (GO:0051010),0.2805506219748625,0.7206272737186146,0.8270799347471451,0.9736671989837175,1.0,5/20,15.81%,CLIP3;CLIP2;CLASP2;STIM1;CLASP1
prerank,GABA receptor binding (GO:0050811),0.3162438971120552,0.7203703075370641,0.8157894736842105,0.9714007101383899,1.0,1/11,1.57%,AKAP5
prerank,adenylyltransferase activity (GO:0070566),0.27932149887686475,0.7199922217906645,0.8305921052631579,0.9692306294266705,1.0,4/21,11.83%,NMNAT3;COASY;TENT4B;TENT2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.2586992705031722,0.7182169001571728,0.8533541341653667,0.9689822321323027,1.0,10/29,20.89%,CDKN2A;SPRED1;CDKN2D;SPRED2;CDKN2C;PKIG;PRKAR1A;PKIB;SPRY2;PRKAR1B
prerank,carbohydrate kinase activity (GO:0019200),-0.28637323571415696,-0.7166509621483875,0.8175519630484989,0.9396013076544513,1.0,2/11,7.72%,HK1;HK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.32741013669186403,0.7166107825188448,0.8096118299445472,0.9684350000539922,1.0,3/10,16.77%,DPYSL2;DPYS;DPEP1
prerank,thioesterase binding (GO:0031996),0.32169466424095217,0.7160519350519082,0.7828467153284672,0.9665384735299805,1.0,1/11,1.93%,TRAF4
prerank,lipase activity (GO:0016298),0.24102085141443183,0.715811706838736,0.8693759071117562,0.9642748946188943,1.0,5/43,12.04%,CEL;LIPC;LIPH;ABHD16A;ABHD12
prerank,endopeptidase regulator activity (GO:0061135),-0.20671435064160945,-0.7152928938105626,0.9305555555555556,0.9372965393911982,1.0,12/40,23.10%,CST3;PSMF1;SERPIND1;RENBP;APH1A;APH1B;PSME3;SPINT2;PSME2;CAST;ADRM1;TFPI
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.3151153342630301,0.7150936411015272,0.815929203539823,0.9626061255993785,1.0,4/12,18.93%,TENT4B;TENT5A;TENT2;PAPOLB
prerank,ubiquitin-specific protease binding (GO:1990381),-0.2493283592106777,-0.7127207369776698,0.8837209302325582,0.9362431885466151,1.0,7/19,26.32%,LCOR;VCP;AMFR;SELENOS;RHBDD2;SUMO1;PARK7
prerank,nucleotidyltransferase activity (GO:0016779),0.2857273155907927,0.7112633949053669,0.8425324675324676,0.9647367354157568,1.0,5/19,15.97%,PAPSS2;TENT4B;TENT2;REV1;CRPPA
prerank,RNA polymerase binding (GO:0070063),-0.2441118026075738,-0.703565686134316,0.9129353233830846,0.9416034182482689,1.0,2/18,4.28%,PHRF1;STOM
prerank,ribonuclease activity (GO:0004540),0.22740768230752087,0.7032801717848977,0.9042857142857142,0.9716085998109487,1.0,15/56,19.33%,RPP40;ZC3H12D;AGO3;EXOSC9;ENDOU;DIS3L2;RNASEH1;EXOSC10;CNOT7;EXOSC8;EXOSC5;PPP1R8;AGO1;RNASE12;NOB1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21111585051848294,-0.702368096143139,0.9080118694362018,0.9390105263969056,1.0,8/34,15.85%,PARN;PAN3;ERI1;CNOT8;DIS3L;EXOSC2;ANGEL2;EXOSC3
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.2973740517285952,0.701174290944259,0.8353765323992994,0.9714461810963609,1.0,1/13,1.50%,ALDH1A1
prerank,N-methyltransferase activity (GO:0008170),0.27020971309294217,0.6977969403324389,0.8843648208469055,0.9726906846585682,1.0,5/20,23.62%,HNMT;DIMT1;N6AMT1;METTL15;METTL5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.17952561028111955,-0.6958736153514732,0.9891304347826086,0.9414592780604707,1.0,16/69,20.93%,LPGAT1;KAT6B;ZDHHC21;PLA2G4A;DBT;ESCO1;ZDHHC16;ZDHHC14;SOAT1;PLAAT3;ZDHHC18;PLA2G4E;CERS2;ZDHHC3;PLA2G4C;ELP3
prerank,DNA secondary structure binding (GO:0000217),0.24256364111687162,0.6943233622016739,0.8725637181409296,0.9740358707811171,1.0,10/31,22.80%,KMT2A;ERCC5;NEIL3;XPC;MSH6;WRN;MEN1;LIN54;HMGB1;ABL1
prerank,protein phosphatase 2A binding (GO:0051721),0.26280097491383014,0.6914074837135953,0.8657187993680885,0.9748697480403371,1.0,5/23,12.99%,BOD1;ADCY8;TP53;PTPA;ANKLE2
prerank,protein kinase inhibitor activity (GO:0004860),0.23202867256639023,0.6900047566292306,0.9269005847953217,0.9738134138650838,1.0,4/42,8.14%,SPRY4;SPRED1;DUS2;SPRED2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.24068456999721358,0.6890689176942862,0.8867924528301887,0.9697568493405376,1.0,13/34,26.69%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.24068456999721358,0.6890689176942862,0.8867924528301887,0.9697568493405376,1.0,13/34,26.69%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.2756235606907156,-0.6875204887373162,0.8577878103837472,0.9454876170723636,1.0,3/11,21.37%,AMFR;ANAPC11;PRPF19
prerank,hormone receptor binding (GO:0051427),0.2877352131442817,0.6866304973001071,0.8369565217391305,0.9697889579936252,1.0,1/14,3.37%,JAK1
prerank,mannose binding (GO:0005537),0.3002734911282401,0.6830711534833357,0.8566493955094991,0.9709370158469707,1.0,2/12,9.25%,ACR;MBL2
prerank,P-type ion transporter activity (GO:0015662),-0.2667308811960891,-0.6814677362777983,0.8800959232613909,0.9471476647526829,1.0,3/12,12.89%,ATP2B1;ATP2B2;ATP2A3
prerank,calcium channel inhibitor activity (GO:0019855),0.3054289240885654,0.6764122979406058,0.8581081081081081,0.9751034523028194,1.0,1/11,2.31%,ITPR1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3093374698995315,0.6733004300337739,0.8333333333333334,0.975585490545069,1.0,2/10,9.83%,SETD5;NSD1
prerank,tRNA methyltransferase activity (GO:0008175),0.2770080652820238,0.6695653152004835,0.8672413793103448,0.9765568453613395,1.0,7/16,21.93%,TRMT13;TYW3;TRMT44;THUMPD3;METTL2A;METTL2B;LCMT2
prerank,acetyltransferase activity (GO:0016407),0.2399250244296221,0.6691811116867075,0.8973561430793157,0.9744345352803951,1.0,4/31,10.37%,NAA10;NAT10;NAA50;NAT8L
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.30277844342513277,0.665037446231672,0.8243727598566308,0.9757720718528075,1.0,1/10,4.12%,FEN1
prerank,gap junction channel activity (GO:0005243),0.2510578116207245,0.6601380101532327,0.8765432098765432,0.9777769979997509,1.0,4/22,15.14%,GJA1;GJC3;GJA4;GJA5
prerank,four-way junction DNA binding (GO:0000400),-0.23743458067245787,-0.66001960058429,0.9219858156028369,0.9608045410872292,1.0,8/17,30.56%,RAD51D;RAD51C;HMGB2;XRCC2;GEN1;MSH2;YY1;XRCC3
prerank,diacylglycerol kinase activity (GO:0004143),0.3007905915712618,0.6596873657237994,0.8756660746003553,0.9757639575557863,1.0,3/11,12.14%,DGKQ;DGKI;AGK
prerank,RNA cap binding (GO:0000339),-0.24005898178855659,-0.6591141776481823,0.9183168316831684,0.9577427917146901,1.0,6/16,26.30%,EIF3D;AGO2;DCPS;NCBP2;CYFIP2;NCBP3
prerank,actin monomer binding (GO:0003785),-0.22372263347371413,-0.6586869695707721,0.9416243654822335,0.9543042457744304,1.0,9/22,32.23%,NOS3;COBL;LIMA1;TMSB4X;TWF2;MYL4;PRKCE;PFN2;MRTFA
prerank,CARD domain binding (GO:0050700),0.27654694119203976,0.6578851000608733,0.8894736842105263,0.9749701979759624,1.0,2/14,6.84%,CASP4;CARD19
prerank,O-methyltransferase activity (GO:0008171),0.29907825050336934,0.654977733043585,0.8702702702702703,0.9750341028392435,1.0,1/10,5.60%,COQ3
prerank,wide pore channel activity (GO:0022829),0.24655272694473762,0.6504419317201172,0.9066874027993779,0.9766334356904462,1.0,4/23,15.14%,GJA1;GJC3;GJA4;GJA5
prerank,retinoid X receptor binding (GO:0046965),0.2860498344408399,0.6502371741058195,0.8867256637168142,0.9744021502073401,1.0,3/11,14.16%,NSD1;NRIP1;MED25
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.22196560266339832,0.6386074767235043,0.929745889387145,0.981322286899453,1.0,9/31,20.86%,UBE2QL1;UBE2G2;UBE2Q2;UBE2D1;UBE2E3;UBE2E2;BIRC6;UBE2J1;UBE2K
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.19198853191515336,-0.6361038738371199,0.9452887537993921,0.9663424986287036,1.0,8/33,19.32%,PARN;ERI1;CNOT8;DIS3L;EXOSC2;ANGEL2;EXOSC3;ANGEL1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.2734122347535512,0.6357335297247148,0.8941605839416058,0.9810849825510615,1.0,3/13,12.95%,SLC66A1;SLC7A3;SLC25A29
prerank,aminopeptidase activity (GO:0004177),-0.2066196743162821,-0.6334447189867998,0.943342776203966,0.9642228870464695,1.0,4/26,13.17%,XPNPEP3;ERAP1;CTSH;MMP15
prerank,ATPase regulator activity (GO:0060590),0.21443240075934203,0.6306014096403746,0.9472913616398243,0.9823339668847597,1.0,7/38,16.23%,DNAJC19;DNAJC1;DNAJC24;DNAJC10;DNAJC15;BRSK2;TSC1
prerank,ribosomal large subunit binding (GO:0043023),0.2723835681420465,0.628361265445304,0.8990654205607477,0.9814762896764013,1.0,3/11,21.58%,NMD3;MALSU1;DHX33
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.24106514023417125,0.6273131874625358,0.9224806201550387,0.9798143438067572,1.0,6/24,15.02%,AK4;NME6;IP6K1;AK8;NME1;AK3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.24278832585649918,-0.6228394751074278,0.930952380952381,0.9670344388213404,1.0,5/12,25.59%,NQO2;CBR4;CRYZ;CBR1;NQO1
prerank,ankyrin binding (GO:0030506),-0.21778305440264567,-0.6178552784315541,0.9526184538653366,0.9661370475768786,1.0,2/19,3.96%,CDH1;PLEC
prerank,store-operated calcium channel activity (GO:0015279),0.27712914299891844,0.6161002034190277,0.9124087591240876,0.9846124315634546,1.0,3/10,19.43%,TRPC3;TRPC7;TRPC1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.24568735609058334,0.6149477811626839,0.9405940594059405,0.9829626703276322,1.0,3/18,9.55%,NOL3;PRDX5;BIRC2
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.26161152164421475,0.6130404114734034,0.9226804123711341,0.981896525953884,1.0,5/14,21.42%,MINDY4;ATXN3;YOD1;USP13;MINDY2
prerank,fatty acid synthase activity (GO:0004312),0.2812848193667673,0.6130107733422864,0.8973451327433628,0.9795330577592696,1.0,5/10,26.23%,ELOVL2;ELOVL6;ELOVL1;ELOVL5;OXSM
prerank,cAMP response element binding (GO:0035497),0.28159033220511503,0.6108145382699371,0.9102803738317757,0.9785059621718557,1.0,3/10,15.32%,CREB3L2;CREB3L1;ATF2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.18980661635914223,0.6025500366334511,0.9732394366197183,0.9810193561703653,1.0,15/57,22.58%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;UQCRH;CYBRD1;COX7A2L;NDUFS4;COX5A;NDUFB3;UQCR11;NDUFA10;NDUFS1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.27047115749578715,0.600672581106208,0.9108061749571184,0.9797595710946471,1.0,2/11,12.95%,SLC25A20;SLC25A29
prerank,inward rectifier potassium channel activity (GO:0005242),0.22690965294362964,0.5974940352082506,0.9521531100478469,0.9791808781858832,1.0,7/24,21.24%,KCNK1;KCNN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9
prerank,proton transmembrane transporter activity (GO:0015078),-0.17677809463542324,-0.5945160474726239,0.9827586206896551,0.974226492249275,1.0,12/39,29.15%,CLCN5;COX15;SLC33A1;NNT;COX5B;COX4I1;COX6B1;UQCRQ;SLC11A2;UQCRC1;ATP6V1B2;NDUFA4L2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.19789233160627082,-0.5891617845686536,0.9744245524296675,0.97295353769639,1.0,8/21,41.38%,FGF1;FRS2;FGF2;NPTN;FGF18;KLB;FGF22;FGF20
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.19252071820012367,0.5768197769680089,0.9776119402985075,0.9869698480995875,1.0,9/40,21.03%,RRP8;HNMT;GAMT;METTL9;N6AMT1;DNMT3A;THUMPD3;METTL2A;METTL2B
prerank,telomeric DNA binding (GO:0042162),0.1955661968583805,0.5632693669219833,0.9809523809523809,0.9905848362486038,1.0,4/32,8.12%,RPA1;HNRNPA2B1;TERF1;PIF1
prerank,snRNA binding (GO:0017069),0.18944775656254134,0.5593129534787472,0.9806547619047619,0.9897871064294096,1.0,4/42,8.46%,SNRNP35;LSM4;LSM11;SNRPB2
prerank,palmitoyltransferase activity (GO:0016409),-0.1701734749908988,-0.5480496487704185,0.9865591397849462,0.9835762089805014,1.0,10/28,30.47%,ZDHHC21;ZDHHC16;ZDHHC14;ZDHHC18;ZDHHC3;GLUL;GOLGA7;ZDHHC5;ZDHHC23;ZDHHC12
prerank,neuropeptide receptor binding (GO:0071855),0.22926575019641313,0.534736920582119,0.9742710120068611,0.9955421378419085,1.0,2/14,14.72%,NPY;NMU
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.1791579619756901,0.5037287850952383,0.9967948717948718,1.0,1.0,10/29,26.72%,ENGASE;PGGHG;GUSB;IDUA;NEU3;GANAB;CTBS;GLA;PARG;MGAM
prerank,U6 snRNA binding (GO:0017070),0.20718535048119194,0.49966799652716265,0.9776632302405498,0.9994794188551909,1.0,6/14,28.32%,LSM4;PRPF8;DDX39B;LSM3;TUT1;EIF5A
prerank,glutathione transferase activity (GO:0004364),0.1879626069251396,0.49862509397429927,0.9872,0.9973267844325886,1.0,2/23,8.13%,GSTA3;PTGES
prerank,peptide hormone receptor binding (GO:0051428),-0.2033425328337639,-0.4950393580744373,0.9753363228699552,0.9916406575746167,1.0,3/11,27.69%,PTHLH;GNRH1;CCK
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.22255007218220216,0.48278229950628376,0.9817850637522769,0.9978767505614768,1.0,2/10,16.78%,CYBA;NOX1
prerank,O-acyltransferase activity (GO:0008374),0.17193356565449527,0.4746612560330014,0.9968304278922345,0.9968061082702151,1.0,4/30,14.42%,PRDX6;SOAT2;MBOAT7;GPAT3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.17393351123703674,0.46882439868092274,0.9935275080906149,0.9952889458352653,1.0,6/24,20.03%,ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.1946859249848113,0.45946436756049547,0.9896013864818024,0.9941144804502997,1.0,3/14,17.55%,CYBA;NOX1;KMO
